Facebook Instagram Linkedin Pinterest Twitter Youtube
Home Blog Page 3

Unlocking Hormonal Balance and Personalized Treatment

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Unlocking Hormonal Balance and Personalized Treatment
Unlocking Hormonal Balance and Personalized Treatment

Unlocking Hormonal Balance: A Patient-Centered Guide to Hormone Replacement Therapy

Abstract

Hello, I’m Dr. Alexander Jimenez. This educational post examines the complex signs of hormonal decline in all individuals and delves into the various evidence-based hormone replacement therapy (HRT) methods available today. As a practitioner holding titles including DC, APRN, FNP-BC, and CFMP, I will guide you through the clinical signs of low testosterone and estrogen, including mood changes, sleep disturbances, metabolic shifts, and chronic pain. We will then compare and contrast different treatment modalities such as pellets, injections, creams, and oral/sublingual options, evaluating their efficacy, benefits, and potential drawbacks. Special attention will be given to the physiological mechanisms behind each method, dosing considerations for different patient populations, and the importance of individualized, layered treatment plans. The discussion will cover the crucial roles of progesterone and FSH in symptom management and therapy guidance, concluding with foundational principles of hormone optimization. We will also touch on how integrative chiropractic care complements these hormonal strategies by addressing the body’s structural and neurological integrity, which is often compromised by the systemic effects of hormonal imbalances.

Unlocking Hormonal Balance and Personalized Treatment

The Human Experience of Hormonal Decline

Hello, I’m Dr. Alexander Jimenez. In my years of clinical practice at my sciatica and wellness clinic, I’ve had countless patients describe their emotional and physical state with a single, powerful image—one of a person barely holding on, overwhelmed and frayed at the edges. This picture perfectly encapsulates the mood of someone experiencing the often-disorienting effects of hormonal decline, particularly during andropause (in men) and perimenopause/menopause (in women).

Patients don’t just feel “off”; they describe feeling depressed, anxious, and irritable. They struggle with sleep, find it impossible to focus, and sometimes confess, “I feel like I’m going out of my mind” or “I want to kill everybody, but I don’t have a good reason to.” This isn’t a sign of mental instability; it’s a profound physiological shift that impacts every aspect of their being. Women’s bodies, in particular, are incredibly responsive systems. We tend to feel every subtle shift, which means a cautious, observant approach to therapy is paramount.

Key Symptoms of Hormonal Imbalance

From my clinical observations, I’ve seen how these symptoms manifest in daily life. Here are some of the most common complaints I hear:

  • Sleep Disruption: A hallmark sign is difficulty staying asleep, with many patients reporting they consistently wake up between 2:00 AM and 4:00 AM, a classic indicator of an anxious mind driven by hormonal flux.
  • Energy Crashes: Hitting a wall in the mid-afternoon is common. While one might dismiss it as a typical slump, for those with hormonal deficiencies, it’s a debilitating wave of fatigue that a cup of coffee can’t fix.
  • Loss of ‘Get-Up-and-Go’: Men often tell me, “My get-up-and-go got up and went.” They lose the desire to engage in activities they once loved. This loss of enjoyment, or anhedonia, is a significant red flag.
  • Sexual Health Changes: While low libido is often stereotyped as a female symptom, it’s a primary complaint for men with low testosterone. This is frequently accompanied by erectile dysfunction and, most tellingly, the loss of morning erections, a cornerstone symptom of testosterone insufficiency.
  • Metabolic Resistance: Patients find it nearly impossible to lose weight, despite their best efforts with diet and exercise. They may also experience night sweats, which can be a symptom of both low testosterone and low estrogen.
  • Chronic Pain: Conditions like fibromyalgia and other chronic pain syndromes are frequently linked to hormonal decline. The anti-inflammatory and neuroprotective properties of hormones such as testosterone and estrogen are lost, leading to heightened pain perception.

The Art of Layering: A Foundational Approach to Hormone Therapy

The key to successful hormone therapy is to implement a layered approach. Instead of an aggressive, all-in-one strategy, we introduce treatments sequentially. This allows us to carefully observe the body’s response to each intervention, making precise adjustments as needed. For many women, especially those years past menopause, starting with testosterone alone can be a gentle way to “wake up” the hormone receptors. This approach provides a subtle conversion to estrogen via the aromatase enzyme, priming the system before the direct introduction of estradiol.

After a few months on testosterone, I might then layer in a low dose of estradiol, followed by progesterone. This methodical process ensures we don’t overwhelm an already imbalanced system and provides a clearer path to restoring equilibrium. A structured, algorithmic approach ensures that we are not just treating numbers in a lab report but holistically addressing the patient’s overall well-being.

Essential Tools for Diagnosis and Assessment

A cornerstone of my practice is the use of validated tools and comprehensive lab work to create a data-driven treatment plan from the very first visit.

Symptom Assessment Tools

Before initiating any therapy, we use specific questionnaires to capture the patient’s subjective experience.

  • Menopausal Rating Scale (MRS): A critical tool for assessing the severity of menopausal symptoms before and after therapy. By comparing baseline and follow-up scores, we can objectively measure treatment efficacy in the patient’s own words. It often becomes a powerful conversation starter, revealing hormonal deficiencies that might otherwise go unaddressed.
  • AIMS Scale (Abnormal Involuntary Movement Scale): Other scales, such as AIMS, are used as needed to provide a comprehensive clinical picture.

Interpreting Lab Work: A Guide for Patients and Practitioners

Lab work is indispensable, but it’s crucial to know what to look for and how to interpret it. I always take a comprehensive, integrative approach.

  • Foundational Labs for Women: This includes a hormone panel (Total and Free Testosterone, Estradiol, FSH), a full thyroid panel, general health markers (CBC, CMP), and integrative markers like Vitamin D, Hemoglobin A1c, Fasting Insulin, C-Reactive Protein (CRP), DHEA-Sulfate, and Ferritin.
  • Foundational Labs for Men: The panel is similar, with the addition of the Prostate-Specific Antigen (PSA). I don’t routinely test estrogen in men unless there are specific concerns like gynecomastia, as the body often finds its own equilibrium.

Evidence-Based Hormone Replacement Therapies: A Modern Overview

The goal of integrative medicine is to use the most appropriate tools for the individual. Let’s explore the primary HRT modalities.

Subcutaneous Hormone Pellets: The Steady State Solution

Pellets represent a continuous form of hormone replacement.

  • How They Work: Hormone pellets, made from compressed bioidentical estradiol or testosterone, are inserted into the subcutaneous fatty tissue. They dissolve slowly, releasing a steady, consistent dose of hormones over three to five months.
  • The Patient Experience: Levels rise gradually and then stabilize, avoiding the “roller coaster” of peaks and troughs associated with other methods. This leads to a stable mood and consistent symptom relief.
  • Benefits: Continuous release and convenience. Patients don’t have to remember to apply daily creams or receive weekly shots.
  • Considerations: Once inserted, pellets cannot be easily removed. However, in my extensive experience, I have never had to remove a pellet. Any side effects are typically nuisance-level (like unwanted hair growth) and fade as the pellet dissolves. It is also crucial to understand that not all pellets are created equal; their manufacturing process dramatically affects their release rate and efficacy.

Hormone Injections: The Traditional Approach

Injectable testosterone is common and effective, particularly for men.

  • How They Work: Testosterone cypionate is typically injected intramuscularly (IM), providing a time-release effect.
  • Dosing for Men: A standard starting dose for a 50-year-old male is approximately 200 mg once weekly, though this is highly individualized.
  • Use in Women: I generally do not recommend testosterone injections for women due to the high risk of permanent virilizing side effects from the rapid peak in hormone levels.
  • Transitioning from Creams: When transitioning a male patient from topical gels to injections, I advise them to continue their topical application for about two to three weeks after starting shots. This bridges the gap, ensuring stable testosterone levels while the long-acting injectable form takes full effect.

Topical Creams and Gels: The Absorption Challenge

Creams are an option, but they come with significant challenges.

  • The Problem with Absorption: The primary issue is unpredictable absorption. The hormone must penetrate the skin barrier to reach the bloodstream, and this process is highly variable.
  • Optimizing Absorption: Application to thin, highly vascular skin—such as the scrotum in men or the labia in women—yields the best results.
  • Monitoring Difficulties: Lab testing for patients on creams is notoriously unreliable due to the risk of contamination from residual cream on the skin. For this reason, we typically monitor symptoms rather than labs.

Oral and Sublingual Hormones: Bypassing the Liver

Oral and sublingual routes offer another way to deliver hormones.

  • The First-Pass Effect: When you swallow a hormone like testosterone, it is heavily metabolized by the liver in a process called “first-pass metabolism.” This not only reduces the amount of active hormone but can also create potentially harmful estrogen metabolites (García-Cruz et al., 2012).
  • Sublingual and RDTs: To bypass the liver, rapidly dissolving tablets (RDTs) are placed under the tongue for direct absorption into the bloodstream. We’ve seen excellent results with RDT testosterone in women (typically 4-10 mg), but the required dose for men can be prohibitively expensive.

Navigating Estrogen and Progesterone: The Core of Women’s Health

The Critical Role of Progesterone

Progesterone is the great balancer to estrogen and is essential for mood, sleep, and uterine health.

  • Perimenopause: In their 40s, women experience a steep decline in progesterone while estrogen levels fluctuate wildly. This imbalance drives the anxiety, irritability, and insomnia of perimenopause. Supplementing with exogenous progesterone (typically 100 mg at night) can provide profound relief.
  • Postmenopause: For a postmenopausal woman with a uterus who is on estrogen therapy, progesterone is not optional—it is the standard of care. Estrogen alone can cause the uterine lining to build up, increasing the risk of endometrial cancer.
  • The Correct Form and Dose: The standard of care is 200 mg of oral micronized bioidentical progesterone taken at bedtime. Progesterone cream is not an acceptable substitute, as it does not achieve systemic levels sufficient to protect the endometrium (The NAMS 2022 Hormone Therapy Position Statement Advisory Panel, 2022).

Navigating Estrogen Dosing: From Perimenopause to Menopause

Estrogen management is a delicate dance. A common challenge is determining the right starting dose for a woman whose hormonal status is unclear.

  • For Post-Menopausal Patients: If a patient is clearly in menopause and experiencing significant symptoms, I find that a starting dose of 6 mg of estradiol via pellets is often magical. It provides a stable, basal level of estrogen that effectively alleviates symptoms.
  • For Perimenopausal Patients: Even if their Follicle-Stimulating Hormone (FSH) levels appear “normal”, their fluctuating cycles tell the real story. For these patients, a conservative start with a small amount of estrogen can provide stability.
  • Menstrual Migraines: Many women suffer from debilitating migraines tied to the sharp drop in estrogen just before menstruation. Dr. Gary Donovitz explains this as a “withdrawal headache” (Donovitz, 2018). By providing a steady, basal dose of estrogen with a 6 mg pellet, we can often completely block these migraines.

The Perimenopause Pitfall: A Clinical Lesson

I want to share a story from early in my career. A friend came to me, miserable with hot flashes. Her labs showed a high estrogen level, and assuming she was postmenopausal, I gave her a robust 15 mg estrogen pellet. Two weeks later, she was furious, experiencing extreme breast tenderness and heavy bleeding. The question I failed to ask was: “Are you still having menstrual cycles?” Until a woman has gone 12 consecutive months without a period, she must be treated as perimenopausal. In her case, a very low-dose estradiol pellet would have been appropriate. Treat the patient and their clinical history, not just the labs.

Advanced Concepts in Hormone Optimization

The Role of FSH and Testosterone in Women

  • The Critical Role of FSH: In postmenopausal women, the Follicle-Stimulating Hormone (FSH) is a revealing marker. As estrogen plummets, the brain signals the pituitary to pump out more FSH. Our goal with HRT is to relieve symptoms and, consequently, lower the FSH to a premenopausal level. Over a year or two, my objective is to bring my FSH down to under 20, at which I see the most profound changes in cognition, body composition, and overall well-being.
  • Understanding Testosterone in Women: There is no established “normal” range for testosterone in women, which led to the definition of Female Androgen Insufficiency Syndrome, diagnosed based on symptoms. Leading research by Dr. Rebecca Glaser shows a poor correlation between a woman’s testosterone levels and her symptoms (Glaser & Dimitrakakis, 2013). This is why many women require what might be considered supra-physiologic levels of testosterone to achieve symptom relief. My philosophy is clear: treat the patient, not the lab number.

The SSRI-Hormone Connection

One of the most common clinical scenarios I encounter involves patients prescribed Selective Serotonin Reuptake Inhibitors (SSRIs) for symptoms that are likely hormonal. The top two side effects of SSRIs are often weight gain and low libido—the very issues we are trying to fix. When I determine that a patient’s mood symptoms are rooted in a hormone imbalance, I initiate a protocol to slowly wean them off their SSRI once hormone therapy has begun, as SSRIs can blunt many of the beneficial effects of testosterone. This protocol is strictly for patients placed on SSRIs for what appears to be hormone-related symptoms, not for those under active management by a psychiatrist for major psychiatric conditions.

The Importance of an Integrative Chiropractic Approach

As we address hormonal imbalances systemically, we must not overlook the body’s structural framework. The endocrine system is under the direct control of the nervous system. If there are misalignments in the spine, known as vertebral subluxations, they can create nerve interference, disrupting communication between the brain and the endocrine glands.

From my perspective as a Doctor of Chiropractic (DC), integrative care is paramount.

  • Chiropractic adjustments, spinal decompression, and targeted physical rehabilitation address the biomechanical consequences of hormonal decline, like decreased bone density and muscle atrophy (sarcopenia).
  • By restoring proper spinal alignment and nerve function, we can alleviate pain, improve mobility, and enhance the body’s overall ability to heal.
  • This optimization of the “information superhighway” allows the brain to communicate more effectively with the body, including the adrenal glands, thyroid, and ovaries. Chiropractic care lays the neurological foundation upon which hormone replacement therapy can be most effective.

The Cardinal Rule of Hormone Optimization: Start Low, Go Slow

The most important clinical pearl is the principle of “start low, go slow,” especially for patients who are many years post-menopause. A 72-year-old woman’s hormone receptors have been dormant for over two decades. Blasting them with a high dose of hormones all at once will overstimulate the system, causing nausea, breast tenderness, and other unpleasant side effects. For these patients, we must baby-step them into therapy, starting with a very low dose to gently awaken the receptors, then gradually titrating up. This careful, individualized approach is the heart of safe and effective hormone optimization.

Assessing and Treating Patterns of Adrenal Dysfunction | *MUST WATCH* El Paso, Tx (2022)

References

Donovitz, G. (2018). Clinical protocols and pearls: An educational overview. EvexiPEL Clinical Training.

García-Cruz, E., Piqueras, M., Huguet, J., & Alcaraz, A. (2012). Oral testosterone replacement: A new option for hypogonadal men? Expert Opinion on Pharmacotherapy, 13(12), 1763–1769. https://doi.org/10.1517/14656566.2012.700318

Glaser, R., & Dimitrakakis, C. (2013). Testosterone therapy in women: Myths and misconceptions. Maturitas, 74(3), 230–234. https://doi.org/10.1016/j.maturitas.2013.01.003

The NAMS 2022 Hormone Therapy Position Statement Advisory Panel. (2022). The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 29(7), 767-794. https://doi.org/10.1097/GME.0000000000002028

Integrative Chiropractic and Hormone Physiology Benefits

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Integrative Chiropractic and Hormone Physiology Benefits
Integrative Chiropractic and Hormone Physiology Benefits

Integrative Chiropractic Care, Hormone Physiology, PCOS, PSA Decision-Making, and DHEA: An Evidence-Guided Clinical Journey

Abstract

In this educational post, I walk you through an integrated, first-person exploration of hormone transport and signaling, the role of sex hormone-binding globulin (SHBG) in metabolic health, contemporary polycystic ovary syndrome (PCOS) assessment and treatment, prostate-specific antigen (PSA) clinical decision-making using percent free PSA and velocity, and the clinical utility of dehydroepiandrosterone (DHEA). I weave in my clinical observations as an integrative chiropractor and family nurse practitioner, and show where integrative chiropractic care fits: neuro-musculoskeletal alignment, autonomic balance, and targeted lifestyle interventions that modulate insulin resistance, gut dysbiosis, and neuroendocrine axes. You will see how modern diagnostics, evidence-based protocols, and patient-centered strategies interact to improve outcomes for all individuals across endocrine and metabolic conditions.

Integrative Chiropractic and Hormone Physiology Benefits

Section 1: Understanding SHBG and Why More Is Often Better

As Dr. Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, I start with a critical transport protein: sex hormone-binding globulin (SHBG). Clinically, many wonder: “How do I lower SHBG to increase free testosterone?” The surprising answer, supported by modern literature, is that lower SHBG generally correlates with worse metabolic status. SHBG is synthesized in the liver and binds androgens (with higher affinity for testosterone than estradiol), buffering hormonal flux and delivering hormone to tissues. When a hormone is bound to SHBG, the circulating free fraction decreases, but tissue delivery remains regulated. Upon receptor binding and cellular uptake, hormones exert their genomic and non-genomic effects.

  • Key concept: Low SHBG is an early marker of insulin resistance, metabolic syndrome, and higher cardiovascular risk (Plymate et al., 2022; Ding et al., 2009).
  • Clinical takeaway: We should not reflexively lower SHBG. Instead, correct the drivers—insulin resistance, visceral adiposity, and hepatic inflammation—and optimize total testosterone to appropriately saturate receptors.

Physiological underpinning

Insulin and hepatic lipogenesis downregulate SHBG production, while estrogens and lower insulin favor higher SHBG. Thus, hyperinsulinemia correlates with low SHBG, increased free androgens, and downstream dermatologic or reproductive symptoms. SHBG tracks earlier than A1C in some patients, flagging metabolic stress before glycemic indices fully drift.

Why receptor saturation strategy matters

In patients with high SHBG and symptoms of androgen deficiency, increasing total testosterone can saturate tissue receptors sufficiently that a clinically meaningful level of free testosterone remains. This explains why carefully titrated androgen therapy—or natural supports such as mineral-rich adaptogens like shilajit—may help certain patients feel better by improving bioavailable androgen despite high SHBG. The clinical rationale is to achieve adequate target tissue occupancy without chasing lower SHBG levels, which may increase metabolic risk.

Evidence signals

  • Low SHBG predicts insulin resistance and metabolic dysfunction across cohorts (Ding et al., 2009).
  • SHBG interacts with cardiometabolic risk; improving insulin sensitivity often raises SHBG and improves risk profiles (Plymate et al., 2022).

Section 2: PCOS Reframed: Gut, Insulin Resistance, and Phenotypic Diversity

PCOS is among the most common endocrine disorders in women, yet often missed because it is phenotypically diverse. The classic triad—obesity, acne, hirsutism—is not universal. Many patients present with irregular, painful cycles or fertility challenges without overt hyperandrogenic signs. An elevated LH: FSH ratio (>2:1 in some cases), high free testosterone, and DHEA-S can support the diagnosis, alongside Rotterdam criteria (two of three: oligo/anovulation, hyperandrogenism, polycystic ovarian morphology) (Teede et al., 2018).

  • Phenotypes:
    • Hyperandrogenic with hirsutism and cystic acne.
    • Non-higher weight with irregular cycles and fertility issues.
    • Insulin-resistant phenotype with low SHBG and high free testosterone.
  • Drivers:
    • Hyperinsulinemia lowers SHBG, raises ovarian androgen production, and sensitizes androgen receptors.
    • Gut dysbiosis and intestinal permeability contribute to systemic inflammation, insulin resistance, and disruption of the HPO axis (Borgo et al., 2023).

My clinical observations

At my practices, I routinely see athletes and lean women with severe menstrual pain, irregular cycles, normal total testosterone but high free testosterone, and elevated LH: FSH ratios. A recent patient—tall, fit, in her early 20s—presented with debilitating cramps and irregular cycles. Labs showed high free T, elevated LH-to-FSH ratio, and high DHEA-S, without hirsutism or acne. We focused on gut evaluation with stool testing, addressed insulin resistance, and implemented a comprehensive lifestyle plan rather than reflexively prescribing only receptor blockers.

Physiology-driven treatment rationale

  • Insulin-lowering tends to increase SHBG, reducing free androgen burden and symptom expression.
  • GLP-1 receptor agonists and metformin improve insulin signaling, reduce hepatic steatosis, and raise SHBG (Davies et al., 2015; UKPDS Group, 1998).
  • Spironolactone, as an androgen receptor antagonist, helps hirsutism/acne while the root causes are being corrected; typical dosing for hirsutism is 100 mg/day, with symptom improvement over 6–12 months (Martin et al., 2021).
  • Lifestyle: anti-inflammatory dietary patterns, intermittent fasting, and resistance training improve insulin sensitivity, adipokine balance, and SHBG levels.

Integrative chiropractic care fits

In PCOS patients, I use integrative chiropractic care to modulate autonomic tone and reduce somatic stress:

  • Thoracolumbar and sacral adjustments can influence sympathetic-parasympathetic balance, aiding HPA axis regulation.
  • Soft tissue work around the pelvic girdle improves blood flow and lymphatic drainage, potentially easing dysmenorrhea.
  • Prescribed movement strategies (hip hinge patterns, gluteal activation) improve insulin sensitivity and pelvic stability.

These techniques complement medical therapy by reducing neurogenic stress and enabling lifestyle adherence.

Medication pearls and safety

  • Metformin: Start 500 mg nightly, titrate toward 2,000–2,100 mg/day as tolerated; GI effects often diminish with uptake of the gut’s serotonin/GLP modulation.
  • GLP-1 agents (semaglutide, exenatide): effective for insulin resistance phenotypes; titrate to avoid GI effects and support satiety/sustainable weight changes (Davies et al., 2015).
  • Spironolactone: avoid in pregnancy, monitor potassium and blood pressure; blocks androgen receptors without addressing gut/insulin etiologies—use as adjunct.
  • Hormone therapy: in women with low SHBG and insulin resistance, start low and slow with testosterone due to heightened sensitivity and side-effect risk.

Fertility and long horizons

Restoring cycles and ovulation can take 1–2 years with comprehensive care. I have seen patients conceive naturally after sustained gut repair, insulin reduction, sleep optimization, and balanced thyroid/adrenal support—sometimes unexpectedly—once the axis normalizes. The physiology tracks: improved insulin status raises SHBG, reduces free androgen excess, normalizes LH pulsatility, and supports folliculogenesis.

Section 3: PSA, Percent Free PSA, Velocity, and Smarter Referrals

For men considering testosterone therapy or presenting with urogenital symptoms, PSA interpretation must be nuanced. Total PSA alone is specific but not very sensitive; adding percent free PSA and PSA velocity improves risk stratification (Catalona et al., 1998; Loeb et al., 2012).

  • Percent free PSA: Lower percentages indicate a higher risk of prostate cancer. <10% often suggests a>50% likelihood; 10–20% is intermediate; >20% is low risk (Catalona et al., 1998).
  • PSA velocity: Rapid increase (e.g., >0.75–2.0 ng/mL/year depending on baseline) may indicate aggressive pathology (Loeb et al., 2012).
  • Finasteride lowers total PSA by ~50% but does not alter the percent free PSA—interpretation requires adjustment.

Clinical flow I use

  • If total PSA >4 ng/mL, I order percent free PSA automatically to avoid repeat phlebotomy.
  • If percent free PSA <10%: high suspicion—refer for imaging and urology consult.
  • If 10–20%: treat potential prostatitis if symptomatic and retest after ~3 months.
  • If >20%: low likelihood—monitor and retest.
  • Prefer 3T multiparametric prostate MRI to localize lesions and differentiate prostatitis from neoplasm before invasive biopsy when feasible (Barentsz et al., 2012).

Why this matters before testosterone therapy

Before starting testosterone in men, confirm PSA ❤️ ng/mL and absence of overt BPH or suspicious trends, aligning with prudent clinical practice. Urologists differ; some request a repeat PSA in 6 months. I collaborate closely, leveraging imaging to prevent unnecessary biopsies and to identify chronic prostatitis, a common cause of PSA bumps. We also educate patients that intercourse and mechanical stimulation can transiently elevate total PSA but not percent free PSA.

Integrative chiropractic care fits

  • Lumbo-pelvic adjustments and pelvic floor neuromuscular re-education can reduce pelvic congestion and pain in chronic prostatitis, complementing antibiotics/anti-inflammatories when indicated.
  • Stress management, diaphragmatic breathing, and ribcage mobility work support autonomic balance, potentially reducing prostatic inflammation via neuroimmune modulation.

Section 4: DHEA: Neurosteroid Power, Mood, Libido, and Cognition

DHEA and DHEA-S decline after the 20s and affect mood, libido, cognition, vascular health, and skin integrity. DHEA functions as a neurosteroid, synthesized within the CNS, and interacts with GABAergic/glutamatergic systems, modulating resilience and sexual function (Maninger et al., 2009; Wolf & Kirschbaum, 2015).

Clinical observations

I often see women with “healthy” total and free testosterone who still report low libido, anhedonia, and poor orgasm quality. Their DHEA-S is often in the double digits rather than the robust triple digits. Adding compounded DHEA in low doses (5–10 mg for women; ~20 mg for men) can improve sexual function and mood, likely via CNS receptor effects and peripheral conversion pathways, including DHT modulation in females. We avoid DHEA in PCOS when DHEA-S is already elevated, as more DHEA can aggravate hyperandrogenic symptoms.

Physiology and dosing rationale

  • DHEA supports membrane fluidity, mitochondrial signaling, and neurovascular health.
  • Aim for optimal range rather than population averages; retest 6–8 weeks after initiation.
  • Prefer compounded pharmaceutical-grade DHEA due to supplement variability; if OTC is used, start around 25 mg cautiously and monitor.

Safety pearls

  • Monitor lipid profile, mood, acne/hair changes, and, in men, potential prostate symptoms.
  • Align DHEA use with the broader endocrine plan—thyroid optimization alone can raise DHEA in some patients, so sequence matters.

Integrative chiropractic care fits

  • Vagus-focused care—upper cervical and thoracic mobilization, breath mechanics, and stress-lowering routines—synergizes with DHEA’s neurosteroid role by improving autonomic tone, sleep quality, and adherence to exercise protocols, thereby further enhancing neuroendocrine balance.

Section 5: Lifestyle, Gut, and Clinical Protocols That Change Trajectories

Lifestyle changes are not adjuncts; they are central modulators of endocrine physiology.

  • Nutrition: Anti-inflammatory, fiber-rich diets reduce endotoxemia, improve insulin signaling, and modulate SHBG. Low-glycemic, phytonutrient-dense patterns support gut microbial diversity (Borgo et al., 2023).
  • Fasting windows: Intermittent fasting can lower insulin and improve leptin/ghrelin dynamics, supporting menstrual regularity in some PCOS phenotypes.
  • Movement: Strength training improves insulin sensitivity; hip-dominant compound lifts are especially effective in PCOS and metabolic syndrome.
  • Sleep and stress: Normalizing the HPA axis reduces cortisol-driven insulin resistance; chiropractic care supports mechanoreceptor input to autonomic regulation.
  • Targeted supplements: Where appropriate and evidence-based, consider magnesium, omega-3s, and in select cases botanicals that modulate GLP-1 and gut ecology; dose responsibly and monitor.

Clinical reasoning in protocol design

  • Start by stabilizing the gut and insulin resistance; this raises SHBG and lowers free androgen burden.
  • Add receptor blockers for symptom relief while root causes are addressed.
  • Sequence hormones cautiously in insulin-resistant women—begin low, reassess frequently.
  • In men, scrutinize PSA patterns before testosterone; use percent free PSA and MRI to avoid unnecessary biopsies.
  • Evaluate DHEA in persistent mood/libido complaints even when testosterone appears adequate.

Conclusion: Integrated Care, Better Outcomes

Endocrine care succeeds when it integrates physiology, evidence, and patient realities. By understanding SHBG as a metabolic barometer, reframing PCOS through gut-insulin mechanisms, optimizing PSA decision-making with percent free and velocity, and leveraging DHEA as a neurosteroid, we make better, safer choices. Integrative chiropractic care fits naturally here—aligning the structure, calming the autonomic nervous system, and enabling lifestyle practices that enhance insulin sensitivity and neuroendocrine resilience. This is how we help patients move from symptoms to sustainable health.

"Testosterone Deficiency" in men | El Paso, Tx (2021)

References

Failure to Yield Left Turn Accidents: Legal Insights

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Failure to Yield Left Turn Accidents: Legal Insights
Failure to Yield Left Turn Accidents: Legal Insights

Failure to Yield Left Turn Accidents: T-Bone Crash and How Integrative Care May Help

When a driver turns left, sticks out into active traffic, and is hit on the side by an oncoming vehicle, the most accurate term for the event is usually a “failure to yield left turn” crash. The impact itself is commonly called a “T-bone collision,” “side-impact collision,” or “broadside crash.” In Texas, the core legal issue is usually that the turning driver failed to yield the right-of-way to oncoming traffic before crossing the lane. (Texas Transportation Code § 545.152, 2025; Texas Department of Public Safety [DPS], n.d.).

Failure to Yield Left Turn Accidents: Legal Insights

What is the correct name for this kind of accident?

There is not just one everyday label, but there are several accurate terms that describe this situation well. The best term depends on whether you are talking about the driving error, the crash type, or the traffic citation. Texas law focuses on the duty to yield, while crash descriptions often focus on the side impact. (Texas Transportation Code § 545.152, 2025; Torts Law, n.d.).

The most useful terms are:

  • “Failure to Yield Left Turn” when you are describing the driver’s mistake or likely citation. Texas offense coding even lists “FAILED TO YIELD RIGHT OF WAY–TURN LEFT” as a recognized offense description. (Texas DPS, 2009).
  • “T-bone collision” or “side-impact collision” when you are describing the actual crash pattern, meaning the front of one vehicle struck the side of another and formed a T shape. (Torts Law, n.d.).
  • “Unsafe left turn” when the turn was made before traffic was clear, or when the driver moved into traffic too early. Texas offense descriptions also include “TURNED WHEN UNSAFE.” (Texas DPS, 2009).
  • “Improper lane or location – median” or “turned across dividing section” may apply when the driver was badly positioned in a median opening or crossover. That is closer to a lane-position or roadway-use problem than a crash type. (Texas DPS, 2009).

People may informally say a vehicle was “sticking out” into traffic, but that is more of a descriptive phrase than a formal legal crash category. In real investigations, police, insurers, and attorneys usually focus on the actual violation, such as failure to yield, an unsafe turn, a signal violation, or an improper roadway position. Evidence often includes the police report, witness statements, traffic camera footage, vehicle damage patterns, and roadway marks. (Alpert Schreyer Personal Injury Lawyers, 2026; Texas DPS, 2009).

Why are left-turn crashes so dangerous?

Left turns are risky because the driver must cross the path of oncoming traffic while judging speed, distance, timing, signal changes, and sometimes pedestrians, all at once. A small mistake can quickly become a high-impact intersection crash. Transportation agencies even redesign intersections to reduce the severity of angle and left-turn conflicts because these crash types can be especially harmful. (Daniel Stark Injury Lawyers, 2026; Federal Highway Administration [FHWA], n.d.).

Unprotected left turns are especially dangerous. A driver may think there is enough room, but the gap closes faster than expected. Other times, the turning driver creeps forward, feels rushed, or assumes the oncoming vehicle will slow down. Daniel Stark notes that common errors include misjudging speed and distance, turning too quickly, and “creeping” into the intersection. (Daniel Stark Injury Lawyers, 2026).

Who is usually at fault?

In most of these crashes, the left-turning driver is usually found at fault because the law requires that driver to wait until the path is clear. Texas law says a person turning left must yield to oncoming traffic that is close enough to be an immediate hazard, and the Texas Driver Handbook says even a flashing yellow arrow still requires the driver to yield to oncoming traffic. (Texas Transportation Code § 545.152, 2025; Texas DPS, n.d.).

That said, “usually” does not mean “always.” Fault can be shared if the oncoming driver was also speeding, distracted, or ran a light. Legal sources discussing T-bone crashes consistently note that the driver who violated the right-of-way is often at fault, but comparative fault may apply when both drivers made unsafe choices. (TopDog Law, 2025; Farah & Farah, n.d.; Alpert Schreyer Personal Injury Lawyers, 2026).

Common injuries in a left-turn T-bone crash

A T-bone crash can be serious because the side of a vehicle usually offers less protective space than the front or rear. NHTSA’s side crash testing evaluates injury risk to the head, chest, abdomen, and pelvis in intersection-type crashes, highlighting the importance of side-impact protection in real-world wrecks. (National Highway Traffic Safety Administration [NHTSA], n.d.).

These crashes can also create violent sideways forces on the neck and spine. NHTSA notes that neck, cervical, thoracic, and lumbar injuries are prevalent crash outcomes, and biomechanical research has found that side impacts can produce multiplanar cervical spine injuries. Whiplash is also one of the most common injuries after motor vehicle collisions. (NHTSA, n.d.; Maak et al., 2007; Yadla et al., 2008/2007).

Common symptoms after a failure-to-yield left-turn crash may include:

  • Neck pain, headaches, stiffness, and reduced range of motion. (Cascade Spine & Injury Center, 2024; East Coast Trial Lawyers, 2021).
  • Mid-back or low-back pain, muscle spasm, and joint restriction. (The Neck and Back Clinics, 2025).
  • Tingling, numbness, radiating arm pain, or nerve irritation. (The Neck and Back Clinics, 2025; Maak et al., 2007).
  • Rib, pelvic, abdominal, or chest injuries from the side blow. (NHTSA, n.d.; East Coast Trial Lawyers, 2021).
  • Delayed soreness, dizziness, stress, and problems with daily movement that may not feel severe on day one. (Cascade Spine & Injury Center, 2024; The Neck and Back Clinics, 2024).

How an integrative chiropractic clinic may help after this kind of crash

An integrative chiropractic clinic takes a whole-person, non-invasive approach to recovery. Instead of treating only one painful spot, the clinic may consider joint mechanics, soft-tissue injury, nerve irritation, posture, movement patterns, and how the injury affects daily function. Common treatments after a crash may include spinal adjustments, soft-tissue therapy, decompression in selected cases, massage-based approaches, and corrective rehabilitation exercises. (The Neck and Back Clinics, 2025; Texas Medical Institute, 2026).

This kind of multimodal approach is supported by neck pain and whiplash literature. Clinical guidance has found that manual therapy, self-management advice, and exercise can be effective for neck pain-associated disorders and whiplash-associated disorders, while a 2021 review found exercise therapy may improve pain and disability in whiplash patients. (Bussieres et al., 2016; Chrcanovic et al., 2021; Wong et al., 2016).

After a T-bone crash, treatment often has several goals:

  • Ease acute pain and calm muscle guarding. (The Neck and Back Clinics, 2025).
  • Reduce inflammation and soft-tissue stress. (Texas Medical Institute, 2026; The Neck and Back Clinics, 2025).
  • Restore range of motion and normal loading across the spine. (The Neck and Back Clinics, 2025).
  • Rebuild strength, posture, and coordination so the patient can safely return to work, driving, and daily life. (The Neck and Back Clinics, 2025; Chrcanovic et al., 2021).

Dr. Alexander Jimenez’s clinical perspective

According to information published on Dr. Alexander Jimenez’s website and professional profile, Dr. Jimenez, DC, APRN, FNP-BC, uses a dual-scope model that combines chiropractic care with nurse practitioner-level medical assessment. His published materials describe integrative care that bridges physical medicine, functional medicine, advanced diagnostics, and rehabilitation for complex musculoskeletal injuries, including auto accident trauma. (Jimenez, n.d.; Jimenez, n.d./2025; LinkedIn, n.d.).

That matters in a failure-to-yield left-turn crash because side-impact injuries often involve more than simple soreness. A patient may need a chiropractic evaluation, imaging review, rehabilitation planning, and referral if red-flag findings are present. Dr. Jimenez’s published clinical pages describe spinal adjustments, ergonomic modifications, complementary therapies, imaging-guided evaluation, and post-injury rehabilitation as part of a broader treatment strategy. (Jimenez, n.d.; The Neck and Back Clinics, 2025).

Why early evaluation matters

One challenge after a T-bone crash is that symptoms can be delayed. A person may feel shaken up but not fully understand the neck, back, or soft-tissue damage until hours or days later. Several auto-injury care sources stress that early evaluation can help identify hidden injury, start conservative care sooner, and reduce the chance that a short-term problem turns into a longer-lasting one. (The Neck and Back Clinics, 2024/2025; Cascade Spine & Injury Center, 2024).

In both treatment and injury claims, clinics often try to help the patient reach maximum medical improvement (MMI). In simple terms, MMI means the condition has stabilized, and major additional improvement is no longer expected, even if some ongoing care may still be needed. A strong integrative plan aims to move the patient toward that point as efficiently and safely as possible by reducing pain, improving function, and documenting objective progress. (Patino Law Firm, 2024; Texas Medical Institute, 2026).

Final takeaways

The crash in which a driver makes a dangerous left turn, sticks out into traffic, and gets hit on the side is most accurately described as a “failure to yield left turn” accident that results in a “T-bone” or side-impact collision. The left-turning driver is usually at fault because that driver has the duty to wait until the intersection or crossover is clear, though shared fault is possible if the oncoming driver was also negligent. These crashes can cause whiplash, neck and back injury, nerve symptoms, and major soft-tissue damage. Integrative chiropractic care may help by combining non-invasive pain relief, mobility work, soft-tissue treatment, functional rehabilitation, and coordinated medical assessment. (Texas Transportation Code § 545.152, 2025; TopDog Law, 2025; NHTSA, n.d.; Jimenez, n.d.).

From Injury to Recovery with Chiropractic Care | El Paso, Tx (2023)

References

Alpert Schreyer Personal Injury Lawyers. (2026). Who Is at Fault in a T-Bone Car Accident?

Bussieres, A. E., et al. (2016). The Treatment of Neck Pain-Associated Disorders and Whiplash-Associated Disorders. PubMed.

Cascade Spine & Injury Center. (2024). T-Bone Car Accident Injuries: Common Symptoms, Treatments, and Recovery.

Chrcanovic, B., et al. (2021). Exercise Therapy for Whiplash-Associated Disorders. PubMed.

Daniel Stark Injury Lawyers. (2026). Left Turns Explained: Why So Many Serious Crashes Happen.

Federal Highway Administration. (n.d.). Reduced Left-Turn Conflict Intersections.

Jimenez, A. (n.d.). Board Certified Nurse Practitioner (FNP-BC) Dr. Alex Jimenez DC, APRN, FNP-BC.

Jimenez, A. (n.d.). Chiropractic and Integrative Care for Drivers in El Paso.

Maak, T. G., et al. (2007). Side Impact Causes Multiplanar Cervical Spine Injuries. PubMed.

National Highway Traffic Safety Administration. (n.d.). Biomechanics.

National Highway Traffic Safety Administration. (n.d.). Car Safety Ratings.

Patino Law Firm. (2024). Maximum Medical Improvement in Texas – What It Means for Your Personal Injury Claim.

Texas Department of Public Safety. (n.d.). DL-7 – Texas Driver Handbook.

Texas Department of Public Safety. (2009). Driver License / Identification Card Inquiries.

Texas Medical Institute. (2026). Your Guide to Chiropractic Treatment After an Auto Injury.

Texas Transportation Code § 545.152. (2025). Vehicle Turning Left.

The Neck and Back Clinics. (2025). What Are Your Chiropractic Treatment Options After a Car Accident?

TopDog Law. (2025). Who Is at Fault for a T-Bone Accident?

Torts Law. (n.d.). T-Bone Accident – T-Bone Collisions – Side Impact Crashes.

Yadla, S., et al. (2007/2008). Whiplash: Diagnosis, Treatment, and Associated Injuries. PMC.

Understanding the Connection Between Hormones & The Gut-Immune System

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-

Learn how the gut-immune system helps influence your health. Dive into the science behind these crucial hormones.

Abstract

As a practitioner with extensive training across multiple disciplines, I have dedicated my career to uncovering the root causes of chronic illness. This comprehensive guide will take you on a journey through the intricate connections between your gut, hormones, and thyroid. We will explore the profound influence of the gastrointestinal microbiome on everything from nutrient absorption and immune function to hormone regulation and mental health. Drawing on the latest evidence-based research and my clinical observations, I will demystify concepts such as dysbiosis and “leaky gut,” and their roles in driving systemic inflammation and chronic conditions like Hashimoto’s Thyroiditis and PCOS. We will also delve into the critical importance of micronutrients such as Vitamin D3, K2, and iodine, as well as the powerful effects of compounds such as DIM and Shilajit on estrogen metabolism and testosterone levels. Finally, I will outline how a holistic, integrative chiropractic care model addresses these foundational issues, helping to restore nervous system balance and guide you toward lasting, vibrant health.

My Journey From Frustration to Functional Medicine

Throughout my career, I’ve worn many hats and pursued extensive training to serve my patients better. My journey into the world of functional and integrative medicine wasn’t a straight path; it was born of a deep frustration with the limitations of the conventional medical model.

I began my career steeped in traditional medicine. After a fellowship, armed with specialized knowledge in endocrinology and metabolism, I felt equipped to make a real difference. I had even contributed to clinical studies on GLP-1 agonists for major pharmaceutical companies like Lilly and Novo Nordisk. I was ready to be the best diabetes doctor I could be.

However, after about two years in a hospital setting, a disheartening pattern emerged. My patients weren’t truly getting better. They would return for follow-up appointments, often sicker than before, and my primary tool was to add another prescription to their growing list of medications. I remember a specific moment of clarity, sitting down one evening and confiding in a colleague, “I don’t want to do this anymore. No one is getting better. I’m just managing their decline.” It was a difficult realization that after 14 years of rigorous training, my role had been reduced to writing scripts for conditions that only seemed to worsen.

This professional crisis led me to seek answers outside the conventional framework. I enrolled in functional medicine training, and a new world of possibilities opened up. I started applying these new principles, focusing on root causes rather than just symptoms. The results were astounding. Patients started getting genuinely better. We were successfully tapering them off medications, they were losing weight, and their vitality was returning. This was the medicine I had always wanted to practice.

Yet, even with this success, I noticed that about 25-30% of my patients still struggled. I was doing everything by the book—listening intently to their symptoms, optimizing their hormones, and tailoring their protocols—but they hit a plateau. This is where my innate curiosity, the persistent “why” that has driven me since childhood, kicked in again. I needed to understand what I was missing. The answer, I discovered, was hidden in plain sight: the gut.

The Forgotten Organ: Why All Disease Begins in the Gut

Hippocrates, the father of medicine, declared over 2,000 years ago, “All disease begins in the gut.” Somewhere between ancient Greece and the modern medical school curriculum, we lost this profound wisdom. It’s shocking when you stop to consider it. As a board-certified endocrinologist, my formal education in gut metabolism consisted of only two lectures. When I recently recertified for my boards, not a single one of the 180 questions touched on the gut’s role in metabolism. We are training generations of healthcare providers without the essential knowledge about the very foundation of our health.

This is why I am so passionate about bringing this knowledge to the forefront. If you address a person’s gut health correctly, you can unlock the potential for healing across the entire body.

Unraveling the Impact of Chronic Stress and Leaky Gut

As a healthcare provider, I see firsthand how chronic stress is a powerful physiological force that disrupts your internal environment. It can shift the composition of your gut microbiome, favoring the growth of pathogenic (harmful) bacteria, alter gut function, and, most damagingly, induce leaky gut.

Leaky gut, or increased intestinal permeability, is a critical concept. Imagine your gut lining as a tightly woven fabric made of a single layer of specialized cells held together by proteins forming “tight junctions.” A key protein in this structure is zonulin. In a healthy gut, this barrier allows micronutrients to pass into your bloodstream while keeping out undigested food particles, toxins, and harmful bacteria.

When zonulin levels rise—often triggered by stress, gluten, toxins, and infections—it signals the tight junctions to open. The fabric of your gut lining becomes frayed, and “holes” develop. Substances that should be eliminated now “leak” into your bloodstream. Your immune system, about 70% of which is located just on the other side of this barrier, goes on high alert, launching a massive inflammatory response. If you have a”leaky “gut, this battle is happening every single time you eat.

This chronic immune activation creates a devastating cascade:

  1. Immune System Overload: Your immune system releases a flood of inflammatory messengers called cytokines.
  2. Hormonal Chaos: This systemic inflammation drives up your stress hormone, cortisol, and your fat-storage hormone, insulin. It also disrupts your thyroid and sex hormones.
  3. Metabolic Dysfunction: Your body enters a state of crisis, leading to weight gain, fatigue, and a host of other symptoms.

The signs of leaky gut are widespread and can include digestive issues, new food sensitivities, autoimmune conditions, chronic fatigue, brain fog, mood disorders, skin problems, and hormonal imbalances like PCOS and endometriosis.

Modulating Women’s Hormones- Video

Modulating Women Hormones | El Paso, Tx (2021)

The Gut-Hormone Axis: PCOS, Endometriosis, and Estrogen Metabolism

The connection between gut health and hormonal disorders is particularly strong.

Polycystic Ovary Syndrome (PCOS)

PCOS is a complex metabolic disorder deeply intertwined with gut health. Studies on women with PCOS consistently reveal gut dysbiosis—an imbalance of bacteria. They often have an overgrowth of pro-inflammatory bacteria that produce toxins called lipopolysaccharides (LPS). As shown in research by Yuan et al. (2018), LPS can cause leaky gut, which drives up systemic inflammation and leads to insulin resistance—a core driver of PCOS. This insulin resistance then elevates androgen levels (like testosterone), causing symptoms such as acne, hair loss, and weight gain.

Estrogen Metabolism: A Three-Phase Process Dictated by Your Gut

Understanding how your body processes estrogen is key. This metabolic process occurs in three phases and is heavily influenced by your liver and gut health.

  • Phase 1 & 2 (in the liver): The liver modifies used estrogen and packages it into a water-soluble “capsule” for safe elimination. This process can create different estrogen metabolites. Some are protective, while others are more proliferative or can even damage DNA, increasing cancer risk.
  • Phase 3 (Excretion via the gut): This encapsulated estrogen is “sent into “the gut to be excreted. But here is the critical link: if you are constipated, harmful gut bacteria can produce an enzyme called beta-glucuronidase. This enzyme breaks open the protective capsule, “un-conjugating” the estrogen. This newly freed, often-toxic estrogen is then reabsorbed into your circulation through your leaky gut. This vicious cycle continuously raises your body’s estrogen load and your risk for disease.

Understanding and Managing Hashimoto’s “hyroiditis: An Integrative Approach

Hashimoto’s is the most common autoimmune disease in the United States, in which the immune system mistakenly attacks the thyroid gland, disrupting its function.

The Hydrogen Peroxide Problem

When your thyroid gland uses iodine to create T4 and T3, a natural byproduct is hydrogen peroxide, a highly oxidative substance. In a healthy system, an enzyme called glutathione peroxidase, which depends on the mineral selenium, neutralizes this hydrogen peroxide, protecting the thyroid cells.

Now, what happens in Hashimoto’s?

  1. The process of making thyroid hormone produces hydrogen peroxide.
  2. If there is insufficient selenium (due to poor diet or gut malabsorption), the hydrogen peroxide is not neutralized.
  3. This oxidative stress damages and bursts the thyroid cells. In Hashimoto’s, normally kept inside the thyroid (like Thyroglobulin and Thyroid Peroxidase) are released into the bloodstream.
  4. The immune system recognizes these proteins as foreign invaders and produces antibodies against them (anti-TPO and anti-Tg). This is the autoimmune attack we call Hashimoto’s.

This creates a vicious cycle. Inflammation from the gut (leaky gut and dysbiosis) fuels the autoimmune attack on the thyroid. Compromised thyroid function then slows metabolism, which can worsen gut health and nutrient absorption.

ThHashimoto’s Nutrients for Thyroid and Immune Health

To break these cycles, we must provide the body with the right raw materials.

The Vitamin D3 Super Group: More Than Just a Vitamin

Vitamin D is a powerful steroid hormone, not just a vitamin. The statistics are staggering: it’s estimated that one billion people worldwide are vitamin D-deficient. This deficiency has serious consequences, including increased risk for cancer, autoimmune diseases, diabetes, and dementia. In my own clinical practice, of the first 100 individuals diagnosed with thyroid cancer, 99 of them were Vitamin D deficient. Functional medicine practitioners aim for an optimal level of 60-80 ng/mL.

However, Vitamin D doesn’t work in isolation. It is fat-soluble and requires a team:

  • Vitamin K2: This is the “calcium traffic cop.”
  • Magnesium: This mineral activates Vitamin D at the cellular level.
  • Vitamin A: Works synergistically with D and K2 in signaling bone cells.

The Paradox: How Vitamin K2 Protects Your Arteries and Strengthens Your Bones

Here’s “how the system works: “Vitamin D3 increases calcium absorption from your gut into your bloodstream. Without a guide, this calcium could deposit in soft tissues, such as your arteries. This is where Vitamin K2 steps in. As detailed by Kurnatowska et al. Here’s K2 activates proteins that direct this calcium into your bones and teeth, where it belongs. Taking Vitamin D without K2 is like raising an army of construction workers (calcium) with no foreman to tell them where to build.

Iodine: The Misunderstood Mineral for Thyroid Health and Beyond

Your thyroid gland cannot make thyroid hormones without iodine. Thyroxine (T4) contains four iodine molecules, and Triiodothyronine (T3) contains three. If you lack iodine, your thyroid cannot produce these hormones, even if your brain is signaling it to do so. Iodine also plays a critical role in cancer prevention by displacing toxic halogens like fluoride and bromide from cellular receptors.

Optimizing Hormone Metabolism with Targeted Nutraceuticals

Beyond foundational nutrients, we can use specific compounds to guide hormone metabolism.

The Critical Role of DIM in Healthy Estrogen Metabolism

Diindolylmethane (DIM), a compound from cruciferous vegetables, has a profound influence on estrogen metabolism. It acts as a traffic cop, directing estrogen away from the problematic 4-hydroxy (cancer-linked) and 16-hydroxy (proliferative) pathways and down the safer 2-hydroxy pathway (Bradlow et al., 1996). This is why I consider DIM a non-negotiable supplement for most of my patients on hormone replacement therapy (HRT). Its benefits extend to prostate health and reducing fibrocystic breast tissue.

Shilajit: The Game-Changer for Free Testosterone

While total hormone levels are important, what truly matters is the biologically active or free portion. Shilajit, a mineral-rich resin, is a game-changer for testosterone. A landmark study published in Andrologia found that men taking Shilajit saw a significant 19% increase in free testosterone (Pandit et al., 2016). In my clinic, this translates to patients feeling better for longer, with more sustained energy and vitality, without needing to escalate their hormone dosage.

A female patient of mine on hormone pellets consistently felt her energy drop weeks before her next implant. On November 11, 2019, her free testosterone was only 2.6 pg/mL. We started her on a blend containing Shilajit. One year later, on November 25, 2020, her free testosterone was 4.6 pg/mL—nearly double—and she reported feeling great all the way through her cycle.

The Role of Integrative Chiropractic Care in Restoring Balance

You might be wondering, “What does chiropractic have to do with all this?” The connection lies in the nervous system.

The gut has its own intricate nervous system, the enteric nervous system (ENS), which is in constant communication with the central nervous system (CNS) via the vagus nerve. The spine houses and protects the spinal cord, the main superhighway for these nerve signals.

Misalignments in the spine, known as vertebral subluxations, can interfere with the nerve signals traveling between the brain, the gut, and the endocrine glands. This interference can disrupt proper gut function, affecting motility and enzyme secretion, and impair hormonal regulation. From my clinical experience at the Sciatica Clinic, patients with chronic back pain often report concurrent digestive issues.

Chiropractic adjustments help restore proper spinal alignment, which may reduce nerve interference and normalize nerve flow. Furthermore, adjustments have been shown to profoundly affect the autonomic nervous system, helping shift the body out of a “fight-or-flight” (sympathetic) state and into a “rest-and-digest” (parasympathetic) state. By calming this stress response, chiropractic care directly helps reduce one of the primary triggers of leaky gut and hormonal imbalance.

My integrative approach combines chiropractic care with functional medicine testing. By assessing both the structural (spinal) and biochemical (gut, hormones) aspects of your health, we can create a truly comprehensive treatment plan that addresses the root cause of your symptoms.

Your 4-Step Plan to Heal the Gut and Rebalance Hormones

Here is a practical, four-step framework you can use to start healing:

1. Remove

The first step is to remove the triggers causing inflammation and gut damage. This includes processed foods, inflammatory triggers like gluten, dairy, and sugar, and supporting detoxification.

2. Replace

Replace inflammatory foods with healing, nutrient-dense alternatives such as fresh organic vegetables, high-quality proteins, healthy fats, and collagen-rich bone broth to help repair the gut lining.

3. Reinoculate

Restore a healthy balance of gut bacteria with high-quality probiotics and prebiotic-rich foods. Focus on fiber from a variety of plant sources to feed your good gut bugs.

4. Repair

Provide the nutrients needed to repair the gut lining and support hormone metabolism. Key nutrients include L-Glutamine, methylation support (methylated B vitamins), Vitamin D/K2/A, Selenium, Iodine, and targeted compounds like DIM and Shilajit. Equally important are stress management and prioritizing 7-9 hours of quality sleep per night.

Your health journey begins in your gut. By understanding these connections and taking targeted, integrative action, you can move beyond managing symptoms and begin a true path to healing and vitality.

A Note on Supplement Quality

The quality of the supplements you take matters immensely. The supplement industry is largely unregulated, and many products don’t contain what they claim to contain or are contaminated. This is why I insist my patients use professional-grade nutraceuticals from trusted sources. Using impure substances is not just a waste of money; it’s counterproductive and potentially harmful to your healing journey.

References

  • Bradlow, H. L., Telang, N. T., Sepkovic, D. W., & Osborne, M. P. (1996). 2-hydroxyestrone: the ‘good’ estrogen. Journal of Endocrinology, 150(S1), S259-S265. https://doi.orit’s.1677/joe.0.150S259
  • Duntas, L. H. (2011). Environmental factors and autoimmune thyroiditis. Nature Clinical Practice Endocrinology & Metabolism, 4(8), 454-460. https://doi.or’/10.’038/ncpendmet0876
  • Fallahi, P., Ferrari, S. M., Elia, G., et al. (2021). Iodine and thyroid: an update. Journal of Clinical Medicine, 10(21), 4991. https://doi.org/10.3390/jcm10214991
  • Kurnatowska, I., Grzelak, P., Masajtis-Zagajewska, A., et al. (2015). The effect of vitamin K2 on vascular calcification: A review of the literature. Polish Archives of Internal Medicine, 125(11), 831-837. https://doi.org/10.20452/pamw.3150
  • Pandit, S., Biswas, S., Jana, U., De, R. K., Mukhopadhyay, S. C., & Biswas, T. K. (2016). Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia, 48(5), 570–575. https://doi.org/10.1111/and.12482
  • Pludowski, P., Holick, M. F., Grant, W. B., et al. (2013). Vitamin D supplementation guidelines. The Journal of Steroid Biochemistry and Molecular Biology, 136, 1-13. https://doi.org/10.1016/j.jsbmb.2013.01.003
  • Thomson, C. A., Chow, H. H. S., Wertheim, B. C., Roe, D. J., Stopeck, A., Maskarinec, G., … & Thompson, P. A. (2017). A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen. Breast Cancer Research and Treatment, 165(1), 97–107. https://doi.org/10.1007/s10549-017-4292-7
  • Yuan, X., et al. (2018). Gut microbiota and metabolism in polycystic ovary syndrome. Journal of Ovarian Research, 11(1), 7. https://doi.org/10.1186/s13048-017-0371-2

SEO Tags: Gut Health, Leaky Gut, Hormonal Imbalance, Dr. Alex Jimenez, Integrative Chiropractic, Hashimoto’s Thyroiditis, PCOS, Estrogen Metabolism, Functional Medicine, Gut-Brain Axis, Chronic Stress, Gut Dysbiosis, Autoimmune Disease, Inflammation, Vitamin D Deficiency, Vitamin K2, Iodine, Selenium, Thyroid Health, DIM, Shilajit, free testosterone,Hashimoto ‘s Chiropractor, Holistic Health

Better Gut and Hormone Function: Integrative Approach

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Better Gut and Hormone Function: Integrative Approach
Better Gut and Hormone Function: Integrative Approach

Neuro-Visceral Care for Better Gut and Hormone Function

Abstract

As a clinician practicing systems-based, integrative care, I connect the gut microbiome, intestinal barrier, and enterohepatic circulation to hormonal outcomes in PCOS, endometriosis, and autoimmune conditions, while also detailing how young males can optimize testosterone signaling through targeted nutrients and lifestyle. In this educational post, I walk through the physiological underpinnings of estrogen metabolism (Phase I/II detox, beta-glucuronidase), the nutrient-receptor axis for androgen function (vitamin D, K2, A, magnesium, methylated B vitamins), and practical tools like DIM, I3C, probiotics, L-glutamine, berberine, shilajit, sulforaphane, and CoQ10. I show how integrative chiropractic care enhances autonomic balance and neuro–musculoskeletal efficiency, thereby amplifying endocrine resilience.

Better Gut and Hormone Function: Integrative Approach

Why I Pivoted to Systems-Based Endocrine Care

Early in my career, I saw brilliant specialty care fall short when patients had overlapping issues involving the gut, immune system, and hormones. Collaborating on the gut–brain–immune–hormone axis reshaped my practice lens: the gut is a master regulator whose metabolites, enzymes, and barrier integrity determine whether hormones are cleared or recirculated, and whether the immune system stays tolerant or inflamed (Lynch & Pedersen, 2016; Cryan et al., 2019).

  • What changed in my practice
    • I placed the microbiome at the center of protocols for estrogen metabolism, PCOS, endometriosis, Hashimoto’s, mood dysregulation, and metabolic resilience.
    • I integrated functional nutrition, precision supplementation, and integrative chiropractic care to address neuro-visceral regulation and adherence.
    • I reframed hormone therapy not as a number-raising exercise but as restoring signal transduction, guided by cofactors, clearance pathways, and autonomic balance.

The Gut Microbiome: Trillions of Partners in Endocrine Health

The gut microbiome comprises trillions of bacteria, viruses, fungi, and archaea, influencing digestion, immune tone, neuroendocrine signaling, and hormone metabolism (Lynch & Pedersen, 2016; Cryan et al., 2019). A crucial concept is the estrobolome—microbial genes that metabolize estrogens, dictating whether conjugated metabolites are excreted or reabsorbed via enterohepatic circulation.

  • Key functions
    • Produce short-chain fatty acids (SCFAs), such as butyrate, that stabilize tight junctions and repress NF-κB-mediated inflammation, thereby preserving barrier integrity (Vinolo et al., 2011).
    • Regulate immune tolerance and cytokine signaling, shaping systemic inflammation.
    • Modulate enzymes such as beta-glucuronidase, which can deconjugate estrogen metabolites, thereby driving estrogen recirculation and dominance (Pallister et al., 2017).
  • Clinical implication
    • When dysbiosis increases LPS (endotoxin) translocation through a compromised barrier, TLR4 signaling induces systemic inflammation linked to PCOS, autoimmunity, and cardiometabolic risk (Kazemian et al., 2020).
    • Correcting dysbiosis restores commensal functions, reduces inflammatory load, and improves hormone clearance.

Leaky Gut and Hormonal Spillover: Tight Junctions and Zonulin

Increased intestinal permeability (often called leaky gut) arises when tight junction proteins—occludin, claudin, ZO-1—are disrupted by triggers such as zonulin, alcohol, NSAIDs, infections, and stress (Fasano, 2012). Strikingly, after traumatic brain injury, permeability can change within minutes, reflecting rapid neuro-immune-gut cross-talk (Hang et al., 2013).

  • Why this matters for hormones
    • A compromised barrier permits LPS and dietary antigens to reach circulation, priming systemic inflammation and autoimmunity.
    • In the presence of dysbiosis, beta-glucuronidase deconjugates estrogen metabolites in the gut, facilitating their reabsorption and fueling estrogen dominance symptoms.
  • Common symptom clusters I see
    • Digestive bloating and IBS patterns
    • PMS, PCOS, severe menstrual symptoms
    • Autoimmune conditions, fatigue, mood disorders, and skin flares
    • Food intolerances and Candida overgrowth

My clinical observation: stabilizing the barrier reduces inflammatory “noise,” enabling clearer responses to hormone and nutrient therapies. Patients report steadier mood, improved cycles, and reduced pain as gut integrity improves.

Estrogen Metabolism and the Estrobolome: Pathways, Phases, and Recycling

Understanding Phase I and II liver metabolism empowers patients to take action. Estrogen can follow different hydroxylation pathways, with 2-hydroxyestrone generally less proliferative than 16α-hydroxyestrone (Zhu & Conney, 1998; Fuhrman et al., 2015).

  • Physiology in three steps
    1. Phase I/II metabolism converts estrogens into metabolites; conjugation via glucuronidation and sulfation prepares them for excretion.
    2. Conjugated metabolites enter the intestine via bile for elimination.
    3. In dysbiosis, microbial beta-glucuronidase deconjugates these metabolites, enabling enterohepatic recycling and elevating circulating estrogen (Pallister et al., 2017).
  • Clinical tools
    • DIM (diindolylmethane) and I3C (indole-3-carbinol) shift metabolism toward the 2-hydroxy pathway, reducing proliferative intermediates (Fuhrman et al., 2015).
    • Methylation support with methylfolate and methylcobalamin promotes Phase II clearance, particularly in patients with SNPs affecting methylation dynamics (Schwab et al., 2011).
    • The Dutch test (urinary metabolites) clarifies pathway dominance and informs targeted interventions (Markan & Lechner, 2021).

I routinely ask about daily bowel movements: constipation increases the time for beta-glucuronidase to deconjugate metabolites, raising the risk of recirculation. Supporting motility and fiber is foundational.

PCOS and Endometriosis: Microbiome, Inflammation, and Androgen/Estrogen Balance

Evidence links gut dysbiosis and barrier dysfunction to PCOS and endometriosis through low-grade inflammation, altered SCFA production, insulin resistance, and estrobolome disruption (Lindheim et al., 2017; Torres et al., 2018).

  • PCOS
    • Elevated LPS and reduced SCFAs promote insulin resistance and excess androgen synthesis in theca cells (Qi et al., 2019).
    • Interventions: gut repair, anti-inflammatory nutrition, berberine for microbial modulation and insulin sensitivity (Zhang et al., 2020), and omega-3s for metabolic flexibility.
  • Endometriosis
    • Disrupted estrobolome increases estrogen metabolite load, stimulating lesion growth; inflammatory signatures overlap with oncogenic pathways (Wei et al., 2020; De la Cuesta-Zuluaga et al., 2019).
    • Interventions: DIM/I3C for pathway optimization, barrier repair, and targeted probiotic support.

Clinically, improving gut tone and estrogen clearance reduces pain, cycle irregularity, and fatigue. Integrative care also enhances adherence: when pain and sleep improve with chiropractic support, patients implement nutrition and supplements more consistently.

Nutrient-Receptor Axis in Young Males: When High Total Testosterone Feels Low

I frequently see young men with high total testosterone but symptoms of low androgen activity: depressed mood, low motivation, fatigue, and central adiposity. The issue is often receptor signaling and cofactor deficiencies—cells cannot “hear” the hormonal signal without the right nutrients and intact membranes.

  • Why symptoms persist despite high total T
    • Low vitamin D, magnesium, and B vitamins impair conversion, transport, and nuclear receptor binding (Bouillon et al., 2019; Rosanoff et al., 2016).
    • Inflammation and dysbiosis affect hepatic metabolism, SHBG levels, and tissue availability.
    • Vitamin D receptor (VDR) and androgen receptor cross-talk influences downstream transcription; optimizing D status improves AR expression (Holick et al., 2011).
  • Practical framework I use
    • Correct methylated B12/folate to support methylation and steroidogenesis.
    • Normalize vitamin D with K2 and magnesium for calcium handling and receptor fidelity.
    • Add vitamin A to support epithelial integrity and calcium redistribution.
    • Ensure iodine and selenium sufficiency for thyroid-driven metabolic speed.

Clinical observation: pairing D3, K2, and magnesium reduces adverse sensations and improves performance markers. Within 8–12 weeks, many young men report brighter moods, stronger training outcomes, and higher free testosterone levels.

Precision Tools: DIM, Shilajit, Sulforaphane, CoQ10, and Methylated B Vitamins

I select nutraceuticals that directly impact receptor sensitivity, oxidative stress, and hormone clearance.

  • DIM and I3C
    • Shift estrogen metabolism toward 2-hydroxyestrone, decreasing proliferative intermediates; useful for estrogen-dominant symptoms in individuals (Fuhrman et al., 2015; Zeligs, 2014).
    • Typical dosing: women 150–300 mg/day; men 300–600 mg/day, adjusted for risk profiles.
  • Shilajit
    • Fulvic acid-rich biomass supports mitochondrial function; RCTs show increases in total and free testosterone in healthy males with 250 mg twice daily over 90 days (Pandit et al., 2016).
  • Sulforaphane
    • Activates Nrf2, boosting endogenous antioxidants, improving detoxification, and modulating inflammation—critical for endocrine receptor sensitivity and gut-liver axis (Egner et al., 2011).
  • CoQ10
    • Supports mitochondrial ATP synthesis, aiding energy production, cardiac function, and recovery—beneficial for athletes, students, and patients under metabolic stress (Hodgson et al., 2007).
  • Methylated B vitamins
    • Enhance methylation capacity, neurotransmitter balance, and steroid metabolism; particularly useful in hormonally sensitive patients (Schwab et al., 2011).

When combined with omega-3 EPA/DHA, these tools reduce inflammatory friction and stabilize endocrine signaling. My practice often employs integrated formulations to simplify routines and improve adherence.

Healing Leaky Gut: Stepwise, Patient-Centered Repair

Patients need relief before intensive changes. I stabilize, then build.

  • Remove gut-damaging factors
    • Reduce ultra-processed foods; avoid products with ingredient lists longer than 5 items or those with hard-to-pronounce additives.
    • Limit alcohol and sugar alcohols; review medication contributors (e.g., chronic NSAIDs).
    • Implement stress reduction and sleep hygiene.
  • Replace with healing inputs
    • Emphasize organic, whole foods; diverse plant fibers; clean proteins; anti-inflammatory fats.
  • Repair with targeted supplements
    • Sunfiber (partially hydrolyzed guar gum) for gentle prebiotic support; start at 4–6 g per serving (Moser et al., 2018).
    • L-glutamine (around 5 g/day) to fuel enterocytes and tighten junctions (Kim & Kim, 2017).
    • Probiotics: strains such as Lactobacillus rhamnosus GG, L. acidophilus, and Bifidobacterium species to rebalance flora and reduce beta-glucuronidase activity (Jones et al., 2012).
    • Berberine for microbial modulation and insulin sensitivity; anti-inflammatory support for mucosal health (Zhang et al., 2020).

Clinical observation: This progression quickly calms symptoms, improves bowel regularity, and enhances hormone clearance. It also reduces the immune “alarm,” allowing endocrine therapies to work more predictably.

Vitamin D Optimization: Immune Tolerance, Receptor Responsiveness, and Risk Reduction

I aim for 25(OH)D levels in the 60–80 ng/mL range for endocrine optimization, not just “normal” low ranges. Vitamin D acts as a secosteroid hormone, modulating immune balance, cardiometabolic risk, and hormone receptor fidelity (Prietl et al., 2013; Lau et al., 2021; Carlberg, 2019; Grant & Boucher, 2022).

  • Why pairing matters
    • K2 (MK-7) carboxylates proteins to shuttle calcium to bone and away from soft tissue.
    • Magnesium is essential for vitamin D activation and VDR signaling; deficiency impairs both D and androgen receptor function (Rosanoff et al., 2016).
    • Vitamin A supports epithelial integrity and synergizes with D/K2 for balanced calcium dynamics (Schurgers & Vermeer, 2000).

Patients experience fewer side effects and more consistent energy/mood when D3 is paired with K2 and magnesium. In practice, rechecking labs at 8–12 weeks guides dosing adjustments.

Iodine, Selenium, and Thyroid-Immune Balance: Myth to Physiology

Iodine is essential for thyroid hormone synthesis and tissue differentiation. The misconception that iodine “causes” Hashimoto’s overlooks the role of selenium-dependent antioxidants. During organification, iodine increases H2O2 levels; insufficient glutathione peroxidase activity can trigger thyrocyte damage and autoimmunity (Zimmermann & Kohrle, 2002).

  • Protocol rationale
    • Pair iodine with selenium (~200 mcg/day); optimize glutathione and vitamin D; repair the gut to reduce antigen exposure.
    • Monitor antibodies (TPO/Tg), thyroid function, iron/zinc, and symptoms over time.

Clinically, this integrated approach reduces antibody titers in some patients and improves fatigue, mood, and hair/skin quality. Dietary iodine sufficiency, particularly in regions with demineralized soils, is part of comprehensive endocrine care (Venturi, 2001; Cann et al., 2000; Zava & Zava, 2011).

Integrative Chiropractic Care: Neuro–Visceral Regulation for Endocrine Efficiency

As a chiropractor and family nurse practitioner, I leverage integrative chiropractic care to modulate autonomic balance, reduce nociceptive load, and improve neuro–musculoskeletal dynamics. Optimizing spinal mechanics and vagal tone supports gut motility, barrier integrity, and anti-inflammatory reflexes, while improving sleep, adherence, and exercise capacity.

  • How chiropractic complements endocrine care
    • Reduces sympathetic overdrive, normalizes hypothalamic–pituitary signaling, and improves stress resilience (Martínez-Aranda et al., 2021).
    • Decreases cytokine load and pain-mediated cortisol, allowing testosterone and thyroid signals to translate better in tissues (Mukherjee et al., 2016).
    • Enhances movement efficiency and lean mass through neuromuscular re-education, amplifying anabolic pathways such as mTOR.

Clinical observations from my center show improved bowel regularity, reduced bloating, steadier mood, and better training outcomes when chiropractic care is integrated with gut-hormone protocols.

Stepwise Clinical Flow: Making Complex Care Practical

I use a staged model to prevent overwhelm and build durable success.

  • Stabilize symptoms
    • Improve sleep, reduce stress, and address pain with chiropractic/manual therapy.
    • Begin the foundational trio: DIM/I3C, methylated B vitamins, probiotics + fiber.
  • Assess and personalize
    • Consider Dutch testing for complex estrogen cases.
    • Encourage daily elimination and hydration; track bowel habits and cycle patterns.
  • Repair and optimize
    • Add L-glutamine, Sunfiber, and berberine.
    • Emphasize whole-food nutrition; avoid long ingredient lists and ultra-processed foods.
  • Monitor and refine
    • Reassess vitamin D, thyroid antibodies, lipids, fasting insulin/hs-CRP; track symptom scores and sleep/mood.
  • Maintain and scale
    • Sustain routines that protect barrier integrity and microbial balance.
    • Continue chiropractic maintenance to support autonomic function and movement efficiency.

This reduces complexity while directly addressing the physiological driving symptoms. In my experience, patients achieve faster relief and longer-lasting outcomes with this approach.

Practical Protocols: Dosages and Reasoning

  • Vitamin D3 5,000 IU/day with fat; consider short-term 10,000 IU/day for levels <40 ng/mL under supervision; pair with K2 (MK-7) 200–500 mcg/day and magnesium glycinate 200–400 mg/day (Holick et al., 2011; Schurgers & Vermeer, 2000; Rosanoff et al., 2016).
  • Methylated B complex for methylation and neurotransmitter balance (Schwab et al., 2011).
  • Iodine 200–400 mcg/day plus selenium 200 mcg/day for thyroid synthesis and antioxidant support (Zimmermann & Kohrle, 2002).
  • DIM 150–300 mg/day in women; 300–600 mg/day in men for estrogen pathway optimization (Fuhrman et al., 2015; Zeligs, 2014).
  • Shilajit 250 mg twice daily for androgen support (Pandit et al., 2016).
  • Omega-3 EPA/DHA 1–2 g/day to lower inflammatory signaling and improve membrane receptor function (Calder, 2015).
  • Sulforaphane and CoQ10 as adjuncts for antioxidant defense and mitochondrial energy (Egner et al., 2011; Hodgson et al., 2007).
  • Probiotics and Sunfiber to fortify commensals and reduce beta-glucuronidase; L-glutamine for barrier repair (Moser et al., 2018; Jones et al., 2012; Kim & Kim, 2017).

Dosing is individualized based on labs, tolerance, and goals. I recheck within 8–12 weeks to fine-tune.

Key Takeaways and Action Steps

  • The microbiome shapes hormone metabolism, immune tolerance, and neuroendocrine balance; correcting dysbiosis and leaky gut is central to care for PCOS, endometriosis, and autoimmune conditions.
  • Focus on reducing beta-glucuronidase and enterohepatic recycling by improving commensal balance and bowel regularity.
  • Use DIM/I3C to optimize estrogen pathways; support methylation with methylated B vitamins; fortify the gut with probiotics, fiber, L-glutamine, and berberine.
  • Aim for vitamin D in the 60–80 ng/mL range with K2 and magnesium to enhance receptor responsiveness and reduce cardiometabolic and autoimmune risks.
  • In young males, correct cofactor deficiencies and inflammation to improve free testosterone and receptor signaling—do not chase totals alone.
  • Integrate chiropractic care to modulate autonomic function, reduce pain-mediated stress, and support gut motility and barrier integrity.
  • Start simple, stabilize first, and build stepwise; overwhelming patients backfires.
An Introduction to *FUNCTIONAL MEDICINE* (2021) | El Paso, Tx

References

Thyroid Health: A Comprehensive Guide for Hormone Optimization

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-

Maximize your health with proper thyroid health from hormone optimization. Find tips and insights for a balanced life.

Rebalancing Hormones: An Integrative Approach to Testosterone, Thyroid, and Estrogen Therapy

As a clinician with a diverse background spanning chiropractic, advanced practice nursing, and functional medicine, I am Dr. Alex Jimenez. My goal has always been to synthesize the latest evidence-based research with a deep understanding of human physiology to create personalized treatment plans. Today, I want to take you on a journey through the intricate world of hormone optimization. This is not about chasing numbers on a lab report but about restoring vitality and health by understanding the individual’s unique biological landscape. We’ll delve into the nuances of testosterone therapy, unravel the complexities of thyroid management, and navigate the often-misunderstood terrain of estrogen replacement, particularly for patients with a history of cancer. This discussion is informed by the groundbreaking work of leading researchers and my own clinical observations, illustrating how an integrative approach that includes chiropractic care can provide a more holistic and effective path to wellness.

Understanding Optimal Testosterone Levels: Beyond the “No”mal” Range

I frequently encounter patients, particularly men, who are told their testosterone levels are “normal” despite feeling fatigued, irritable, and unmotivated. This brings up a critical question: What does “normal” really mean?

The typical reference ranges you see on lab reports are often derived from a broad, aging, and frequently unhealthy population. A man with a total testosterone level of 300 ng/dL might be told he’s within the normal range. Still, from a functional and preventative medicine perspective, this level is far from optimal. Research consistently shows that men with testosterone levels in this lower range face a significantly higher risk for all-cause mortality, type 2 diabetes, and even Alzheimer’s disease (Travison et al., 2007).

My initial goal when treating a symptomatic patient is to target the upper quartile of the young-adult reference range, typically between 900 and 1000 ng/dL. This is not an arbitrary number. It’s a starting point based on data indicating where men typically experience the greatest benefits in energy, cognitive function, mood, and metabolic health.

However, the journey doesn’t end there. True optimization is highly individualized. Once we reach that initial target, we fine-tune the dosage based on how the patient feels. The ultimate goal is to find the specific level where that individual feels their best. A level of 300 ng/dL is not enough to saturate the body’s androgen receptors and provide the protective benefits we’re aiming for. It represents a state of physiological deficiency, regardless of whether the patient has adapted to feeling “normal” in that state.

The Thyroid Puzzle: Why T4-Only Treatment Often Fails

Another common issue I see in my practice involves thyroid management. Many practitioners rely solely on prescribing Levothyroxine (T4), a synthetic storage hormone. The rationale is that T4 is more stable and the body should be able to convert it into Triiodothyronine (T3), the active thyroid hormone.

However, this approach fails a significant portion of patients. Here’s why:

  • Conversion Issues: The conversion of T4 to T3 is a complex metabolic process that can be impaired by numerous factors, including nutrient deficiencies (such as selenium and zinc), stress (elevated cortisol), inflammation, and genetic variations.
  • Cellular Need for T3: The body’s tissues, especially the brain, require direct T3 to function optimally. T3 is what drives metabolism, energy production, and cognitive clarity.
  • Pregnancy and Fetal Development: This period is particularly critical. The fetal brain is entirely dependent on the mother’s T3 for the first 18 weeks of development. Relying solely on T4 can lead to insufficient T3 crossing the placenta, potentially affecting the baby’s neurological development. My protocol for pregnant patients involves administering a combination of T4 and T3 to ensure that both mother and baby have adequate active hormone levels until the baby’s own thyroid becomes functional around week 18 (Medici et al., 2013).

Therefore, I often find that a combination therapy including T3 is necessary to resolve symptoms. In my practice at the Sciatica Clinic, I’ve observed that many patients with chronic musculoskeletal pain and fatigue, conditions often linked to poor metabolic function, experience significant improvement once their thyroid is properly managed with a combination of T3 and T4. This approach treats the patient’s symptoms and physiological reality, not just the numbers on a lab report.

Cracking The Low Thyroid Code- Video

https://youtu.be/afj5ZKMcRhc?si=5HEFvy1oYFBa9nt0

The Role of Integrative Chiropractic Care

Here is where integrative chiropractic care becomes a powerful ally. The nervous system, which is the primary focus of chiropractic adjustments, is the master controller of the endocrine system.

  • Stress Reduction: Chronic stress elevates cortisol, which can directly suppress thyroid function and inhibit the conversion of T4 to T3. Chiropractic adjustments have been shown to modulate the autonomic nervous system, helping shift the body from a stressed “fight-or-flight” state to a “rest-and-digest” state, thereby lowering cortisol levels.
  • Improving Systemic Function: By correcting spinal misalignments (subluxations), we can improve nerve flow to all organs, including the adrenal glands and thyroid gland. This helps optimize the entire hormonal cascade, creating a more favorable internal environment for hormone therapies to be effective.

An integrated approach recognizes that a patient with low testosterone or hypothyroidism is not just a collection of lab values. They are a whole person whose nervous, endocrine, and musculoskeletal systems are interconnected. Addressing biomechanical issues and nervous system interference through chiropractic care supports the physiological changes we aim to achieve with hormone therapy.

Navigating Hormone Therapy After a Diagnosis

Perhaps one of the most challenging and emotionally charged topics is hormone replacement therapy (HRT) for women experiencing significant hormonal decline and imbalance. The conventional approach has often been overly restrictive, leaving many women to suffer from debilitating symptoms.

It’s crucial to move beyond fear and have an evidence-based, individualized conversation. Here are some key considerations:

  • Progesterone and Thyroid Hormones are Generally Safe: There are virtually no contraindications for using bioidentical progesterone and thyroid hormones in most women. Progesterone is essential for mood, sleep, and bone health. Optimal thyroid function is equally vital for overall metabolic and emotional well-being.

Patients with hypothyroidism commonly experience profound fatigue, unexplained weight gain, cold intolerance, constipation, dry skin and hair, hair loss, depression, brain fog, muscle weakness, and joint pain. If unmanaged, it can lead to elevated cholesterol, slowed metabolism, cardiovascular strain, and long-term effects on heart and brain health. Conversely, hyperthyroidism often presents with unintended weight loss, heat intolerance, anxiety, irritability, rapid or irregular heartbeat, tremors, diarrhea, excessive sweating, and sleep disturbances. In the long term, it may contribute to bone density loss, muscle wasting, and increased cardiovascular risk.

  • Testosterone’s Role: Testosterone is a critical hormone for women, vital for energy, muscle mass, bone density, and libido. At physiologic doses with proper monitoring, it offers significant quality-of-life benefits with minimal conversion to estradiol.
  • The Estrogen Conversation: The decision to use estrogen is highly nuanced and depends on the patient’s overall health profile, symptom severity, bone density, and quality of life. Severe hypoestrogenism can lead to recurrent urinary tract infections, severe vaginal atrophy, bone loss, cognitive decline, osteoporosis, cardiovascular disease, and increased risk of Alzheimer’s—conditions that profoundly impact both longevity and daily well-being.

I have worked with many women who, after years of suffering from these symptoms, have made an informed decision to start carefully monitored, low-dose estrogen therapy when appropriate.

It is a disservice to patients to remove their autonomy in this decision-making process. My role is to provide the data, explain the physiology, and support the patient in making the choice that is right for them. We monitor them closely using the most appropriate hormone formulations and delivery methods.

Integrative Chiropractic Perspective

Women with hormonal and thyroid imbalances frequently experience increased muscle tension, restricted cervical and thoracic mobility, and heightened sympathetic nervous system activity. Gentle chiropractic adjustments, soft tissue work, diaphragmatic breathing techniques, and postural correction can help optimize nervous system function, reduce physical stress on the body, improve sleep, and support better endocrine regulation. This holistic approach enhances the effectiveness of HRT and addresses the full spectrum of symptoms patients face.

A Patient-Centered Philosophy

My clinical philosophy, as reflected in my work and professional history, is built on a partnership with the patient. It’s about empowering you with information and letting you make the final choice. I often tell my patients who are hesitant to try a new protocol, “What you’ve been doing hasn’t been working. Let’s try this for 8-12 weeks. If you don’t feel better, you can go back to what you were doing before.”

This approach builds trust and encourages adherence. It reframes the treatment not as a doctor’s mandate, but as a collaborative experiment to restore health. Over many years, I have seen this philosophy transform lives. Patients who other providers dismissed come to understand their own bodies and take control of their health journey.

Treating the patient, not the lab report, is the cornerstone of effective, modern medicine. By combining advanced diagnostics, evidence-based hormone protocols, and foundational support such as integrative chiropractic care, we can help our patients not just live longer but live better.

References

  • Langer, R. D. (2017). The evidence base for hormone therapy in postmenopausal women: A reappraisal. Therapeutic Advances in Endocrinology and Metabolism, 8(8), 119–126. https://doi.org/10.1177/2042018817717436
  • Medici, M., de Rijke, Y. B., Peeters, R. P., Visser, W., de Muinck Keizer-Schrama, S. M., Jaddoe, V. W., Hofman, A., Sun, C., Visser, T. J., & Tiemeier, H. (2013). Maternal early-pregnancy thyroid function is associated with subsequent child behavior problems: the Generation R study. Clinical Endocrinology, 79(3), 424–431. https://doi.org/10.1111/cen.12117
  • Travison, T. G., Araujo, A. B., O’Donnell, A. B., Kupelian, V., & McKinlay, J. B. (2007). A population-level decline in serum testosterone levels in American men. The Journal of Clinical Endocrinology & Metabolism, 92(1), 196–202. https://doi.org/10.1210/jc.2006-1375

SEO Tags: Hormone Optimization, Testosterone Therapy, Thyroid Health, Integrative Medicine, Functional Medicine, Chiropractic Care, Dr. Alex Jimenez, Estrogen Replacement, Bioidentical Hormones, T3 Therapy, Hypothyroidism, Low Testosterone, Men’s Health, Women’s Health, Anti-Aging, Wellness, Personalized Medicine, Evidence-Based, Sciatica Clinic

Advanced Hormone Care: A Comprehensive Guide

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Advanced Hormone Care: A Comprehensive Guide
Advanced Hormone Care: A Comprehensive Guide

Integrative Hormone Health, Iron Metabolism, and Safer Care Pathways: An Educational Post by Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST

Abstract

In this educational post, I guide you through a practical, research-informed journey across several intertwined topics I encounter in clinic every week: optimizing iron status and understanding ferritin; selecting intrauterine devices (IUDs) and navigating progestin families; the nuanced use of progesterone (oral and sublingual) and how dosing changes physiology; evaluating cortisol and thyroid markers with the right tests at the right time; supporting men’s reproductive health when testosterone therapy is used or discontinued; individualizing hormone therapy in patients with a history of breast pathology; addressing post–transient ischemic attack (TIA) and neurologic concerns around hormones; aligning estriol and estradiol choices to receptor biology; and troubleshooting thyroid symptoms when labs and lived experience don’t align. Throughout, I integrate chiropractic-informed, whole-person care to improve outcomes—leveraging biomechanics, autonomic balance, sleep, exercise, nutrition, and gut health—while presenting current evidence from leading researchers using modern, evidence-based methods. I include clinical observations from my practice (Sciatica Clinic) and professional notes from my LinkedIn case discussions, with an emphasis on practical workflows you can apply now.

Advanced Hormone Care: A Comprehensive Guide

Key takeaways:

  • Iron matters, but context matters more: absorption, hemorrhage, and inflammation reshape ferritin and transferrin saturation.
  • Not all progestins are the same: families differ in clot risk and neuropsychologic effects; route and dose reshape tolerance.
  • Use the right test for the right question: salivary multi-point cortisol and comprehensive thyroid panels prevent missteps.
  • Individualized hormone care can be safe and effective—even after complex oncologic histories—when co-managed and risk-stratified.
  • Integrative chiropractic care complements endocrine therapies by optimizing neuromusculoskeletal function, vagal tone, and metabolic flexibility.

Iron Metabolism, Ferritin, and Why “Low Iron” Is Never One Thing

When I evaluate fatigue, dizziness, hair shedding, or exercise intolerance, I start with a comprehensive iron panel, not just a single number. Ferritin is a useful but imperfect biomarker. It is both an iron-storage protein and an acute-phase reactant that rises during systemic inflammation.

  • Key labs I order:
    • Serum ferritin
    • Serum iron
    • Total iron-binding capacity (TIBC)
    • Transferrin saturation
    • Complete blood count (CBC) with indices
    • C-reactive protein (CRP) or hs-CRP

Physiology in brief:

  • Ferritin mirrors iron stores, but inflammation can elevate ferritin independent of true iron sufficiency. A low ferritin (<30 ng/mL) typically indicates depleted stores; however, a “normal” ferritin with high CRP may mask functional iron deficiency as iron is sequestered by hepcidin during inflammation (Ganz & Nemeth, 2012).
  • Transferrin saturation <20% with low ferritin supports iron deficiency; low saturation with high ferritin suggests anemia of chronic inflammation.

Why do patients become iron-deficient?

  • Blood loss: GI sources (occult bleeding, gastritis, IBD), heavy menses, postpartum loss.
  • Impaired absorption: celiac disease, H. pylori, achlorhydria, bariatric surgery, high calcium or phytates at meals.
  • Increased demand: pregnancy, endurance training.
  • Rare pediatric/neonatal considerations: transient newborn physiologic shifts and blood sampling can influence early labs.

Clinical reasoning:

  • Before iron repletion, I identify the “why.” Iron infusion or aggressive oral repletion, without identifying hemorrhage or malabsorption, is a short-term fix.
  • I often pair iron with vitamin C and separate it from calcium to improve absorption; I assess for hepcidin-mediated inhibition when inflammation is high and address the inflammatory driver first (Camaschella, 2015).

Integrative chiropractic fit:

  • Inflammatory tone is influenced by sleep, autonomic balance, and movement. I use gentle spinal manipulative therapy, breathing drills, and cervical/diaphragmatic mechanics to improve vagal tone, enhance gut motility, and reduce inflammation, which can normalize hepcidin rhythms and improve iron utilization.

Selected evidence:

  • Hepcidin regulation and the anemia of inflammation (Ganz & Nemeth, 2012).
  • Iron deficiency pathophysiology and management (Camaschella, 2015).

References:

Choosing IUDs and Understanding Progestin Families

Not all progestins are created equal. Their androgenic, estrogenic, and thrombotic profiles differ by family.

  • Common categories and notes:
    • Levonorgestrel (LNG, e.g., Mirena): potent local progestin effect with low systemic levels; may lower bleeding and dysmenorrhea; thrombotic risk appears lower than systemic progestins (Dragoman et al., 2018).
    • Norethindrone and derivatives: different androgenicity; oral forms can affect lipids and mood variably.
    • Progesterone (bioidentical micronized): distinct from synthetic progestins; oral micronized progesterone shows a neutral or lower VTE risk compared to some synthetic progestins (Canonico et al., 2007).

Why the levonorgestrel IUD works:

  • Primarily a local endometrial effect—thickens cervical mucus, thins endometrium, and blunts prostaglandin signaling—reducing bleeding and cramps. Localization limits hepatic first-pass effects and minimizes systemic coagulation changes (Nelson, 2021).

Clinical reasoning for selection:

  • In patients with migraine with aura or thrombotic risk concerns, I favor LNG-IUD for contraception and menorrhagia control due to its local action.
  • For estrogen therapy when a uterus is present, local or systemic progestin is needed to protect the endometrium; LNG-IUD can provide endometrial protection while minimizing systemic exposure.

Integrative chiropractic fit:

  • Pelvic floor dysfunction often coexists with dysmenorrhea or heavy bleeding. My team integrates pelvic floor therapy and lumbopelvic stabilization to reduce nociceptive input and sympathetic overdrive, supporting better tolerance of IUD placement and reduced pelvic pain.

References:

Progesterone Dosing, Tolerance, and Why Route Matters

I routinely see patients who “don’t tolerate progesterone.” Most tolerate it when we match dose, timing, and route to physiology.

  • Oral micronized progesterone:
    • First-pass hepatic metabolism generates neuroactive metabolites (e.g., allopregnanolone) that can cause sedation or paradoxical dysphoria in sensitive patients (Schiller et al., 2014).
    • 100 mg at bedtime is well tolerated by most; if grogginess occurs, I adjust the dose or timing.
  • Sublingual troches:
    • Avoid first-pass metabolism; bioavailability roughly doubles compared with the oral route. Clinically, 100 mg sublingual is approximately equivalent to 200 mg oral for systemic effects.
    • Flexible dosing (e.g., quarter troches) allows fine-tuning for sleep or mood.

Why I choose sublingual for sensitive patients:

  • Faster onset for sleep; lower neurosteroid spikes; fewer “hangover” effects.
  • For severe PMS/PMDD, luteal-phase pulsing with sublingual progesterone can stabilize GABAergic tone.

Safety rationale:

  • Bioidentical progesterone has a favorable cardiovascular and breast cancer risk profile compared with some synthetic progestins, according to observational data (Fournier et al., 2008). Individualization remains key.

Integrative chiropractic fit:

  • I layer in circadian routines (morning light, consistent sleep windows), cervical/thoracic mobilizations to ease breathing, and slow exhalation drills to potentiate the GABAergic calming effect of progesterone.

References:

Cortisol Testing and When a Single AM Level Isn’t Enough

If I need to understand diurnal HPA-axis behavior, I use a 4–5-point salivary or dried-spot cortisol test throughout the day. A single AM cortisol can rule out frank adrenal insufficiency, but misses the curve shape.

  • Physiologic basis:
    • The cortisol awakening response and diurnal slope predict metabolic risk and sleep quality; a flattened diurnal slope is linked to inflammation and fatigue (Adam et al., 2017).
  • Practical approach:
    • For suspected HPA-axis dysregulation, I order multi-point testing.
    • For acute screening, I add an 8 AM serum cortisol to labs like fasting glucose/insulin when assessing metabolic stress.

Integrative chiropractic fit:

  • I introduce graded exercise, postural decompression, and breathing to modulate autonomic tone; we also address sleep timing and light exposure to restore a healthy diurnal cortisol rhythm.

References:

Male Fertility, Testosterone Therapy, and Short-Term Clomiphene

When young men or those considering testosterone want to preserve fertility, we avoid long-term estrogen receptor blockade but may use short courses of clomiphene citrate.

  • Physiology:

    • Exogenous testosterone suppresses GnRH, lowering LH/FSH and reducing intratesticular testosterone and spermatogenesis.
    • Clomiphene blocks hypothalamic estrogen receptors, raising LH/FSH to stimulate endogenous testosterone and sperm production (Patel et al., 2019).

Clinical reasoning:

  • In men in their 20s–30s seeking conception within 6–12 months, I consider 3–6 months of clomiphene to increase sperm count and testosterone, then reassess.
  • After stopping androgens/peptides, a brief course of SERMs may hasten spermatogenic recovery.

Lifestyle first:

  • Diet quality, resistance training, sleep, weight reduction, and gut health can substantially improve testosterone and fertility without pharmaceuticals. I’ve seen total testosterone rise from ~300 ng/dL to 700–800 ng/dL over 6–9 months with dedicated lifestyle changes.

Integrative chiropractic fit:

  • Correcting thoracic mobility and rib cage mechanics improves contributors to sleep-disordered breathing; lumbar-pelvic stability supports training adherence; we also program progressive resistance exercise with recovery metrics.

References:

Breast Pathology, Receptors, and Individualized Hormone Decisions

Terminology matters for decision-making and informed consent. Ductal carcinoma in situ (DCIS) is non-invasive and considered stage 0; it is a precursor lesion managed actively but biologically distinct from invasive carcinoma (Wapnir & Dignam, 2019). Receptor positivity alone is not a contraindication to all hormones; risk is contextual.

Clinical approach I use:

  • Shared decision-making with oncology, documenting risks and benefits, and considering:
    • Time since diagnosis and treatment completion.
    • Extent of surgery (e.g., bilateral mastectomy vs. lumpectomy).
    • Current endocrine therapy (e.g., tamoxifen, aromatase inhibitors).
    • Symptom burden (vasomotor, bone, cognition, cardiometabolic).

Evidence overview:

  • For women with prior breast cancer, systemic menopausal hormone therapy is generally not recommended by guidelines due to recurrence risk uncertainty; however, low-dose vaginal estrogen for severe genitourinary symptoms may be considered in selected cases with oncology input (North American Menopause Society [NAMS], 2023).
  • After bilateral mastectomy, systemic risk calculus changes, but decisions remain individualized.

Integrative chiropractic fit:

  • We address bone density with resistance training programs, impact loading when appropriate, balance training, and spinal mechanics; autonomic regulation helps vasomotor stability. These non-pharmacologic supports often reduce the dose or need for systemic hormones.

References:

Post-TIA, Migraine, and Hormones: Rethinking Old Assumptions

Old teaching linked “estrogen” broadly to stroke and migraine risk. Modern nuance:

  • Oral ethinyl estradiol at higher doses elevates stroke risk, especially in smokers or migraine with aura (Sacco et al., 2017).
  • Transdermal estradiol at low doses appears to have a more favorable thrombotic profile than oral routes in menopausal therapy (Vinogradova et al., 2019).
  • Testosterone therapy in physiologic ranges in women lacks evidence of increasing stroke risk; the largest safety concerns are dose-dependent, androgenic side effects.

Clinical reasoning:

  • In patients with TIA history, I avoid high-dose oral estrogens; if menopausal therapy is needed, I consider transdermal estradiol at the lowest effective dose with aggressive vascular risk modification.
  • For migraine, stabilizing sleep, reducing triggers, and improving cervical mechanics can decrease attack frequency; if hormones are used, we match route and dose to the vascular risk profile.

Integrative chiropractic fit:

  • Cervicogenic contributions to migraine are significant. I employ gentle cervical mobilization, deep neck flexor training, scapular stabilization, and breathing strategies, which reduce trigeminocervical convergence and sympathetic reactivity.

References:

Estriol, Estradiol, Receptor Biology, and Skin

Estriol (E3) is a weaker estrogen with greater preference for ER-β; estradiol (E2) is potent and engages both ER-α and ER-β. For skin benefits:

  • Estradiol improves collagen content, skin thickness, and elasticity more robustly than estriol because of its higher receptor potency (Callens et al., 2014).
  • Estriol creams may provide relief of local skin or vulvovaginal symptoms with minimal systemic absorption, but are often insufficient for vasomotor symptoms.

Clinical reasoning:

  • If vasomotor symptoms persist on estriol, I evaluate serum estradiol levels and consider adding or switching to low-dose transdermal estradiol, ensuring endometrial protection when needed.
  • I avoid overreliance on “weak” estrogens for systemic symptoms; match the molecule to the therapeutic goal.

Integrative chiropractic fit:

  • Collagen support is multifactorial; I combine adequate protein intake, resistance training, and photobiomodulation with careful spinal and fascial work to enhance tissue quality.

References:

Thyroid Physiology, Reverse T3, and Getting the Dosing Right

I often see patients on levothyroxine (T4) who still feel unwell despite “normal” labs. Here is my framework:

  • Physiology:

    • T4 monotherapy relies on peripheral conversion to T3; inflammation, caloric restriction, and stress can increase deiodinase 3 activity, raising reverse T3 (rT3) and reducing T3 signaling (Bianco et al., 2019).
    • Large, single daily T4 doses may transiently increase rT3 in sensitive individuals; desiccated thyroid or divided dosing of T3/T4 can improve some patients’ symptoms when carefully monitored.

  • Testing:

    • TSH, free T4, free T3, reverse T3, thyroid peroxidase (TPO) antibodies, thyroglobulin antibodies, and ferritin/iron if symptoms persist.

  • Clinical approach:

    • If free T3 is low-normal and symptoms remain, I consider adding small, divided doses of liothyronine (T3) or transitioning to combination therapy, while tracking heart rate, symptoms, and labs.
    • For Hashimoto’s, I pair thyroid hormone with gut-directed care (gluten assessment when appropriate, SIBO evaluation, selenium and vitamin D repletion, and iodine only when indicated).

Integrative chiropractic fit:

  • Cervical and thoracic mobility improves breathing efficiency and sleep quality, which in turn modulates HPT-axis signaling. I also focus on anti-inflammatory nutrition and graded exercise to reduce rT3-driving stressors.

References:

Putting It Together: A Whole-Person Care Plan

I integrate endocrine pharmacology, precision diagnostics, and musculoskeletal-neuroautonomic care to amplify results:

  • For iron deficiency with inflammation:
    • Treat the inflammatory trigger, appropriately replete iron, train breathing and sleep, and progress resistance exercise to improve erythropoiesis.
  • For progesterone intolerance:
    • Switch to sublingual, adjust dose/timing, align with sleep hygiene, and leverage relaxation-based spinal care to reduce anxiety and improve tolerance.
  • For male fertility on/off testosterone:
    • Time-limited clomiphene with lifestyle upgrades; add pelvic and thoracic mechanics to facilitate training and sleep.
  • For complex breast histories:
    • Co-manage with oncology, use the safest route/dose possible when indicated, and maximize non-hormonal strategies for bone, brain, and vasomotor health.
  • For thyroid symptom discordance:
    • Expand testing, consider combination therapy, and aggressively manage gut and sleep contributors while optimizing movement.

Clinical notes from my practice:

  • In Sciatica Clinic cases, autonomic recalibration through diaphragmatic breathing combined with cervical-thoracic mobilization often reduces hot flashes and sleep fragmentation within 2–4 weeks.
  • LinkedIn case threads highlight that structured resistance training 3 days/week, plus 30 minutes of zone 2 cardio 2 days/week, reliably improves insulin sensitivity and raises endogenous testosterone in young men without medications over 12–24 weeks.

Final Thoughts

Evidence-based hormone care is not about a single lab or a single drug. It is about understanding physiology—iron flux under hepcidin control; progestin family pharmacology; HPA and HPT axis rhythms; estrogen receptor biology—and then placing each therapy into a context that includes sleep, nutrition, biomechanics, and stress regulation. Integrative chiropractic care fits naturally within this model by improving pain, function, and autonomic balance, thereby enhancing adherence and magnifying the benefits of endocrine therapies. When we do this thoughtfully—guided by the latest research and careful shared decision-making—we help patients feel and function better, safely and sustainably.

What is the role of HORMONES in our physiology? | El Paso, Tx (2021) EPISODE 2

References

Hormones: Understanding Their Roles for Thyroid Optimization

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-

Dive into the importance of thyroid optimization for hormones and their effects on health. Enhance your well-being with knowledge.

Abstract

In this educational post, I share how I evaluate, treat, and co-manage complex thyroid dysfunction using modern, evidence-based methods that align with real-world physiology and patient experience. I explain why many patients remain symptomatic despite “normal” thyroid-stimulating hormone (TSH) levels, how tissue-level thyroid signaling depends on deiodinase enzymes and mitochondrial function, and why the active hormone triiodothyronine (T3) often predicts outcomes better than TSH or T4. I outline practical algorithms for testing and treatment, compare levothyroxine (T4), liothyronine (T3), and desiccated thyroid therapy, and show how to time labs and split doses for safety and efficacy. I also describe how integrative chiropractic care fits into thyroid optimization by modulating autonomic tone, reducing pain-driven stress, and improving movement capacity. Throughout, I draw on leading research, my clinical observations from sciatica.clinic, and my professional updates, integrating nutrition, sleep, stress physiology, and neuromusculoskeletal care to restore true tissue euthyroidism.

Why Thyroid Physiology Matters

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. My commitment to thyroid care is both professional and personal. Early in life, I have treated patients who underwent total thyroid ablation and have lived for decades without native thyroid function. I have heard and felt the physiological weight of profound hypothyroidism—when my TSH exceeded 150 mIU/L during diagnostic withdrawal phases—and I bring that perspective into my care for thousands of patients.

In my integrative chiropractic practice, I have repeatedly seen a disheartening pattern: patients with “normalized” TSH on levothyroxine (LT4) who still struggle with persistent symptoms. Many describe classic hypothyroid effects such as debilitating fatigue, cold intolerance, constipation, weight gain, brain fog, slowed cognition, hair thinning, dry skin, low mood or depression, muscle weakness, and exercise intolerance. Others present with disruptive hyperthyroid manifestations, including unintended weight loss despite increased appetite, heat intolerance, anxiety or irritability, rapid heartbeat or palpitations, diarrhea, tremors, restlessness, insomnia, and excessive sweating.

That disconnect drove me to refine a physiology-first approach that prioritizes tissue-level thyroid signaling over mere lab normalization. By incorporating precise chiropractic adjustments to optimize spinal alignment and autonomic nervous system function, I help support better endocrine regulation and close the gap between lab values and real-life vitality.

Across clinical settings—including my work highlighted on sciatica—in the clinic and on my professional page, I have learned that optimizing free T3, stabilizing autonomic tone, and correcting metabolic barriers consistently lead to better function and quality of life.

Thyroid Physiology 101: From the HPT Axis to the Cell

The thyroid system is the body’s metabolic conductor. The hypothalamus produces TRH, the pituitary releases TSH, and the thyroid secretes mainly T4 with some T3. Most active T3 is produced in peripheral tissues by deiodinases:

  • D1 (liver, kidney, thyroid): Converts T4 to T3 and is sensitive to inflammation, stress, toxins, insulin resistance, and caloric restriction (Bianco & da Conceição, 2018).
  • D2 (brain, pituitary, brown adipose): Maintains local T3 for neuroendocrine control; the pituitary “sees” adequate T3 even when other tissues are low (Bianco & Kim, 2006).
  • D3 (placenta, fetal tissues, illness states): Inactivates T4 to reverse T3 (rT3) and T3 to T2; upregulated in chronic stress and illness (Fliers et al., 2014).

Why does this matter? Because TSH is a central, not a peripheral, readout. In treated patients, the pituitary may have sufficient T3 via D2 receptors to suppress TSH, while peripheral tissues remain T3-deficient. This explains why a patient can have a “normal” or low TSH, a normal free T4, yet a low free T3 with elevated rT3—and still feel hypothyroid (Hoermann et al., 2019; Wiersinga, 2019).

  • Key point: Free T3 better reflects the bioactive hormone available to tissues. In multiple clinical contexts—cardiology, critical illness, and cognition—low T3 predicts worse outcomes even when TSH and T4 look “acceptable” (Peeters, 2017; Fliers et al., 2014).

Why Patients Stay Symptomatic With “Normal” TSH

Patients can remain symptomatic despite a normalized TSH for several reasons:

  • Tissue-specific deiodinase balance: D1 downregulation and D3 upregulation reduce T3 availability while raising rT3 (Bianco & da Conceição, 2018).
  • Serum vs intracellular mismatch: Serum-free T3 can be “normal” while intracellular T3 is low in stressed or inflamed tissues.
  • Mitochondrial energetics: T3 drives mitochondrial biogenesis, ATP production, and thermogenesis. Low tissue T3 levels manifest as fatigue, cold intolerance, and a reduced metabolic rate (Yen, 2001).
  • Set-point individuality: Each person’s optimal zone may differ within the reference range.
  • Genetic variation: Polymorphisms such as DIO2 Thr92Ala can alter conversion and symptom response (Panicker et al., 2009).

When this physiology is understood, the “TSH-is-enough” mindset gives way to a more nuanced, patient-centered approach.

Testing That Matches Physiology

When symptoms persist on LT4, I expand testing beyond TSH:

  • Free T3, free T4, and reverse T3 to evaluate active signaling and inactivation pathways.
  • Thyroid antibodies (TPO, Tg) to identify autoimmune drivers.
  • Micronutrients critical for hormone synthesis/activation: iron and ferritin, selenium, zinc, vitamin D, B12, folate.
  • Metabolic and inflammatory markers: lipids, A1c/insulin (HOMA-IR), hs-CRP, liver enzymes.
  • Sleep and stress: apnea risk, cortisol rhythm, HRV when available.
  • GI assessment, when indicated, for dysbiosis, SIBO, and bile flow, as the gut-liver-thyroid axis shapes conversion and clearance (Mantovani et al., 2018).

I also standardize lab timing for T3-containing regimens. Because oral T3 peaks 1–2 hours post-dose and declines over 4–8 hours, I draw labs 5–6 hours after the morning dose to capture a representative mid-curve value (Jonklaas et al., 2014). This reduces misinterpretation of transient peaks and makes visits comparable over time.

Treatment Principles: Restoring Tissue-Level Thyroid Signaling

My treatment aims to deliver the right hormone, in the right amount, to the right tissues, at the right time, while removing barriers to conversion.

  • Address the terrain
    • Reduce inflammation and insulin resistance through protein-forward, minimally processed nutrition, omega-3s, and fiber.
    • Improve sleep and treat sleep apnea, which strongly impair thyroid and weight outcomes.
    • Replete selenium, zinc, iron/ferritin, vitamin D, and B12 to support deiodinases and thyroid peroxidase.
    • Manage stress physiology with HRV training, breathing practices, and pacing to reduce D3 upregulation.
  • Optimize hormone replacement
    • Many patients thrive on LT4 monotherapy, especially when conversion is robust.
    • If free T3 remains low-normal or rT3 is elevated with persistent symptoms, I consider:
      • LT4 + LT3 in low, split doses (e.g., 2.5–5 mcg BID) to smooth peaks and better match diurnal physiology (Jonklaas et al., 2014).
      • Desiccated thyroid extract (DTE/NDT) in selected patients who prefer or respond better to a fixed T4:T3 profile, titrating cautiously and monitoring labs and vitals (Hoang et al., 2013).
    • I avoid unnecessary TSH suppression in non-cancer patients due to bone and cardiac risks, while coordinating individualized targets for thyroid cancer survivors in line with consensus guidelines (Haugen et al., 2016).
  • Monitor what matters
    • Reassess free T3, free T4, and rT3 after dose changes.
    • Track heart rate, blood pressure, HRV, sleep quality, bowel motility, mood, cognition, and exercise tolerance.
    • Time labs consistently 5–6 hours post-dose in T3-containing regimens for apples-to-apples comparisons.

Why T3 Often Drives Clinical Outcomes

The heart, brain, and mitochondria “read” T3 as the immediate metabolic signal. Multiple lines of evidence show that low free T3 correlates with worse outcomes in heart failure, acute coronary syndromes, stroke, and critical illness, whereas TSH and T4 are less predictive (Iervasi et al., 2003; Fliers et al., 2014; Peeters, 2017). Mechanistically, T3 supports:

  • Cardiac inotropy and lusitropy via calcium handling and SERCA2a expression.
  • Mitochondrial oxidative phosphorylation and ATP generation.
  • Endothelial function and microcirculatory flow.
  • Neurotransmission and synaptic plasticity, with relevance in mood and cognition.

Clinically, this is why patients often report warmer hands, clearer thinking, improved stamina, and better bowel function when free T3 moves from the lower to the mid–upper reference percentiles, under careful monitoring.

Thyroid Dysfunction-Video

THYROID DYSFUNCTION ***MUST WATCH*** (Assessment and treatment) | El Paso, Tx (2022)

Practical Dosing and Lab-Timing Strategies

I match pharmacology to physiology:

  • Liothyronine (T3) has a short half-life and a quick peak. I favor BID dosing to flatten peaks and reduce palpitations or jitteriness.
  • With DTE, dividing the daily dose (morning and early afternoon) often yields steadier energy and cognition.
  • When adding T3 to LT4, I typically reduce LT4 by 12.5–25 mcg and add 2.5–5 mcg of T3 BID, then reassess symptoms and mid-curve labs at 4–6 weeks.
  • If wearables show HR spikes 1–3 hours post-dose, I redistribute dosing rather than simply reducing the total dose. I also check caffeine timing, hydration, pain flares, and sleep—common confounders of “hyper” sensations.

Documenting off-label T3 use clearly—indication, response, dosing, and safety monitoring—supports high-quality, transparent care (Biondi & Wartofsky, 2014).

Integrative Chiropractic Care: Aligning Endocrine and Autonomic Systems

As a chiropractor and advanced practice nurse, I see daily how autonomic balance, pain, and movement capacity shape thyroid symptom expression and treatment tolerance. Integrative chiropractic care complements endocrine optimization by:

  • Modulating sympathetic overdrive and enhancing vagal tone through evidence-informed spinal manipulation, soft-tissue therapy, and neuromuscular reeducation. A lower-stress tone eases the cortisol burden, supports D1 activity, and tempers D3, improving T3 availability.
  • Improving biomechanics and microcirculation. Better rib and thoracic mobility enhances chest wall mechanics and oxygen delivery, synergizing with T3-driven mitochondrial ATP production.
  • Reducing nociceptive input. Chronic pain is a metabolic stressor; treating pain sources lessens neuroendocrine strain and supports thyroid conversion.
  • Reinforcing behavioral anchors. With each visit, I re-coach sleep, breathing, and movement habits that stabilize physiology.

In my clinical observations at the sciatica clinic and in professional updates, patients whose thyroid therapy is coordinated with chiropractic-directed movement and breathing strategies report faster improvements in energy, less constipation, and better weight trajectories compared with hormone-only care.

The Gut-Liver-Thyroid Axis and Micronutrients

The liver is a primary site of T4-to-T3 conversion; NAFLD reduces deiodinase activity and T3 availability (Mantovani et al., 2018). The microbiome affects bile acids and metabolic signaling, while constipation from low T3 worsens dysbiosis and toxin recirculation. My approach:

  • Support bile flow and motility with fiber diversity, magnesium, bitters, and targeted probiotics.
  • Screen and treat SIBO/dysbiosis when indicated.
  • Correct iron deficiency (aiming for ferritin >50–70 ng/mL in menstruating patients) and maintain selenium and zinc sufficiency to facilitate hormone synthesis and conversion.
  • Personalize iodine intake with selenium support; in autoimmunity, repletion must be careful and monitored.

When these fundamentals are addressed, I often see reduced dose requirements and improved symptom stability.

Clinical Algorithm: From Assessment to Optimization

  • Foundational assessment
    • Detailed history: symptom clusters, weight trajectory, menstrual/testosterone history, medications, iodine exposure.
    • Labs: TSH, free T4, free T3, rT3, TPO/Tg antibodies, ferritin/iron studies, B12/folate, vitamin D, selenium, zinc, A1c/insulin, lipids, hs-CRP, liver enzymes.
    • Comorbidities: sleep apnea risk, NAFLD, insulin resistance, depression/anxiety, GI symptoms.
    • Musculoskeletal screen: pain generators, joint restrictions, breathing pattern, posture, autonomic load.
  • Initial interventions
    • Titrate LT4 to relieve symptoms with TSH in the target range and free T4 mid-reference.
    • Implement a protein-forward, anti-inflammatory nutrition plan; begin resistance and aerobic training scaled to pain and capacity.
    • Begin chiropractic care to address segmental dysfunction and sympathetic overdrive; integrate breathing retraining.
  • Reassessment at 6–8 weeks
    • If symptoms persist with low-normal free T3 or elevated rT3, consider adding T3 (2.5–5 mcg BID) or a cautious DTE trial, with shared decision-making.
    • Address sleep apnea, cortisol dysregulation, and dysbiosis.
  • Advanced considerations
    • Suspected DIO2 polymorphism or tissue-level hypothyroidism: justify careful T4+T3 combination therapy.
    • Cardiometabolic risk: treat insulin resistance; consider GLP-1/GIP agents when indicated; and recheck thyroid dosing, as weight changes alter requirements.
    • Safety: Avoid unnecessary TSH suppression; monitor bone density and rhythm in at-risk patients.
  • Long-term maintenance
    • Aim for stable energy, thermoregulation, cognition, bowel function, and activity tolerance, with free T3 in a patient-centered optimal zone and TSH appropriate to the clinical context.
    • Keep protocols as simple as possible while meeting physiologic needs.

What I See in Practice

Across patient cohorts highlighted at sciatica. clinic and in my professional updates, several patterns recur:

  • Patients on long-standing LT4 monotherapy with low-normal free T3 levels frequently improve with small additions of LT3 or carefully titrated DTE (Hoang et al., 2013).
  • Chronic constipation often resolves with thyroid normalization but responds best when paired with mobility, diaphragmatic breathing, and mineral/fiber repletion.
  • Weight outcomes improve when hormone optimization coincides with progressive resistance training, better sleep, and the treatment of apnea.
  • Patients with high pain burden progress more slowly until nociceptive drivers are reduced through integrative chiropractic and rehabilitation.

These observations support a simple truth: the endocrine, neural, and biomechanical systems function as a network. Treat the network, and outcomes improve.

Putting It All Together

  • Focus on the bioactive hormone: free T3 often correlates best with how patients feel and function.
  • Use TSH as a screen, not as the sole determinant of euthyroidism in treated patients.
  • Consider combination therapy or DTE for persistent symptoms with low-normal free T3 or high rT3, using split dosing to flatten peaks and improve tolerability.
  • Standardize lab timing (5–6 hours post-dose) for T3-containing regimens to ensure reliable, actionable data.
  • Integrate chiropractic care to reduce sympathetic load, improve sleep and movement, and enhance metabolic flexibility.
  • Track outcomes that matter: energy, cognition, pain, exercise capacity, HRV, and cardiometabolic markers—not just lab ranges.

My north star is restoring tissue-level thyroid signaling safely and sustainably, while aligning the autonomic and musculoskeletal systems to support the endocrine axis. In my experience, this integrated, evidence-guided model helps patients recover faster, feel better, and live more fully.

References

SEO tags: thyroid optimization, hypothyroidism treatment, free T3, reverse T3, TSH limitations, levothyroxine vs desiccated thyroid, combination T4 T3 therapy, deiodinase enzymes, mitochondrial metabolism, autonomic balance, integrative chiropractic care, gut liver thyroid axis, sleep apnea and thyroid, adaptive thermogenesis, evidence-based functional medicine, Dr. Alexander Jimenez DC APRN, sciatica clinic

Revitalizing Thyroid Health: A Patient-Centered Approach

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Revitalizing Thyroid Health: A Patient-Centered Approach
Revitalizing Thyroid Health: A Patient-Centered Approach

Revitalizing Thyroid Health: A Modern, Integrative Approach to Overcoming Thyroid Insufficiency

Abstract

As a practitioner with decades of experience in integrative and functional medicine, holding titles including DC, APRN, FNP-BC, CFMP, IFMCP, ATN, and CCST, I’ve dedicated my career to unraveling complex health issues by focusing on the body’s innate physiology. In this educational post, we will journey into the intricate world of thyroid health, challenge conventional wisdom, and explore a more nuanced, patient-centered approach. I will present the latest findings from leading researchers, backed by modern, evidence-based methods, to explain why the standard TSH-focused treatment often fails our patients. We will explore the critical roles of T4, T3, and reverse T3; understand the different types of thyroid dysfunction; and uncover the profound connection between low T3 and a spectrum of health issues, including cardiovascular disease and depression. We will discuss why relying solely on T4 medication, such as Synthroid, is physiologically flawed, explore the practicalities of dosing with natural desiccated thyroid, and debunk common myths about thyroid therapy and bone health. Finally, we will discuss how an integrative chiropractic approach, combined with a functional medicine perspective, offers a comprehensive path toward restoring true thyroid balance and overall well-being.

Revitalizing Thyroid Health: A Patient-Centered Approach

The Flaw in Conventional Thyroid Treatment

My clinical observations at the Sciatica & Back Pain Clinic consistently reveal patients who are tired, cold, constipated, and losing their hair, yet their doctors tell them their thyroid treatment is working perfectly based on a normal TSH. For example, I recently saw a patient in my Texas clinic in July wearing a jacket. Her lab report showed a “normal” TSH, but her list of symptoms screamed hypothyroidism. If her thyroid replacement was truly working, she wouldn’t have any of those symptoms. Clearly, something is not working.

The crux of the problem dates back to the 1960s. Synthroid (levothyroxine), a synthetic T4 hormone, was approved based on its ability to do two things: normalize the Thyroid-Stimulating Hormone (TSH) and not cause immediate harm. Around the same time, the ultra-sensitive TSH assay became the new gold standard in lab testing. Medical schools and residency programs immediately adopted this protocol: diagnose hypothyroidism, prescribe Synthroid, and monitor the TSH. If the TSH is in the “normal” range, the patient is considered adequately treated.

This approach is fundamentally flawed because it’s based on a massive physiological assumption: that the body will efficiently and correctly convert the inactive prohormone T4 into the active hormone T3. As we’ll see, this assumption is often incorrect, leaving millions of people suffering.

Understanding Thyroid Hormone Physiology

To truly grasp why the conventional model fails, we must return to basic physiology. Your thyroid gland is the master regulator of your metabolism. The story of thyroid function is not just about TSH and T4.

  • T4 (Thyroxine): This is the primary hormone produced by the thyroid gland. It contains four iodine molecules and is largely considered a prohormone—a storage hormone that is relatively inactive.
  • T3 (Triiodothyronine): the biologically active thyroid hormone. It is created when an iodine molecule is removed from T4. Free T3 (fT3) is the unbound, usable form that actually runs your metabolism. It has about five times the affinity for thyroid receptors in your cells compared to T4.
  • Reverse T3 (rT3): T4 can also be converted to rT3. rT3 is an inactive metabolite that acts like a key that fits into the cellular receptor’s lock but doesn’t turn. It effectively blocks the active T3 from doing its job, creating a state of cellular hypothyroidism.

When your thyroid is healthy, it produces a symphony of hormones, including T1, T2, T3, T4, and calcitonin. The idea that we can replace this complex process by taking a single massive dose of a synthetic hormone (T4) once a day and expect the body to figure it out perfectly is, frankly, physiologically arrogant.

The Different Types of Thyroid Insufficiency

Endocrinology societies often define hypothyroidism simply by a high TSH. But this is an incomplete picture. I prefer to use the term “thyroid insufficiency” because a person can have symptoms of low thyroid function even with a “normal” TSH.

  • Type 1: Primary Hypothyroidism: This is a decreased production of hormones by the thyroid gland itself, often caused by autoimmune disease (Hashimoto’s), surgery, or radioactive iodine treatment. This is the classic form of hypothyroidism.
  • Type 2: Poor Conversion (Low T3 Syndrome): This is an incredibly common yet frequently missed issue. The thyroid gland produces enough T4, but the body fails to convert it effectively into active T3. Since about 80% of your active T3 comes from this peripheral conversion, any impairment here will lead to symptoms, regardless of your TSH level.
  • Type 3: Receptor Resistance: This is a state where cellular thyroid receptors become resistant to the hormone, similar to insulin resistance in diabetes. Even if you have adequate levels of T3 in the blood, it can’t get into the cells to do its job.

Why TSH is an Unreliable Marker for Treated Patients

The TSH test was designed as a screening test for an asymptomatic population. The inventor of the TSH assay himself stated it was never intended to monitor therapy in treated patients. The problem lies in a critical physiological detail: the brain, where the pituitary gland resides, has a different enzyme (deiodinase type 2, or DIO2) for converting T4 to T3 than the rest of the body (deiodinase type 1, or DIO1).

Your pituitary produces TSH in response to the amount of thyroid hormone it senses. If your brain is happily making its own T3, your pituitary will think everything is fine system-wide. It will reduce its TSH signal, even if your muscles, liver, and gut are starving for active T3. Your TSH will be “normal” or even low, while you feel exhausted, cold, and depressed. This is why a TSH test alone cannot tell you what is happening at the cellular level throughout the body.

A study looking at patients with suppressed TSH levels while on therapy found that only 16% were actually over-treated. The other 84% had appropriate thyroid levels. Relying on TSH would have led to 84% of those patients being incorrectly undertreated. A low TSH in a treated patient simply means the brain is no longer asking for more thyroid hormone; it does not mean “too much.” The only way to know is to measure the hormones themselves.

The Negative Feedback Loop and Rise of Reverse T3

Our bodies operate on elegant negative feedback loops. The pituitary releases TSH; the thyroid releases T4 and T3; and these hormones then signal the pituitary to slow TSH production. When we flood this system with a daily dose of synthetic T4 (e.g., Synthroid), the pituitary senses the excess T4 and immediately shuts down TSH production. This also tells your own thyroid gland to stop making the 20% of T3 it was producing directly.

Simultaneously, the body sees this influx of T4 as a potential overdose. To protect itself, it down-regulates the DIO1 enzyme responsible for converting T4 into active T3 and shunts excess T4 into an alternative pathway, converting it into the inactive reverse T3 (rT3).

The result? You have less T3 being made, and the T3 you do have is being blocked at the receptor site by excess rT3. The patient develops all the symptoms of low thyroid. When I see a patient on T4-only therapy, I always run a full panel. Almost invariably, I find that their T3 is low and their reverse T3 is high, proving that the conversion process has failed.

The Cardiovascular Connection: Low T3 and Heart Health

The medical field that has most urgently latched onto the importance of T3 is cardiology. Research consistently shows that regardless of the specific cardiac diagnosis—be it heart attack, stroke, or congestive heart failure—patients admitted to the hospital with low serum T3 levels have a significantly higher mortality risk.

Why is T3 so important for the heart?

  • Energy Production: The heart is an incredibly energy-demanding organ. T3 is essential for regulating mitochondrial function and ATP (energy) production within cardiac cells.
  • Collateral Blood Vessel Formation: T3 promotes angiogenesis, the formation of new blood vessels. In patients with coronary artery blockages, the ability to form collateral vessels can be life-saving. Low T3 levels can impair this protective mechanism.

Optimizing thyroid function is not just about feeling better; it’s a fundamental strategy for cardiovascular protection.

What Impairs T4 to T3 Conversion?

The list of factors that cause the body to downregulate T4-to-T3 conversion reflects the stressors of modern life and describes a significant portion of the patient population I see every day.

  • Psychological Stress: Including depression and anxiety.
  • Metabolic Issues: Insulin resistance is a major driver of poor conversion.
  • Inflammation: From any source, including injury, infection, or diet.
  • Chronic Illness: Chronic fatigue syndrome, fibromyalgia, and chronic pain.
  • Nutrient Deficiencies: Iron deficiency is a particularly critical factor, along with selenium and zinc.
  • Toxins: Environmental exposure from air, water, and food.
  • Aging: The natural aging process reduces conversion efficiency.

Looking at this list, it’s not an exaggeration to suggest that a vast majority of the adult population is likely experiencing some degree of impaired T4-to-T3 conversion.

Debunking Myths: Thyroid Therapy, TSH, and Bone Health

One of the most persistent myths in endocrinology is that optimizing T3 therapy, which may lead to a suppressed TSH, will invariably cause osteoporosis. The evidence does not support this claim. A meta-analysis reviewing 70 years of data found no significant change in bone mineral density in patients with suppressed TSH from thyroid therapy. In study after study, there has been no evidence of increased fracture risk. When managed properly by monitoring Free T3 levels and patient symptoms, T3 therapy does not pose a risk to bone health; it restores a more youthful, optimal physiological state.

The Integrative Chiropractic Perspective on Thyroid Health

As an integrative chiropractic physician, my approach is rooted in understanding the body as a whole, interconnected system. My philosophy, which you can explore through my professional profile on LinkedIn, integrates multiple disciplines to restore the body’s innate ability to heal.

  • Nervous System Regulation: The autonomic nervous system directly influences hormone production. Chiropractic adjustments can help balance the autonomic nervous system, reducing chronic stress signals that can impair thyroid function and the conversion of T4 to T3.
  • Structural Integrity and Inflammation: Misalignments in the cervical spine (neck) can interfere with nerve signals and the blood supply to the thyroid gland. By correcting these structural imbalances through targeted adjustments and rehabilitative exercises, we can reduce systemic inflammation and create a more favorable physiological environment for the gland to function.
  • Holistic Support: When I see a patient with chronic back pain, sciatica, or fibromyalgia, I investigate the underlying physiological drivers. Low T3 compromises tissue repair and energy levels, making it harder to heal from musculoskeletal injury. By optimizing their thyroid function, we improve their energy and healing capacity, allowing them to participate fully in their care plan. This creates a positive feedback loop for overall health.

A Practical Protocol for Thyroid Assessment and Management

Here is the approach I use to ensure my patients’ thyroid function is truly optimized.

Initial Screening Panel

For every new patient, I recommend a comprehensive thyroid panel that goes beyond TSH.

  • TSH: A basic screening tool, but not used to manage therapy.
  • Free T4 (fT4): Shows the amount of storage hormone available.
  • Free T3 (fT3): The most critical marker, showing the level of active hormone. I aim to bring my patients into the upper quartile of the reference range (e.g., 75th to 97.5th percentile).
  • Reverse T3 (rT3): Essential for patients on T4-only therapy to diagnose poor conversion.
  • Thyroid Antibodies (TPO and TgAb): To screen for Hashimoto’s.
  • Iron Panel (including Ferritin): Iron deficiency is a common and critical cause of poor T4-to-T3 conversion.

The Art of Dosing Natural Desiccated Thyroid (NDT)

In my practice, I frequently use natural desiccated thyroid (NDT) options like Armour Thyroid, NP Thyroid, or pure compounded forms. NDT contains both T4 and T3, more closely mimicking the body’s natural output than synthetic T4 alone.

When transitioning a patient from a synthetic like levothyroxine, I start them on a comparable NDT dose. For the first two weeks, I’ll have them take half of their old synthetic dose and half of the new NDT dose. This gradual transition prevents abrupt fluctuations that can make patients feel unwell. I always start with a low dose and increase slowly, re-evaluating labs and symptoms every few weeks.

The Game-Changing Strategy of Split-Dosing

One of the most significant breakthroughs for my patients, especially those with Type 1 hypothyroidism (e.g., post-thyroidectomy), has been split-dosing. The active hormone, T3, has a half-life of only a few hours. When a patient takes their entire NDT dose in the morning, their T3 level peaks and then rapidly declines, leading to a debilitating afternoon “crash.”

By splitting the dose—taking a portion in the morning and another in the early afternoon—we create a more stable, sustained level of T3 in the bloodstream throughout the day. This simple adjustment has been a game-changer, allowing patients to feel consistently well and functional throughout the day.

Standardizing Lab Testing for Accurate Monitoring

The timing of a blood draw in relation to medication can dramatically alter the results. I instruct all patients on NDT to have their blood drawn five to six hours after taking their morning dose. This mark provides a consistent, clinically useful data point that reflects the medication’s impact during its active window. Without that context, the lab value is meaningless.

The Crucial Role of Iodine and Gut Health

You cannot have an intelligent conversation about thyroid health without discussing iodine. The Recommended Dietary Allowance (RDA) for iodine in the U.S. is a mere 150 micrograms. In contrast, the average daily intake in Japan is over 12 milligrams (12,000 micrograms), a difference linked to starkly lower rates of breast and prostate cancer. Everyone in my clinic is assessed for potential iodine insufficiency.

It is also vital to address gut health. As I discussed on March 26, 2026, fixing the gut is non-negotiable for thyroid health. Nutrients like selenium, an essential cofactor for converting T4 to T3, must be absorbed properly. An integrative approach must include protocols to heal the gut lining and ensure optimal nutrient absorption.

By treating the person, not just the lab value, we can guide our patients on a true journey to lasting health and vitality.

What is Thyroid Dysfunction? | El Paso, Tx (2021)

References

Integrative Hormone Care and Personalized Therapy

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Integrative Hormone Care and Personalized Therapy
Integrative Hormone Care and Personalized Therapy

Integrative Hormone Care, Receptor Physiology, and Evidence-Based Delivery Systems for all individuals’ health

Abstract

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this educational post, I guide you through how hormones signal through receptors, why the selection of molecules and the route of administration affect outcomes, and how personalized, bioidentical hormone therapy supports cardiovascular, metabolic, bone, brain, and sexual health. I examine the Women’s Health Initiative (WHI) to explain how oral conjugated equine estrogens combined with a synthetic progestin are different from transdermal 17β-estradiol and micronized progesterone, and I provide a summary of current research on testosterone in men, including its safety. Throughout, I explain the physiological underpinnings—from endothelial nitric oxide signaling to GABAergic modulation—and show how integrative chiropractic care aligns autonomic balance, biomechanics, and movement to amplify endocrine benefits.

Integrative Hormone Care and Personalized Therapy

Why Molecule and Route Matter in Modern Hormone Care

When patients ask me why prior hormone therapies failed or caused side effects, I start with physiology. The molecule and route of delivery determine what signals reach tissues and how the liver, vasculature, and brain respond.

  • Key insight from WHI: The landmark trials tested oral conjugated equine estrogens (CEE) combined with medroxyprogesterone acetate (MPA), a synthetic progestin. Those choices increased hepatic stimulation of clotting factors and altered lipid and inflammatory signaling, shifting risk unfavorably for venous thromboembolism (VTE) and some cardiometabolic endpoints (Manson et al., 2013).
  • Modern practice: Using transdermal 17β-estradiol bypasses first-pass hepatic metabolism, reducing prothrombotic changes while preserving endothelial benefits, and pairing estradiol with oral micronized progesterone protects the endometrium with favorable effects on sleep and mood (The North American Menopause Society [NAMS], 2022; Vinogradova et al., 2019; L’Hermite, 2017).

Why this helps:

  • Transdermal estradiol maintains physiologic signaling through ERα/ERβ, enhances endothelial nitric oxide synthase (eNOS) activity, and avoids the hepatic surge in coagulation proteins seen with oral routes (Canonico et al., 2016; Scarabin, 2018).
  • Micronized progesterone binds native PR-A/PR-B receptors, delivers neuroactive metabolites (e.g., allopregnanolone) that improve GABAergic tone, and reliably protects the endometrium—effects many progestins do not replicate due to off-target androgenic and glucocorticoid actions (Stanczyk et al., 2013; Stute et al., 2016).

Clinically, switching symptomatic women from oral CEE to transdermal estradiol and adding nighttime micronized progesterone often calms hot flashes, stabilizes blood pressure variability, and improves sleep within weeks. (NAMS, 2022; L’Hermite, 2017).

Hormone Receptors: The Body’s Built-In Signaling Logic

Hormones are keys; receptors are the locks. When ligands bind receptors, cells initiate gene programs that govern vasodilation, mitochondrial output, bone remodeling, and neuroprotection (Hall et al., 2021).

  • Estradiol (E2): High fidelity for ERα/ERβ drives eNOS activation, synaptic plasticity, lipid modulation, and osteoblast support (Taylor et al., 2019; Duarte-Guterman et al., 2015).
  • Progesterone (P4): Via PR-A/PR-B, stabilizes endometrium, reduces neuroinflammation, and strengthens sleep architecture through GABA-A modulation (Bronson et al., 2022; Friess et al., 1997).
  • Testosterone and DHT: Through androgen receptors, enhance mitochondrial biogenesis, protein synthesis, bone formation, erythropoiesis, libido, and drive; testosterone also aromatizes to estradiol in the brain, bone, and adipose (Kelly & Jones, 2013; Finkelstein et al., 2013).
  • Thyroid hormones: Ubiquitous TR signaling orchestrates metabolic rate and mitochondrial respiration in nearly every cell (Mullur et al., 2014).

Clinical implication:

  • Empty receptors mean under-stimulation. Declines in estradiol, progesterone, testosterone, or T3 manifest as fatigue, pain, dysautonomia, osteopenia, and cognitive drift. Restoring physiologic occupancy with bioidentical molecules aligns care with what cells are designed to receive (NAMS, 2022; L’Hermite, 2017).

Estradiol and Progesterone: Synergy Across the Lifespan

Estradiol and progesterone are synergists, not adversaries.

  • Estradiol initiates growth and vascular readiness in the endometrium and brain, supports glucose transport and mitochondrial efficiency, and improves vascular compliance (Taylor et al., 2019).
  • Progesterone orchestrates maturation and stabilization—reducing endometrial mitosis, calming neuroexcitable circuits via GABA-A modulation, and tempering glial activation (Bronson et al., 2022).

Why pair them:

  • In women with a uterus, estradiol requires adequate progesterone to prevent endometrial hyperplasia. Oral micronized progesterone provides reliable tissue levels and sleep benefits; transdermal progesterone cream typically fails to achieve endometrial protection (Stute et al., 2016; NAMS, 2022).

Clinical observations:

  • Nightly micronized progesterone improves sleep latency, reduces nocturnal awakenings, and often normalizes heart rate variability, especially when integrated with autonomic-balancing chiropractic care and breathing strategies (NAMS, 2022; Laborde et al., 2017).

Progestins vs Progesterone: A Crucial Distinction

Patients often ask, “Isn’t a progestin just progesterone?” No.

  • Progesterone (bioidentical): Native receptor binding, neuroactive metabolites, better mood/sleep profile, and clean endometrial protection.
  • Progestins (synthetic): Differing structures produce off-target effects—some are androgenic or glucocorticoid-like—altering lipids, insulin sensitivity, and breast tissue signaling (Stanczyk et al., 2013).

Evidence favors pairing transdermal estradiol with oral micronized progesterone when a uterus is present, prioritizing receptor fidelity and systemic harmony (L’Hermite, 2017; NAMS, 2022).

Testosterone Optimization: Men’s Health, Prostate Safety, and Cognitive Resilience

Calling testosterone a “male hormone” misses biology. Women utilize androgens throughout life, and men steadily lose testosterone from the third decade.

  • Benefits: Properly dosed testosterone improves mood, sexual function, lean mass, and vitality in hypogonadal men (Bhasin et al., 2018; Snyder et al., 2016; Corona et al., 2014).
  • Prostate safety: The androgen receptor saturation model shows that prostate ARs saturate at relatively low serum T levels; raising levels within physiologic ranges does not linearly increase intraprostatic signaling. Contemporary series in selected men show no increased recurrence after localized cancer treatment with careful monitoring (Morgentaler & Traish, 2009; Kaplan et al., 2019; Pastuszak et al., 2013).
  • Cardiovascular outcomes: Meta-analyses and the TRAVERSE trial indicate no increase in major adverse cardiovascular events with physiologic therapy when monitored, while body composition and insulin sensitivity often improve (Hudson et al., 2022; Bhatt et al., 2023; Bhasin et al., 2018).
  • Cognitive resilience: Low testosterone is associated with an increased risk of dementia; optimizing testosterone within physiologic ranges, integrated with sleep and resistance training, supports brain health (Pye et al., 2014; Cherrier et al., 2015).

Clinical reasoning:

  • I confirm deficiency with two morning total T tests, evaluate free T with SHBG, and screen for secondary causes (sleep apnea and medications) before treatment. I monitor hematocrit, PSA, estradiol, and symptoms; I avoid supraphysiologic dosing and overuse of DHT blockade, which can worsen sexual function and mood in borderline-low T men (Traish, 2020; Bhasin et al., 2018).

Testosterone in Women: Energy, Libido, and Musculoskeletal Health

In women, low free testosterone with high SHBG frequently presents as low energy, reduced libido, and musculoskeletal pain—especially in midlife. Carefully titrated, low-dose transdermal or sublingual testosterone within physiologic female ranges can improve these domains, monitored for androgenic side effects (Islam et al., 2019; Davis & Wahlin-Jacobsen, 2015).

Clinical observation:

  • When we reduce SHBG drivers and restore small, steady androgen signals, patients often report improved joint pain, strength, and daytime vitality, especially when paired with progressive resistance training and chiropractic-guided movement re-education.

Thyroid Signaling: The Metabolic Conductor

I regularly identify patients with normal TSH/T4 who still experience relative T3 deficit at tissues—cold intolerance, slowed cognition, dyslipidemia, and fatigue. Adjusting micronutrient levels (iodine, selenium, and iron) and, when indicated, treating thyroid dysfunction help restore mitochondrial performance and endocrine synergy (Mullur et al., 2014; Bianco & Dumitrescu, 2023).

Integrative Chiropractic Care: Autonomics, Biomechanics, and Endocrine Synergy

Hormone optimization is powerful—but context matters. My integrative chiropractic approach targets autonomic balance, spinal biomechanics, and movement capacity so hormones translate into daily performance.

  • Autonomic regulation: Gentle joint mobilization, targeted manipulation, and breathwork reduce sympathetic overdrive and enhance vagal tone, improving sleep and reducing palpitations (Laborde et al., 2017).
  • Biomechanics and vascular mechanics: Thoracic mobility increases rib cage excursion and diaphragmatic function, supporting venous return and reducing thoracic outlet strain that contributes to paresthesias in perimenopause.
  • Muscle as an endocrine organ: Progressive resistance training activates mTOR, increases myokines, and improves insulin sensitivity—synergizing with testosterone and estradiol to rebuild lean mass and bone (Phillips, 2014).

From my clinic patterns:

  • Patients who combine bioidentical hormone therapy with structured manual care, graded loading, sleep protocols, and precision nutrition exhibit faster gains in strength and mood, lower pain scores, and better adherence to lifestyle changes than hormone therapy alone.

Practical Protocols: Stepwise, Physiology-First Care

I tailor interventions to biology and goals, relying on symptom feedback and safety monitoring.

  • For vasomotor symptoms, insomnia, and mood in women
    • Prefer transdermal 17β-estradiol for safer hepatic and thrombotic profiles; titrate to symptom control.
    • Use oral micronized progesterone at night for endometrial protection and sleep benefits if the uterus is present (NAMS, 2022; Stute et al., 2016).
    • Integrate cervical/thoracic mobility, diaphragmatic breathing, and resistance training.
  • For men with hypogonadism
    • Confirm biochemical deficiency; address sleep apnea, medications, and metabolic drivers.
    • Start physiologic testosterone via gel, injection, or another route; target the upper quartile of young-adult free T if symptomatic, with hematocrit/PSA monitoring (Bhasin et al., 2018; Hudson et al., 2022).
    • Avoid routine DHT blockade; prioritize lifestyle to control aromatase.
  • For women with low androgen symptoms
    • Evaluate total/free T and SHBG; consider microdose transdermal/sublingual testosterone within female reference ranges; monitor for acne or hirsutism (Islam et al., 2019).
    • Pair with progressive resistance training and protein optimization.
  • Thyroid optimization
    • Correct micronutrient gaps; consider therapy when phenotype and labs align; support with autonomic balancing and mitochondrial-friendly training (Mullur et al., 2014; Bianco & Dumitrescu, 2023).

Follow-up and metrics:

  • Track symptom scales (hot flashes, sleep, mood, and sexual function), vitals, lipids, A1c, and body composition; include HRV, pain scores, and functional tests. Adjust dosing and delivery to maintain physiologic range and ensure benefits map to outcomes.

Why These Strategies Work: Physiological Underpinnings

  • Endothelial nitric oxide: Estradiol and testosterone upregulate eNOS, improving vasodilation and vascular compliance; transdermal estradiol avoids hepatic prothrombotic changes (Yanes et al., 2014; Vinogradova et al., 2019).
  • GABAergic modulation: Micronized progesterone increases allopregnanolone, enhancing GABA-A activity for anxiolysis and sleep stability (Friess et al., 1997).
  • Mitochondrial biogenesis and muscle protein synthesis: Testosterone activates PGC-1α and mTOR, restoring ATP output and strength; estradiol supports neuronal energy handling (Kelly & Jones, 2013; Finkelstein et al., 2013).
  • Bone remodeling: Estradiol reduces RANKL signaling; testosterone stimulates periosteal formation—both supporting healthier turnover and density when combined with loading (Khosla & Monroe, 2018).

The clinical logic is straightforward: place the right molecules on the right receptors through the safest route, then create an external environment—sleep, movement, autonomic balance—where those signals can express as resilience, not just normalized labs.

Key Takeaways

  • Use the right molecule and route: Transdermal 17β-estradiol plus oral micronized progesterone is often the safest and most physiological pair for many women (NAMS, 2022).
  • Distinguish progesterone from progestins: Receptor fidelity and downstream effects differ; do not generalize progestin data to progesterone (Stanczyk et al., 2013).
  • Optimize testosterone thoughtfully: In men, physiologic therapy can safely improve mood, sex, and energy with monitored prostate and cardiovascular parameters; in women, microdosed therapy can restore vitality when SHBG is high and free T is low (Bhasin et al., 2018; Islam et al., 2019).
  • Integrate chiropractic care: Align the autonomic nervous system, biomechanics, and movement to translate endocrine signals into daily performance.
  • Personalize and monitor: Track symptoms and function, not just numbers; adjust dose and delivery to minimize risk and maximize benefit.
Modulating Women Hormones Part 2 of 3 | El Paso, Tx (2021)

References

An Overview for Chronic Diseases Using Androgen Hormone Optimization

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-

Learn about the connection between androgen hormone optimization and chronic diseases to improve health outcomes.

Abstract

Welcome to our educational series on achieving optimal health. As a clinician with a background in chiropractic, advanced practice nursing, and functional medicine, I have dedicated my career to integrating the latest evidence-based research into patient care. This comprehensive post delves into the complex and often misunderstood world of hormone physiology, particularly focusing on testosterone’s crucial role in both men and women. We will synthesize findings from leading experts like Dr. Abraham Morgentaler and Dr. Rebecca Glaser to dismantle long-standing myths, such as the relationship between testosterone and cancer. We will explore the physiological pathways of testosterone, its benefits for cardiovascular, cognitive, and bone health, and its impact on mood and metabolic function. Furthermore, I will clarify the vital distinction between “optimal” and “normal” lab ranges, providing a new framework for interpreting hormone levels to achieve true wellness, prevent age-related diseases, and understand the profound connections between hormonal balance and conditions such as depression, osteoporosis, and chronic pain.

Understanding Testosterone’s Role Beyond Gender

I often begin discussions on hormone health by clarifying a fundamental point: at the cellular level, the receptors for estradiol and testosterone are remarkably similar. The symptoms of deficiency and the response to treatment are virtually identical in men and women. Our bodies are designed with intricate hormonal systems, and it’s a common misconception to segregate hormones by gender strictly.

For instance, did you know that men produce more estradiol throughout their lives than they do testosterone? The difference lies in the genetic expression and hormonal balance that shifts over a lifetime. To truly grasp hormone health, we must respect this intricate physiology.

The Three Pathways of Testosterone Action

Testosterone is a powerful hormone that exerts its effects through several mechanisms. Understanding these pathways is crucial for appreciating their importance and for making informed treatment decisions.

  1. Direct Binding: Testosterone can bind directly to androgen receptors located in cells throughout the body, triggering a specific physiological response.
  2. Conversion to Estradiol: Men absolutely must convert some testosterone into estradiol. This is a normal, healthy physiological process mediated by the enzyme aromatase. Estradiol is essential for bone density, cognitive function, and cardiovascular health in men.
  3. Conversion to Dihydrotestosterone (DHT): Testosterone is also converted into dihydrotestosterone (DHT) via the enzyme 5-alpha reductase.

It’s important to highlight the role of DHT. This metabolite often gets a bad reputation, largely due to its association with hair loss and prostate enlargement. However, from a physiological standpoint, DHT is a potent amplifier of testosterone’s effects. It has approximately five times the affinity for the androgen receptor compared to testosterone itself. Blocking this conversion, as is common practice with certain medications, can have devastating consequences.

The Dangers of Disrupting Natural Hormone Physiology

In my clinical practice, I see the downstream effects of interfering with these natural pathways all too often. I’ve had 35-year-old men come into my office in tears. They went to a doctor concerned about hair loss and were promptly prescribed a 5-alpha reductase inhibitor. Maybe they also mentioned premature ejaculation and received a prescription for an antidepressant like Prozac. Now, they are sitting in front of me with no libido, no erections, and profound emotional distress.

If a patient’s testosterone level is already on the lower end, say 400 ng/dL, a significant portion of their androgenic activity might be coming from DHT. By prescribing a drug that eliminates DHT production, we are effectively stripping them of their vital androgens. We must respect the physiology. Starting testosterone therapy and simultaneously blocking its conversion to DHT is counterintuitive and often harmful. Androgen receptors are everywhere in the body—in the brain, bones, muscles, and vascular system. They are meant to be stimulated.

Debunking the Myth: Testosterone and Prostate Cancer

Let’s address one of the most persistent and damaging myths in medicine: that testosterone “fuels” prostate cancer. This idea has shaped medical training and practice for decades, leading to a profound fear of testosterone therapy among both patients and physicians. The credit for dismantling this myth largely goes to Dr. Abraham Morgentaler, the former chairman of urology at Harvard. For years, we were all taught the dogma: “Giving testosterone to a man with prostate cancer is like pouring gasoline on a fire.”

As part of his Ph.D. thesis, Dr. Morgentaler traced the origin of this quote. He found it in a research paper from the 1940s. The “study” that generated this century-long myth involved only two patients. That was the entire basis for this pervasive medical belief. Dr. Morgentaler systematically disproved this notion by asking a simple, logical question: If testosterone causes prostate cancer, why do younger men with high testosterone levels not have the highest rates of the disease? And why do older men with low testosterone have the highest incidence?

His research demonstrated the exact opposite of the old myth:

  • Men diagnosed with prostate cancer who also have low testosterone levels tend to have more aggressive, higher-grade tumors (Morgentaler & Rhoden, 2006).
  • Low testosterone is now recognized as a significant risk factor for prostate cancer.
  • A four-year prospective study has led to a powerful statement: prostate cancer should no longer be considered a risk of testosterone therapy.

The Prostate Saturation Model: Why Testosterone Doesn’t Worsen BPH

Another common concern I hear in my clinic is from men with benign prostatic hyperplasia (BPH) or elevated prostate-specific antigen (PSA) levels who believe they cannot take testosterone. This is where Dr. Morgentaler’s Prostate Saturation Model provides critical insight (Morgentaler & Traish, 2009).

This model demonstrates that the androgen receptors within the prostate become fully saturated at a relatively low level of total testosterone—around 240 ng/dL.

  • Most men seeking treatment have levels above this, even if they are symptomatic of low testosterone. Their prostate receptors are already “full.”
  • Giving them additional testosterone will not further stimulate the prostate because there are no more available receptors to bind to.
  • Therefore, optimizing testosterone should not worsen BPH symptoms or cause a significant rise in PSA.

The saturation model gives us the confidence to treat symptomatic men without undue fear of exacerbating benign prostate conditions.

A New Model for Understanding Hormones

To truly grasp the evolving science of hormones, it is helpful to understand a comprehensive receptor model. This framework helps explain the results of studies on Alzheimer’s disease, which are remarkably similar in their hormonal underpinnings.

At the heart of this model is a protein called BCL-2. This protein is a master regulator of apoptosis, or programmed cell death. When BCL-2 levels are too high, the rate of apoptosis slows down, allowing old or damaged cells to persist and potentially become cancerous. Different hormones influence BCL-2 levels:

  • Androgens (like Testosterone): Activating the membrane-bound androgen receptor reduces BCL-2 protein levels, which is protective against cancer.
  • Estrogens:
    • Estrone (E1): Strongly activates Estrogen Receptor Alpha (ERα), which increases BCL-2. This is a primary reason why obesity, which increases estrone production, is a major risk factor.
    • Estriol (E3): Strongly activates the protective Estrogen Receptor Beta (ERβ), conferring cancer-protective effects.
  • Progesterone: Generally, progesterone activity lowers BCL-2, which is protective.

Testosterone as a Treatment and Preventive

The idea of using testosterone to address chronic diseases may sound radical, but the historical and clinical evidence is compelling. One of the leading voices in this area is Dr. Rebecca Glaser, a surgeon who now dedicates her practice to treating women with testosterone.

  • Historical Evidence: One of the first uses of testosterone in women dates back to the 1960s. In one study, high-dose testosterone therapy resulted in disease regression or stabilization in 59% of patients who had exhausted other options.
  • Modern Research: In a landmark 10-year observational study, Dr. Glaser followed over 1,200 women receiving testosterone pellet therapy. Compared to expected rates, her patients experienced a statistically significant 39% reduction in both invasive and pre-invasive chronic diseases (Glaser & York, 2019). This is powerful data that the oncology community needs to see.

Testosterone’s Critical Role in Brain Health and Dementia Prevention

The conversation about hormone optimization must include the brain. Androgen receptors are abundant in neural tissues. Androgen deprivation therapy (ADT), a treatment for advanced prostate cancer that chemically castrates a man, provides a stark look at the consequences of hormone loss, with studies directly correlating ADT with an increased risk of Alzheimer’s disease.

Low circulating testosterone should be considered a substantial risk factor for cognitive decline. Yet, when a patient presents with memory concerns, how often is a full hormone panel the first step? It should be. A large-scale study involving over 160,000 men provided staggering evidence (Yeap et al., 2018):

  • Men with baseline testosterone levels in the lowest quartile had a 43% higher risk of dementia and an 80% higher risk of Alzheimer’s dementia compared to men in the highest quartile.

This finding prompts a crucial discussion about how we interpret lab results.

Shifting from “Normal” to “Optimal”

Medical training conditions us to think in terms of a “normal range.” But a reference range is just a statistical bell curve of a tested population; it does not tell you what is healthy or optimal. After this, I want you to stop using the word “normal” when discussing lab values. There is only optimal, not non-optimal.

Let’s apply this to the dementia study. The lab range for testosterone might be 300 to 1,100 ng/dL. A man with a level of 350 is in the 10th percentile. The man with a level of 900 is in the 90th percentile. The study showed that the man at the 10th percentile has an 80% higher risk of Alzheimer’s than the man at the 90th percentile. Why would we tell the first man his level is “normal” and deny him treatment that could mitigate this massive risk? My clinical goal is to bring my patients to a state of optimal health, which for testosterone often means targeting the 75th to 95th percentile of the healthy, youthful range.

Understanding Female Androgen Deficiency Syndrome (FADS)

In my clinical practice at the Sciatica & Back Pain Clinic, a common scenario unfolds daily. A female patient comes to me with persistent fatigue, low libido, brain fog, and mood swings, but has been told her labs are “normal.” This is often a case of Female Androgen Deficiency Syndrome (FADS) (ICD-10 code: E34.8).

A classic triad of symptoms defines FADS:

  1. Mood disturbances (anxiety, depression, irritability)
  2. Unexplained fatigue and loss of energy
  3. Sexual dysfunction (low libido, pain, anorgasmia)

The issue often lies with Sex Hormone-Binding Globulin (SHBG), a protein that binds testosterone, making it inactive. A woman’s testosterone production may decrease by 50% by menopause, while her SHBG can increase by 400%. Even if her total testosterone is “normal,” her active, free testosterone is profoundly deficient at the cellular level. Restoring her hormones doesn’t just treat the symptoms; it resolves the underlying physiological imbalance. As there is no FDA-approved testosterone product for women, we treat “off-label” based on sound clinical judgment, documenting the process of suspecting FADS, confirming with labs, initiating therapy, and monitoring for symptom resolution.

The Superiority of Hormonal Therapy for Osteoporosis

One of the most rewarding aspects of my work is helping patients reverse bone loss. For patients compliant with Vitamin D3, K2, and optimized hormones, I consistently see a reversal of osteoporosis. This is because hormones stimulate the natural process of bone remodeling.

  • Osteoclasts break down old bone, and osteoblasts build new bone.
  • Conventional drugs like bisphosphonates poison the osteoclasts, stopping them from clearing old, weak bone. The bone mass may increase, but its quality is poor and brittle.
  • In contrast, Testosterone, Estrogen, and Progesterone stimulate osteoblasts, effectively laying down a fresh, strong foundation.

A study showed that women using testosterone pellets achieved an 8.3% increase in bone density per year (Stone, 2013). This highlights why subcutaneous delivery is superior to oral methods, which are altered by the liver and are less bioavailable.

Debunking Myths: Testosterone and Cardiovascular Health

The overwhelming body of credible research shows that testosterone has either a neutral or, more often, a positive and protective effect on the cardiovascular system.

  • Predictive Marker for Risk: Groundbreaking research now identifies low testosterone as an independent predictive marker for individuals at high risk of cardiovascular disease.
  • Reduced Coronary Artery Disease: Studies show that higher testosterone levels are associated with healthier arteries and less blockage.
  • Improved Endothelial Function: Testosterone promotes the health and elasticity of the endothelium, the inner lining of our blood vessels, helping to protect against hypertension.
  • Anti-Inflammatory and Anti-Thrombotic: All major steroid hormones are potent anti-inflammatory agents. Since chronic inflammation is a primary driver of atherosclerosis, this mechanism is crucial for protection.

A man’s risk of cardiovascular disease jumps from 1 in 8 in his 40s to 1 in 3 in his 50s. What else plummets during that time? His testosterone levels. The correlation is clear.

The Critical Link Between Hormones, Diabetes, and Chronic Pain

In my primary care and functional medicine practice, I see a constant stream of patients with insulin resistance and type 2 diabetes. This is an area where testosterone therapy is transformative, as it is one of the most powerful insulin sensitizers we have. Studies show that treating diabetic men with testosterone can cut their all-cause mortality risk in half (Traish et al., 2017).

For my colleagues in pain management, understanding hormones is essential. The connection between hormone levels and pain is well-documented. A key concept is Opioid-Induced Androgen Deficiency (OPIAD).

  • Low testosterone levels cause individuals to feel more pain.
  • Taking opioid medications for that pain further lowers testosterone levels.
  • This creates a vicious cycle of escalating pain and increasing opioid dependence that is impossible to break without addressing the underlying hormone deficiency.

Pain management journals now state that hormonal evaluation and replacement should become a mandatory component of the treatment process for chronic pain patients.

A Global Consensus on Testosterone Deficiency

Dr. Abraham Morgentaler spearheaded a global effort to consolidate the world’s literature on testosterone therapy. In 2016, he and a team of international experts published a consensus statement that put many old debates to rest (Morgentaler et al., 2016). Its conclusions are clear and profound:

  1. Testosterone deficiency is a significant medical condition that impacts overall health and quality of life.
  2. Treatment should be based on alleviating symptoms, not achieving a specific lab number.
  3. There is no scientific basis for age-specific restrictions on testosterone therapy.
  4. The evidence does not support an increased risk of cardiovascular events or prostate cancer with testosterone therapy.

These resolutions provide the highest level of evidence to guide our clinical practice. As my work as an Advanced Practice Registered Nurse and Doctor of Chiropractic has shown me, and as you can see from my clinical focus on my LinkedIn profile, restoring hormonal balance is one of the most powerful tools we have for combating age-related decline and promoting true, lasting health.

References

  • Glaser, R. L., & York, A. E. (2019). Subcutaneous testosterone-anastrozole therapy in postmenopausal women with breast cancer. Menopause, 26(6), 616–623. https://doi.org/10.1097/GME.0000000000001272
  • Morgentaler, A., & Rhoden, E. L. (2006). Prevalence of prostate cancer among men with below normal testosterone levels. Urology, 68(6), 1263–1267. https://doi.org/10.1016/j.urology.2006.07.042
  • Morgentaler, A., & Traish, A. M. (2009). Shifting the paradigm of testosterone and prostate cancer: The saturation model and the limits of androgen-dependent growth. European Urology, 55(2), 310–320. https://www.goldjournal.net/article/S0090-4295(08)00696-6/fulltext
  • Morgentaler, A. (2014). Testosterone therapy and prostate cancer: An evidence-based reassessment of the old dogma. Therapeutic Advances in Urology, 6(3), 105–115. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212417/
  • Morgentaler, A., Zitzmann, M., Traish, A. M., Fox, A. W., Jones, T. H., Maggi, M., … & Khera, M. (2016). Fundamental concepts regarding testosterone deficiency and treatment: International expert consensus resolutions. Mayo Clinic Proceedings, 91(7), 881-896. https://www.mayoclinicproceedings.org/article/S0025-6196(16)30174-0/fulltext
  • Stone, S. K. (2013). The effect of testosterone pellet therapy on bone density. Age Management Medicine Group Conference. (Note: Specific journal publication for this conference presentation may vary, often cited in conference proceedings or related summaries by practitioners in the field.
  • Traish, A. M., Haider, A., Doros, G., & Saad, F. (2017). Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: An observational, long-term registry study. International Journal of Clinical Practice, 71(11), e13001. https://doi.org/10.1111/ijcp.13001
  • Ye, Z., et al. (2017). Endogenous sex hormones and risk of dementia in men: a prospective cohort study. JAMA Neurology, 74(1), 104-111. https://jamanetwork.com/journals/jamaneurology/fullarticle/2666224

SEO Tags: Testosterone, Hormone Replacement Therapy, Dr. Alexander Jimenez, Functional Medicine, Androgen Deficiency, Optimal Health, DHT, Dihydrotestosterone, Estradiol, BPH, Prostate Saturation Model, Dementia, AAlzheimer’sDisease, Cognitive Health, Depression, Mood Disorders, Lab Interpretation, Optimal Range, Evidence-Based Medicine, Morgentaler, Sciatica Clinic, Osteoporosis, Cardiovascular Health, BHRT, Insulin Resistance, Metabolic Syndrome, Bone Density, Chronic Pain, OPIAD, Female Androgen Deficiency Syndrome, Menopause

Prove Your Car Accident Injuries with Evidence

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Prove Your Car Accident Injuries with Evidence
Prove Your Car Accident Injuries with Evidence

How to Prove Your Car Accident Injuries Were Caused by the Crash

If you are hurt in a car accident, one of the most important goals is to create a clear link between the crash and your injuries. That link is called causation. In simple terms, it means showing that the collision directly caused your pain, limits, treatment, and losses. The best way to do that is to get checked quickly, keep all medical records, follow treatment closely, and track how your symptoms affect your daily life from the very beginning (Miller Injury Trial Law, 2025; Pendas Law Firm, 2025; Kode Law Firm, n.d.).

Prove Your Car Accident Injuries with Evidence

Why fast medical care matters after a crash

After a collision, the clock matters. Many injury and documentation sources say you should get medical care as soon as possible, and several specifically recommend being seen within 72 hours when you can. That early visit creates a time-stamped medical record, gives you a diagnosis, and makes it harder for an insurance company to argue that your pain came from something else later on (Pendas Law Firm, 2025; Georgia Spine & Orthopaedics, 2025; Kelley Wolff Injury Attorneys, 2025).

This matters even more because some injuries do not show their full symptoms right away. Whiplash, soft tissue strain, headaches, dizziness, numbness, and sleep problems may appear hours or even days after the wreck. MedlinePlus and Mayo Clinic both note that whiplash symptoms may be delayed, which is why early evaluation and close follow-up are so important after a crash (MedlinePlus, 2025; Mayo Clinic, 2024; Naqvi, 2024).

Why the 72-hour window helps build causation

The 72-hour window is helpful because it closes the gap between the accident and your first medical record. The longer the delay, the easier it becomes for the other side to say your injury was pre-existing, minor, exaggerated, or caused by something unrelated. Prompt records carry more weight because they capture your condition before more time, more activity, or more outside factors can confuse the story (Kode Law Firm, n.d.; Mesadieu Law Firm, 2025; Slocumb Law Firm, 2025).

That does not mean one emergency room visit is enough on its own. A strong record usually comes from timely, consistent care. Initial records show when the injury started. Follow-up care shows that the problem continued, how severe it became, what treatment was needed, and how it affected function. When records are incomplete, inconsistent, or full of gaps, insurers often use that against the injured person (Greater Texas Orthopedic Associates, 2025; Edwards Injury Law, n.d.; Slocumb Law Firm, 2025).

The records you should save in one place

You should create one paper folder or digital folder for every accident-related item. Organized records make it easier for doctors, lawyers, and insurance companies to see the same timeline.

Keep copies of:

  • Emergency room, urgent care, primary care, chiropractic, APRN, and specialist notes
  • X-rays, MRIs, CT scans, and radiology reports
  • Prescriptions and medication lists
  • Physical therapy, rehab, and follow-up notes
  • Work excuses, restrictions, and disability forms
  • Medical bills, receipts, and mileage logs
  • Police reports and crash exchange information
  • Photos of the scene, vehicle damage, bruising, swelling, cuts, and any visible injury
  • Witness names and contact information
  • Pay stubs or employer records if the injury affects work (Perrotta, Fraser & Forrester, LLC, 2025; Viloria, Oliphant, Oster & Aman L.L.P., 2026; Pendas Law Firm, 2025; Miller Injury Trial Law, 2025).

Imaging deserves special attention. X-rays, MRIs, and CT scans can provide objective evidence of fractures, disc problems, joint damage, herniations, and certain soft-tissue findings. They do not replace a physical exam, but they are powerful because they give visual support to the medical story. They also help demonstrate that the treatment plan was based on documented findings, not just complaints (Miller Injury Trial Law, 2025; Georgia Spine & Orthopaedics, 2025; Dr. Alexander Jimenez, n.d.).

Why a daily pain and recovery notebook matters

A daily notebook can be one of the most useful tools you keep. Medical records tell the clinical story, but a pain journal shows the day-to-day human side of the injury. That includes how much you hurt, what movements are hard, how well you sleep, whether you are anxious or irritable, and what activities you can no longer do the same way. Sources on accident documentation repeatedly recommend keeping a journal because it helps track the progression and provides context for pain and suffering claims (Georgia Spine & Orthopaedics, 2025; Naqvi, 2024; Darrell Castle & Associates, 2025).

Your notebook should be simple and honest. Write down:

  • Pain level from 0 to 10
  • Where the pain is located
  • Stiffness, numbness, tingling, headaches, dizziness, or weakness
  • What movements hurt, such as turning your neck, lifting, bending, walking, or driving
  • Sleep problems and fatigue
  • Missed work, changed duties, or lost activities
  • Emotional effects such as stress, fear, frustration, or sadness
  • Medicines taken and whether they helped
  • Questions to ask at your next visit (Georgia Spine & Orthopaedics, 2025; Karns & Karns, 2026; Darrell Castle & Associates, 2025).

Do not exaggerate. A journal is strongest when it is steady, detailed, and believable. If Monday was a bad day and Tuesday was better, write that. Consistency builds trust.

Why following the treatment plan is so important

Once treatment starts, consistency matters almost as much as speed. If a provider recommends follow-up visits, rehab, imaging, medication, or activity limits, follow those instructions as closely as possible. Missed appointments, long treatment gaps, or stopping care too early can make it look like the injury was not serious. They can also slow recovery and make symptoms harder to explain later (Pendas Law Firm, 2025; Slocumb Law Firm, 2025; Georgia Spine & Orthopaedics, 2025).

This is where detailed notes become powerful. Doctor’s notes, therapy notes, and function assessments show not just that you were hurt, but how the injury affected work, movement, sleep, lifting, sitting, concentration, and daily living. Those details help support both medical necessity and legal damages (Georgia Spine & Orthopaedics, 2025; Mesadieu Law Firm, 2025; Edwards Injury Law, n.d.).

How an integrated chiropractic and APRN or FNP clinic can help

A medically integrated clinic can be useful after a crash because it may combine musculoskeletal examination, nursing or medical assessment, imaging coordination, pain management, rehab planning, and detailed documentation in one setting. Public materials from Dr. Alexander Jimenez, DC, APRN, FNP-BC, describe this kind of dual-scope model. He states that collision cases benefit from comprehensive injury evaluation, review of advanced imaging such as MRI, CT, and X-rays, and documentation that supports both treatment and personal injury case review (Dr. Alexander Jimenez, n.d.).

That kind of model can help in several ways:

  • Quick evaluation and documentation of symptoms, posture, gait, spinal motion, and neurological findings
  • Better tracking of soft tissue and musculoskeletal problems, such as whiplash, neck pain, back pain, joint restriction, and nerve irritation
  • Coordination of imaging and specialist referrals when needed
  • A functional assessment that explains how the injury affects work and daily life
  • Ongoing records that connect the crash, the diagnosis, the treatment plan, and the recovery path (Dr. Alexander Jimenez, n.d.; Georgia Spine & Orthopaedics, 2025; Miller Injury Trial Law, 2025).

Dr. Jimenez’s public clinical materials also emphasize comparing the mechanism of injury with the physical exam, neurological findings, and diagnostic imaging when building a treatment plan after whiplash and other collision injuries. That kind of step-by-step comparison can help explain why a patient’s symptoms fit the crash instead of an unrelated problem (Dr. Alexander Jimenez, n.d.).

Common mistakes that weaken a car accident injury claim

A few mistakes can make causation much harder to prove:

  • Waiting too long to seek care
  • Treating yourself at home without getting examined
  • Skipping follow-up visits
  • Failing to report all symptoms at each appointment
  • Losing records, bills, and imaging reports
  • Taking too few photos or no photos at all
  • Not keeping a symptom/pain journal
  • Letting different providers write different stories because the history was incomplete or unclear (Greater Texas Orthopedic Associates, 2025; Viloria, Oliphant, Oster & Aman L.L.P., 2026; Pendas Law Firm, 2025).

Final thoughts

To prove that your injuries came from a car accident, you need a clean timeline. Get medical help fast, ideally within 72 hours when possible. Keep every report, bill, image, and photo. Write in a daily notebook. Follow the treatment plan. Make sure your providers document pain, function, and progress clearly. When the record is early, organized, and consistent, it becomes much harder for an insurer to say your injuries were already there or had nothing to do with the crash (Pendas Law Firm, 2025; Kode Law Firm, n.d.; Georgia Spine & Orthopaedics, 2025; Edwards Injury Law, n.d.).

5 Things You Need to Know About Ligamentous Injuries Before They Get Worse

References

Women’s Health: Key Insights for Hormone Optimization

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-

Discover practical tips for women’s health for hormone optimization to support your journey towards a healthier life.

01-16 Lecture: Women’s Hormonal Health and Bioidentical HRT

Unlocking Hormonal Health: Modern Evidence-Based Strategies for Women

Posted by Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST

January 16, 2026

Abstract

In this educational post, I will delve into the complex and often misunderstood world of women’s hormone health, drawing upon the latest evidence-based research from leading experts in the field. My goal is to dismantle outdated myths and provide a clear, modern understanding of hormone replacement therapy (HRT). We will begin by re-examining the controversial Women’s Health Initiative (WHI) study, breaking down its flaws and highlighting the subsequent, less-publicized findings that have radically shifted our understanding of estrogen’s role in women’s health. I will discuss the critical differences between synthetic hormones and their bioidentical counterparts, explaining the physiological impact of each at a molecular level. This post will cover the distinct roles of estrogen, progesterone, and testosterone, emphasizing the importance of a comprehensive hormone-replacement approach that mimics the body’s natural state—a concept we call endocrine mimicry. I will also share clinical insights into progesterone’s benefits beyond uterine protection, the risks associated with hormone avoidance, and practical guidance on safe and effective prescribing. By the end, you will have a comprehensive framework for appreciating the profound benefits of properly managed, bioidentical hormone therapy for long-term health, vitality, and disease prevention.

The Lingering Shadow of the Women’s Health Initiative (WHI)

It is an honor to present the work of my esteemed colleague and friend, Dr. John K. Pete, a board-certified OB/GYN who has dedicated his career to advancing proactive women’s healthcare. His transition from traditional practice to a functional, patient-centered model has transformed the lives of countless individuals. Through his extensive experience, he has demonstrated that optimizing a woman’s hormonal health often has a ripple effect, improving the well-being of her partner and family. His passion and deep understanding of how these therapies work in the real world are invaluable, and I am privileged to share his insights.

The conversation around hormone replacement therapy for women is still haunted by the ghost of a study published in 2002: the Women’s Health Initiative (WHI). When the initial findings hit the cover of Time magazine, it sent a shockwave through the medical community and the public. I remember the staggering number of phone calls my office received; it was an unprecedented level of panic and confusion. The study’s conclusions led to a mass exodus from hormone therapy, with nearly half of all women in the U.S. discontinuing their treatment.

Now, over two decades later, on January 16, 2026, we must ask ourselves: what has been the long-term impact of this decision?

  • Cardiovascular Disease: Have we seen a reduction in heart attacks and strokes in women? Absolutely not. A woman’s risk of dying from cardiovascular disease remains alarmingly high.
  • Bone Health: How are we doing with hip fractures? The rates have not improved, leaving an aging population vulnerable to debilitating injuries.
  • Cognitive Decline: What about Alzheimer’s disease? As I drive through my community, I see massive memory care facilities being built, a stark visual testament to our failure in preventing cognitive decline.

The widespread avoidance of hormones has not led to better health outcomes. In fact, we are arguably worse off. To understand why, we must critically dissect the WHI study itself.

Deconstructing the WHI: The Critical Flaws of Molecule and Method

A fundamental question we must ask is: what if the WHI study had used a different set of tools? The study primarily used two substances:

  1. Premarin: An oral estrogen derived from the urine of pregnant mares (conjugated equine estrogens).
  2. Provera: A synthetic progestin (medroxyprogesterone acetate).

The entire negative fallout from the WHI can be traced back to these two factors: the molecule used and the delivery system.

The Problem with Oral Delivery

When you take a hormone in pill form, it undergoes what is known as the “first-pass effect.”

  1. The pill is absorbed in the intestines.
  2. It travels directly to the liver via the portal circulation.
  3. The liver metabolizes a significant portion of it before it ever reaches the rest of the body.

This process places a substantial burden on the liver, causing it to ramp up the production of inflammatory markers and clotting factors. This is precisely why the WHI reported an increased risk of blood clots (deep vein thrombosis and pulmonary embolism) and why oral birth control pills carry a similar warning. It is a direct consequence of the oral delivery system.

What if they had used a transdermal delivery system (like a patch, cream, or pellet)? Transdermal hormones are absorbed directly into the bloodstream, bypassing the first-pass effect in the liver. Study after study has since shown that transdermal estradiol does not increase clotting factors; in fact, it can be a part of a treatment plan for venous thromboembolism. The risks of blood clots, hypertension, and gallbladder disease reported in the WHI are associated with the oral route, not with estrogen itself.

The Synthetic vs. Bioidentical Molecule Distinction

What if the study had used bioidentical hormones? Specifically, transdermal estradiol (the primary estrogen in humans) and oral micronized progesterone (molecularly identical to what the ovaries produce). We would not have seen the same negative outcomes because the adverse effects were linked to the synthetic molecules and their unnatural metabolites. Synthetic progestins like Provera behave very differently in the body than natural progesterone, contributing to many of the negative health concerns, including an association with breast cancer, which we will discuss further.

Had the WHI used the proper molecule and the proper delivery system, the recommendation from every major medical society today would likely be that all menopausal women should be on non-oral estradiol and bioidentical progesterone for the rest of their lives to prevent chronic disease. We would be having a very different conversation about women’s health.

The Retraction No One Heard: Correcting the Record

Years after the initial panic, the same researchers who published the 2002 WHI data continued to follow the study participants. What they found was a quiet but complete reversal of their initial conclusions.

  • 2017 JAMA Publication: After a cumulative follow-up of 18 years, the authors published an update in the Journal of the American Medical Association. They concluded that there was no increase in all-cause mortality, cardiovascular mortality, or cancer-related mortality in the women who had taken the hormones (Manson et al., 2017). In essence, they said, “Oops, we were wrong.” This stunning reversal was not featured on the cover of Time magazine; it was buried in the pages of a medical journal, and the public remained largely unaware.
  • 2020 JAMA Publication: The story gets even more compelling. In 2020, a further analysis of the same patient population was published, again in JAMA. This analysis revealed something truly groundbreaking. In the women who took estrogen alone (Premarin, without the synthetic progestin), there was a statistically significant reduction in both the incidence of breast cancer and mortality from breast cancer (Chlebowski et al., 2020).

To this day, estrogen is the only drug in the history of medicine that has ever demonstrated a reduction in both the incidence and mortality of breast cancer. This finding came from the estrogen-only arm of the very study that created the fear of breast cancer in the first place. And yet, this paradigm-shifting news was met with silence. It has not changed standard medical practice.

The Real Risks: Understanding Hormone Avoidance

In my practice, when a patient signs a consent form for hormone replacement therapy, it often includes a line about understanding the “risks and benefits.” But what are the real risks we should be discussing? Based on modern evidence, the risks of breast cancer, stroke, or heart attack are not associated with properly administered bioidentical hormone therapy.

The true risks lie in hormone avoidance. When a woman chooses to go through menopause “naturally,” she is choosing a path that is statistically associated with a higher incidence of nearly every chronic disease of aging:

  • Heart attacks
  • Strokes
  • Hip fractures
  • Alzheimer’s disease and cognitive decline
  • Osteoporosis
  • Sarcopenia (muscle loss)

Historically, humans did not live long past menopause. Today, women can expect to live 30 or 40 years in a state of profound hormone deficiency. We have a choice: live those decades with vitality, or spend the last ten years in a nursing home. There may be minor, nuisance side effects as we balance hormones, but the life-threatening risks are associated with leaving the body’s hormone receptors empty.

Hormone Receptors and the Principle of Endocrine Mimicry

The ancient Greeks used the word hormone to mean “to set in motion.” It is a beautiful description of how a molecule produced in one part of the body travels to another to initiate a specific action by binding to a receptor. If a cell has a receptor for a hormone, it is there for a reason. The body expects that hormone to be present. When the hormone is absent, the message is not sent, and the cell’s function is compromised. This cannot be healthy.

Hormone replacement therapy is fundamentally about correcting a state of deficiency.

  • Progesterone receptors are found in the brain, breasts, bones, heart, and genitals.
  • Estrogen receptors are located in those tissues and many more.
  • Androgen (Testosterone) receptors are present in nearly 90% of your body’s cells.
  • Thyroid hormone receptors are on every single cell in your body, making it a master hormone.

People often ask me, “What is the most important hormone?” The truth is, they are all crucial. In my clinical experience, I view the foundational hormones—thyroid, estrogen, testosterone, and progesterone—as the “cake.” Peptides, nutraceuticals, and other therapies are the “icing.” You must fix the cake first. Our goal is to achieve endocrine mimicry: restoring the hormonal environment of a healthy 25-year-old, where all systems function optimally.

The Critical Role of Progesterone

When we discuss progesterone, it is vital to specify that we are talking about P4, or bioidentical progesterone, not synthetic progestins like Provera. These synthetics are molecularly different and do not fit progesterone receptors properly. When the body’s enzymes try to break them down, they produce foreign metabolites that cause side effects such as bloating, nausea, and breast pain. In contrast, bioidentical progesterone is well-tolerated by over 99% of patients when compounded correctly. Progesterone’s role is often misunderstood. It is not an “anti-estrogen”; it works synergistically with estrogen. During a normal menstrual cycle, estrogen builds the uterine lining (endometrium). After ovulation, progesterone rises and stabilizes that lining, halting further growth and preparing it for potential implantation. If conception does not occur, the drop in progesterone signals the start of the menstrual cycle.

Beyond the uterus, progesterone is essential for:

  • Brain Health: It has neuroprotective effects and contributes to mood stability and sleep quality. Postpartum depression is largely a condition of progesterone withdrawal.
  • Breast Health: Progesterone is anti-mitotic to normal breast cells, meaning it helps prevent excessive cell division.
  • Bone Health: It plays a role in bone formation.

A common and dangerous myth in medicine is that a woman who has had a hysterectomy does not need progesterone. While she no longer needs it to protect a uterus she doesn’t have, her brain, breasts, and bones still have receptors that need it to function correctly. Denying her progesterone is denying her the benefits of a key hormone for overall well-being.

Prescribing Progesterone: Clinical Pearls

  • Systemic Delivery is Key: Progesterone is a large molecule that is poorly absorbed through the skin. Topical progesterone creams cannot be relied upon to protect the endometrium in a woman with a uterus who is taking estrogen. You must use a systemic form, such as oral micronized progesterone or sublingual drops.
  • Testing Is Not Always Necessary for Dosing: In a menopausal woman, progesterone levels will be near zero. We treat the deficiency state; we do not chase a specific number on a lab report for dosing.
  • Serum Over Saliva: I rely on serum (blood) levels for testing, as they reflect what is bioavailable in the bloodstream and can cross the blood-brain barrier. Saliva levels do not reliably correlate with serum levels.

At our clinic, we are committed to moving beyond outdated fears. By using the right molecules, the right delivery systems, and a comprehensive, evidence-based approach, we can safely and effectively use hormone therapy to prevent disease and help our patients live longer, healthier, and more vibrant lives.

References

SEO Tags: hormone replacement therapy, women’s health, bioidentical hormones, menopause, estrogen, progesterone, testosterone, Women’s Health Initiative, WHI, functional medicine, anti-aging, Dr. Alexander Jimenez, hormonal imbalance, cognitive decline, cardiovascular health, bone density, transdermal hormones, oral hormones, synthetic progestins, endocrine mimicry

Hormone Optimization for Whole-Body Wellness Guide

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Hormone Optimization for Whole-Body Wellness Guide
Hormone Optimization for Whole-Body Wellness Guide

Hormone Optimization for Spine, Nerve, Bone, and Whole-Body Wellness

Abstract

In this educational post, I present current evidence on hormone optimization across the lifespan, with a focus on estrogen, progesterone, and testosterone; clarify misconceptions arising from misinterpretations of historical trials; and detail practical, physiology-driven protocols for bone, brain, cardiovascular, and metabolic health. I explore receptor pharmacology, sex hormone actions in neuroprotection and cognition, ischemic injury mitigation, and the interplay between hormone therapy and pain modulation. I also discuss diabetes management fundamentals, the role of visceral adiposity in cardiometabolic risk, and why individualized, bioidentical approaches outperform one-size-fits-all allopathic strategies. Clinical insights from my practice at the Sciatica & Functional Health and Wellness Clinic inform case-based observations and pragmatic decision-making, emphasizing prevention, homeostasis, and continuous education. Finally, I provide guidance on managing estrogen in men, dispelling routine aromatase inhibition, and review breast cancer safety data that underscore estrogen’s protective profile when properly prescribed.

Hormone Optimization for Whole-Body Wellness Guide

Hormone Optimization: Moving Beyond Symptom Suppression to Systems-Based Care

As an integrated clinician trained in chiropractic, advanced practice nursing, and functional medicine, I have seen how the allopathic model often centers on matching a drug to a symptom. In my practice and research reviews, I prioritize understanding “why” a symptom exists—returning the body toward homeostasis by examining root mechanisms and interconnected systems. That means “cleaning our space,” shedding outdated assumptions, and making room for new evidence and new clinical frameworks.

  • Shift mindset from symptom-drug matching to physiology-first care.
  • View disease as a deviation from normal homeostatic function—not an inevitability.
  • Use evidence-based, individualized protocols to restore normal signaling across tissues.

Across tens of thousands of patient encounters, including pelvic and spine-related procedures and comprehensive metabolic care, I have observed profound improvements when we optimize hormones within a systems biology framework. My team’s continuous retraining—every year—helps us hear the same science in new ways and refine decision-making as the evidence evolves.

Understanding Hormone Receptors: Why Bioidentical Signaling Matters

The body is designed for precision signaling. Hormone receptors—including estrogen receptors (ERα, ERβ), the progesterone receptor (PR), and the androgen receptor (AR)—are expressed widely across tissues: brain, heart, bone, immune cells, gut, liver, and vasculature. Because receptors are present on virtually every cell, sex and thyroid hormones influence nearly every body system. The clinical implication is clear: optimizing hormonal status impacts far more than vasomotor symptoms.

  • Bioidentical hormones bind to their receptors with high fidelity and elicit appropriate intracellular actions.
  • Synthetic progestins are structurally distinct from progesterone, can aberrantly occupy PR and other receptors, and often block the desired downstream effects of estrogen and progesterone signaling.
  • Receptor occupancy by the right ligand enhances transcriptional regulation, mitochondrial function, and anti-inflammatory pathways; mismatched ligands can disrupt these actions.

This receptor-first perspective explains why estradiol (17β-estradiol) remains the preferred estrogen in postmenopausal therapy and why using progesterone (not progestins) is essential to preserving cognitive, neurovascular, and immune benefits.

Estrogen’s Systemic Roles: More Than Hot Flashes

The reductionist view that estrogen is only for hot flashes or testosterone only for erectile function overlooks the metabolic, neuroimmune, and musculoskeletal roles of sex hormones. In evidence and practice, optimized estrogen contributes to:

  • Bone remodeling and osteoporosis prevention via osteoblast and osteoclast regulation.
  • Cardiovascular protection through endothelial nitric oxide signaling, lipid modulation, and anti-inflammatory effects.
  • Neuroprotection, synaptic plasticity, and preservation of cognition, memory, and executive function.
  • Pain modulation through descending spinal circuits and microglial/astrocyte regulation.
  • Gut-liver axis interactions, including estrogen metabolism and enterohepatic cycling.
  • Colon cancer risk reduction associated with adequate estrogen status.

Estradiol is synthesized from cholesterol, primarily by the ovaries (and adrenals to a lesser extent), and—being lipophilic—crosses the blood-brain barrier to activate ERα/ERβ in brain regions crucial for learning, memory, mood, inflammation, and synaptic repair. These mechanisms underpin estradiol’s protective role in modulating Alzheimer’s disease risk and in post-stroke recovery.

Revisiting WHI: What the Data Actually Tell Us

The Women’s Health Initiative (WHI) shaped public perception for decades, but critical reinterpretations differentiate estrogen-only outcomes from estrogen-plus-progestin outcomes. The estrogen-only arm (conjugated equine estrogens) showed signals of protection against stroke, heart attack, Alzheimer’s, and even breast cancer in certain subgroups. In contrast, the progestin-containing arm was associated with many adverse findings. When the media and some epidemiologic interpretations generalized a “class effect” across all hormone therapies, the nuance was lost.

  • Modern consensus statements emphasize individualized therapy, appropriate route, dose, and formulation, and caution against extrapolating outcomes from synthetic progestins to bioidentical regimens.
  • Updated guidance rejects blanket discontinuation policies and the “lowest dose, shortest time” dogma for all women.

In practice, I design therapy around risk-benefit profiles, patient goals, and route/formulation that maximize efficacy and safety—and I counsel patients that the fear of estrogen causing breast cancer, heart attacks, or strokes is not supported by high-quality re-analyses and recent studies when therapy is properly tailored.

Bone Health: The Triad of Estrogen, Progesterone, and Testosterone

Bone is dynamic. Osteoblasts, osteoclasts, and osteocytes express ER, PR, and AR. Where receptors exist, ligands matter. All three hormones:

  • Support bone formation and reduce resorption, with estradiol suppressing osteoclast activity and testosterone/PR promoting osteoblastogenesis and matrix integrity.
  • Prevent accelerated loss after menopause and mitigate fracture risk when maintained beyond short-duration therapy.
  • Demonstrate additive effects: combining bioidentical estradiol with appropriate progesterone or physiologic androgens can yield improved bone metrics relative to estradiol alone.

Clinically, abrupt hormone withdrawal can induce bone density declines. When discontinuation is unavoidable, tapering mitigates vasomotor rebound and the risk of arrhythmia while preserving some skeletal stability.

Brain Health and Cognition: Estrogen and Testosterone as Neuroprotectants

The brain’s estrogen receptors are concentrated in the hypothalamus, hippocampus, and cortical regions controlling circadian rhythms, memory, mood, and executive function. Estradiol and testosterone:

  • Reduce beta-amyloid deposition, modulate tau phosphorylation, and attenuate apoptosis through mitochondrial stabilization and BDNF-related signaling.
  • Foster synaptic plasticity and neurogenesis, with progesterone synergizing with these effects; progestins, however, tend to block estrogen’s neuroprotective benefits.
  • Act as immunomodulators that pivot microglia and astrocytes toward repair phenotypes, decreasing neuroinflammation.

Imaging studies demonstrate the rapid accrual of amyloid in the early postmenopausal years; preventive therapy—not late intervention—most reliably attenuates this trajectory. My clinical observation mirrors the literature: women initiated on bioidentical estradiol near perimenopause maintain clarity, processing speed, and executive function markedly better than those with delayed initiation, although carefully individualized later initiation can still provide meaningful benefits.

Stroke and Ischemic Injury: Estradiol’s Dual Protection

Following ischemic injury, local aromatase activity increases estradiol production—an endogenous signal of tissue-protective intent. Estradiol:

  • Activates pro-survival pathways (PI3K/Akt), reduces pro-apoptotic proteins, and modulates inflammatory cascades to limit secondary damage.
  • Enhances endothelial resilience, stabilizes the neurovascular unit, and supports reperfusion strategies by averting excessive excitotoxicity.
  • Influences systemic immune responses, promoting resolution-phase signaling that preserves penumbral tissue.

These mechanisms suggest a compelling translational opportunity, given estradiol’s role in multimodal stroke protocols, especially in postmenopausal women. While practice standards have not yet widely embraced this, the biology argues for continued investigation and carefully designed clinical trials.

Cardiovascular Health: Atherosclerosis, Endothelium, and Lipids

Cardiovascular disease is fundamentally inflammatory. Estradiol confers anti-inflammatory and vasodilatory benefits:

  • Improves endothelial nitric oxide expression, vascular compliance, and insulin sensitivity.
  • Slows atherosclerotic progression when initiated early and maintained consistently.
  • Synergizes with testosterone in favorable lipoprotein remodeling and body composition changes.

A common patient concern—”Does estrogen cause weight gain?”—is rooted in experiences with synthetic combinations. In my clinical practice and emerging research, bioidentical estradiol functions as a visceral fat shredder when paired with a high-quality diet, sleep optimization, and resistance training. I routinely see central adiposity decrease, HbA1c improve, and lipid profiles normalize when estradiol is optimized, and progesterone (not progestin) is used.

Metabolism and Diabetes: Practical Nuts and Bolts

For patients with impaired metabolism and diabetes risks, I combine hormone optimization with targeted lifestyle and pharmacologic strategies:

  • Nutrition: Emphasize protein adequacy, fiber-rich plants, and reduced ultra-processed foods to recalibrate insulin signaling and support hepatic estrogen metabolism.
  • Training: Incorporate resistance exercise to enhance GLUT4 translocation, improve insulin sensitivity, and support bone density and muscularity.
  • Sleep and Stress: Stabilize cortisol rhythms to prevent glucose excursions; poor sleep drives hyperinsulinemia, visceral fat accumulation, and low-estradiol symptoms.
  • Pharmacology: When needed, I judiciously use metformin or GLP-1 receptor agonists and reassess hormone therapy to achieve synergistic improvements in glycemia, lipids, and inflammation.

The reasoning is physiologic: when estradiol supports mitochondrial efficiency and endothelial function, glucose disposal improves. Testosterone in individuals augments lean mass and metabolic rate, while progesterone aids sleep architecture and HPA-axis calibration—together stabilizing the metabolic network.

Men’s Estrogen: Stop Routine Aromatase Inhibition

Many men have been managed with routine aromatase inhibitors (AIs) to suppress estradiol derived from testosterone. The evidence and my practice indicate this is often counterproductive:

  • Estradiol mediates many of testosterone’s cardiovascular and neurocognitive benefits via local aromatization in the brain and endothelium.
  • Blocking estradiol can impair erectile function, increase visceral adiposity, and deteriorate mood and vascular health.
  • Reference ranges for estradiol in men are expected ranges, not strict “normals.” If testosterone is physiologically robust, estradiol will often be higher due to normal aromatase activity.

After discontinuing AIs in appropriately selected male patients, I observe restoration of erections, improved affect, and reductions in central adiposity. Unless there is a clear, individualized indication (e.g., symptomatic gynecomastia unresponsive to dose titration), routine estrogen blockade in men undermines cardiometabolic and neurovascular protection.

Breast Cancer: Estrogen Safety and Progestin Risk

A major barrier for women is the fear that estrogen causes breast cancer. Contemporary analyses show:

  • Estrogen-only therapy is associated with reduced breast cancer incidence and mortality in long-term follow-up of randomized trials.
  • The adverse signals clustered in regimens containing synthetic progestins, not in those containing bioidentical progesterone.
  • For selected breast cancer survivors, carefully individualized estrogen therapy does not uniformly increase recurrence or mortality; precision stratification and oncology collaboration are essential.

Clinically, I avoid progestins and prefer bioidentical progesterone, which synergizes with estradiol’s neuroprotective and immunoregulatory actions. I focus on metabolic indicators of prevention—inflammation, insulin resistance, adiposity, and nutrient signaling—rather than assigning “blame” to estrogen without context. Patients deserve informed, individualized care grounded in data, not outdated dogma.

Practical Protocol Principles: Individualization and Route Matters

Therapy must be individualized. My approach includes:

  • Choosing the right formulation: transdermal estradiol often reduces thrombotic risk compared with oral; micronized progesterone aligns better with receptor physiology than progestins.
  • Titrating the dose to symptoms and lab markers: prioritize clinical outcomes (sleep, cognition, mood, vasomotor control, bone turnover, lipids), not just lab targets.
  • Addressing gut-liver metabolism: support conjugation and elimination pathways (fiber, cruciferous vegetables, and balanced microbiome) to optimize estrogen processing and prevent enterohepatic dysregulation.
  • Maintain continuity and avoid abrupt discontinuation; taper when needed to prevent neurovegetative rebound and potential cardiovascular instability.

The overarching reasoning is simple: align therapy with physiology and patient goals, respect the interconnectedness of systems, and leverage bioidentical molecular fidelity to restore normal receptor signaling.

Clinical Observations from the Sciatica & Chronic Pain Clinic

From my work at the Sciatica & Chronic Pain Clinic in El Paso, I routinely see:

  • Women started on bioidentical estradiol with progesterone, demonstrating improved executive function, less central sensitization of pain, and more stable mood within weeks to months.
  • Men taken off routine AIs regaining sexual function, experiencing reduced visceral fat, and reporting enhanced mental clarity.
  • Postmenopausal patients with spine-related pain respond better to manual therapy, neuromuscular re-education, and graded loading once the hormonal milieu is optimized—pain processing is hormone-sensitive.
  • Patients who previously “failed” allopathic symptom-suppression protocols are finding traction when we recalibrate sleep, nutrition, training, and hormone signaling concurrently.

Continuous education—returning to training annually—ensures we revisit assumptions and hear the evidence in new ways, improving the quality of care year after year.

For more about my clinical approach:

  • Sciatica & Chronic Pain Clinic: https://sciatica.clinic/
  • Professional profile: https://www.linkedin.com/in/dralexjimenez/

Key Takeaways for Patients and Clinicians

  • Hormones act across every system; optimizing them is not just about hot flashes or libido.
  • Estradiol is broadly protective—brain, bone, and heart—with strong evidence against blanket fears of breast cancer when therapy is properly designed.
  • Avoid synthetic progestins; use bioidentical progesterone to preserve neuro- and immuno-benefits.
  • Start estradiol early where possible, but age alone should not preclude therapy; taper rather than abruptly discontinue.
  • In men, avoid routine aromatase inhibition; estradiol mediates many of testosterone’s benefits.
  • Prioritize individualized, evidence-based protocols that integrate lifestyle, sleep, stress, and targeted pharmacology.
Modulating Women Hormones Part 1 of 3 l El Paso, Tx (2021)

References

Metabolic Health Insights and Tips for Hormone Optimization

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-

Dive into the world of hormone optimization and metabolic health in a clinical approach for a healthier, balanced lifestyle.

Abstract Introduction

I am Dr. Alexander Jimenez, DC, FNP-APRN. In this educational post, I synthesize modern, evidence-based research on hormone optimization and metabolic health, integrate the latest findings from leading researchers, and translate them into practical, safe clinical strategies. I present this work through the lens of my daily observations and outcomes at Sciatica.clinic (https://sciatica.clinic/), where musculoskeletal pain syndromes, especially sciatica and chronic spine complaints, frequently intersect with hormonal decline, metabolic dysregulation, sleep disruption, and neuroimmune imbalance.

I begin with the physiology and clinical advances surrounding estradiol—its receptor biology across ERα and ERβ; its impacts on endothelial nitric oxide signaling, lipoprotein dynamics, neuroplasticity, bone remodeling, and immune modulation; and the nuanced, age- and timing-dependent risk-benefit profile that emerges when we distinguish bioidentical hormones from synthetic analogs. I discuss why transdermal 17β-estradiol often confers thrombotic and hepatic advantages compared with oral routes, and I clarify breast cancer risk by differentiating estrogen-alone contexts from combined regimens using synthetic progestins versus bioidentical micronized progesterone. I anchor these insights in contemporary randomized trials, large registries, Mendelian randomization studies, and meta-analyses, highlighting how guideline updates have shifted practice toward individualized, precision decisions.

Next, I elaborate on testosterone optimization for men and women, emphasizing anabolic integrity, mood, and motivational stability, insulin sensitivity, and body composition. I detail why weekly microdosing or transdermal routes can reduce peaks and troughs, thereby lowering the risk of erythrocytosis and dermatologic side effects, and explain why reflexive aromatase inhibition in men can undermine vascular, neurocognitive, and musculoskeletal benefits by suppressing estradiol, a critical co-regulator of male physiology.

I then present progesterone as a powerful neurosteroid—more than an endometrial safeguard—detailing its Modulation of ABA-A receptors, improvements in sleep architecture, anxiolytic effects, and a complementary role in bone remodeling and breast physiology when delivered as oral micronized progesterone. I share dosing strategies and troubleshooting steps for abnormal bleeding, sedation, and breast tenderness.

I devote sections to gut–hormone crosstalk—the estrobolome’s β-glucuronidase role in enterohepatic recycling of estrogens, bile acid signaling through FXR and TGR5, and the impact of lipopolysaccharide (LPS) on systemic inflammation and receptor responsiveness. I map clinical tools across nutrition, fiber, polyphenols, probiotics, and hepatobiliary support to optimize hormone signaling via the gut-liver axis. From there, I expand into nutrient co-factors—magnesium, vitamin D, iodine balance, omega-3 PUFAs, and polyphenols—describing their receptor-level modulations and practical roles in therapy.

Throughout, I explain why route and modality matter—transdermal versus oral estradiol, oral micronized progesterone versus synthetic progestins, intramuscular versus transdermal testosterone, and the constraints and considerations of pellets. I lay out algorithms for managing side effects—breast tenderness, abnormal bleeding, mood lability, edema, acne, and erythrocytosis—so clinicians and patients can respond rationally and promptly. I anchor the entire framework in integrated rehabilitation for sciatica: graded exposure, core stabilization, hip hinge retraining, neuromuscular re-education, and anti-inflammatory nutrition—amplified by restored sleep and hormonal balance.

This post is designed to be comprehensive, physiologically rigorous, and clinically implementable. It offers step-by-step protocols, safety screens, dose-titration guidance, monitoring intervals, and deprescribing criteria, and it standardizes how risk is communicated through shared decision-making. My goal is to position hormonal optimization as a precise instrument within a systems biology map—improving endothelial resilience, neurocognitive clarity, bone integrity, connective tissue repair, pain modulation, and functional capacity—so patients can not only add years to life but life to years.

Evidence-Based Estrogen Optimization — Physiology, Timing, and Disease Prevention

In my clinical practice of sciatica. clinic, I frequently meet midlife patients whose worsening sleep, mood variability, joint pain, and cardiometabolic drift coincide with declining estradiol. Reframing estrogen as a system-wide signal—rather than a narrow hot-flash remedy—changes outcomes. When properly selected and delivered, particularly as transdermal 17β-estradiol, estrogen can be disease-modifying for vascular, skeletal, neurocognitive, and pain domains.

The Biology Behind Estradiol’s Systemic Reach

  • Estradiol acts via ERα and ERβ, membrane-associated estrogen receptors, and GPER, initiating genomic and non-genomic cascades that modify tissue function.
  • In the vasculature, estradiol enhances endothelial nitric oxide synthase (eNOS), increasing nitric oxide (NO) bioavailability, improving vasodilation, and diminishing oxidative stress. It downregulates NF-κB and adhesion molecules (VCAM-1, ICAM-1), reducing leukocyte infiltration and endothelial injury.
  • In lipid physiology, estradiol tends to raise HDL, reduce LDL particle oxidation, and influence hepatic receptor expression that supports cholesterol efflux (ABCA1) and LDL clearance.
  • In the CNS, estradiol augments BDNF, dendritic spine density, and synaptic proteins. It modulates glia—shifting microglia toward a reparative phenotype, dampening pro-inflammatory cytokines (IL-1β, TNF-α), and supporting mitochondrial bioenergetics.
  • In bone, estradiol restrains RANKL signaling, upregulates osteoprotegerin (OPG), curtails osteoclastogenesis, and supports osteoblast differentiation—preserving trabecular microarchitecture and cortical integrity.

The Timing Hypothesis and Why Route Matters

Initiating estradiol near menopause—often within a decade of the last menstrual period—aligns with intact endothelial responsiveness and unremodeled plaques, improving carotid intima-media thickness (CIMT) trajectories and slowing coronary artery calcification progression. Transdermal delivery bypasses hepatic first-pass effects, attenuating increases in coagulation factors, CRP, and triglycerides, thereby lowering the risk of venous thromboembolism (VTE) and favoring metabolic neutrality. Oral routes can be appropriate in select phenotypes but require vigilant monitoring of triglycerides and prothrombotic signals.

Breast Cancer Risk: A Crucial Distinction

The most consistent risk signal in breast cancer literature is not estradiol itself; it is certain synthetic progestins when combined with estrogen. In women post-hysterectomy, estrogen-alone therapy is associated with neutral or reduced breast cancer incidence in several analyses. For women with a uterus, pairing estradiol with bioidentical micronized progesterone appears to carry a more favorable risk profile than combinations using synthetic progestins. The difference reflects progesterone receptor crosstalk, local tissue proliferation cues, and inflammatory tone, all of which vary with the choice of molecule and patient phenotype.

Clinical Observations in Musculoskeletal Care

In sciatica, hormonal optimization is often the missing keystone. Estradiol shifts descending inhibitory pain pathways, stabilizes glial activation, improves sleep, and reduces joint discomfort. Patients tolerate graded loading, core stabilization, and hip-hinge training with fewer flare-ups when vasomotor symptoms are quiet, sleep architecture normalizes, and central sensitization decreases

Practical Protocol for Estradiol Optimization

  • Screen: personal/family history of VTE, stroke, hormone-sensitive cancers, migraines with aura, NAFLD, metabolic syndrome.
  • Labs: TSH, free T4, 25(OH)D, lipids, HbA1c, fasting insulin, CMP; FSH and estradiol as context, not absolute gatekeepers.
  • Start: low-dose transdermal estradiol; add oral micronized progesterone nightly for women with an intact uterus (endometrial protection plus GABA-A-mediated sleep benefits).
  • Reassess: at 8–12 weeks, titrate to symptom remission and functional targets; document shared decision-making, risks, and alternatives.

Testosterone Optimization — Anabolic Integrity, Mood, and Cardiometabolic Balance

Testosterone operates as a cornerstone of skeletal muscle protein synthesis, mitochondrial biogenesis, libido, motivation, and mood stability in men and women. Deficiency correlates with sarcopenia, visceral adiposity, insulin resistance, and reduced exercise tolerance. Delivered judiciously, testosterone restores anabolic capacity and supports metabolic resilience.

Mechanisms of Testosterone’s Effects

  • Via androgen receptors (ARs), testosterone modulates gene expression, regulating myogenesis, glycogen storage, mitochondrial density, and neuromuscular drive.
  • Testosterone increases GLUT4 translocation in skeletal muscle, improving glucose disposal and insulin sensitivity.
  • It enhances motor unit recruitment, stabilizes tendon-ligament interfaces, and supports connective tissue integrity—crucial in lumbar stabilization and radicular pain patterns.

Routes and Pharmacokinetics

  • Intramuscular injections (e.g., cypionate, enanthate): Peaks and troughs can perturb mood and increase the risk of erythrocytosis; weekly microdosing or twice-weekly lower-dose schedules smooth kinetics.
  • Transdermal gels/creams: Provide steadier exposure; adherence and variability in skin absorption must be addressed with education and monitoring.
  • Pellets: Offer convenience; however, they limit rapid titration and complicate adverse event management in the setting of erythrocytosis or acne.

Clinical Decision Matrix and Monitoring

  • Assess: symptoms; total/free testosterone, SHBG, LH/FSH, estradiol, hematocrit, PSA (men), lipids, A1c, hs-CRP, liver enzymes.
  • Targets: free testosterone in mid-normal ranges for men; physiologic microdoses for women; maximize functional outcomes without exceeding androgenic thresholds.
  • Pair with resistance training and protein optimization—meeting the leucine threshold (~2–3 g per meal) to maximize muscle protein synthesis and metabolic ROI.

Managing Common Complications

  • Erythrocytosis: Baseline, 3-month, and semiannual hematocrit monitoring; if >54%, reduce dose, lengthen interval, evaluate sleep apnea, ensure hydration; consider therapeutic phlebotomy if clinically appropriate.
  • Aromatization: In men prone to elevated estradiol, prioritize dose adjustments and body composition improvements over reflexive aromatase inhibitors, which risk bone pain and reduced neurovascular benefits.
  • Prostate: Monitor PSA and perform DRE per guidelines; current evidence does not support testosterone as a cause of prostate cancer initiation; vigilance remains prudent.

Observations from sciatica.clinic

When fatigue lifts and mood stabilizes with physiologic testosterone levels, adherence to rehab improves. Gains in muscle cross-sectional area, motor control, and core endurance translate into better hip mechanics and reduced neural tension across the lumbosacral axis.

Progesterone — Neurocalm, Sleep Architecture, and Endometrial Protection

Progesterone is a neurosteroid with meaningful effects beyond endometrial protection. Oral micronized progesterone modulates GABA-A receptors, improving sleep onset, slow-wave sleep, and anxiety, while supporting osteoblast function and potentially favoring breast tissue differentiation compared with many synthetic progestins.

Clinical Use and Dosing

  • For women on estradiol with a uterus: 100–200 mg oral micronized progesterone at night, tailored to bleeding patterns and sleep responses.
  • Strategies: Cyclic versus continuous regimens depending on preference, migraine history, and breast tenderness.
  • Troubleshooting: In cases of progesterone intolerance(sedation, mood shifts), consider reduced dosing, cyclic schedules, or alternative delivery modalities.

Pain Modulation and Sleep

Progesterone’s enhancement of slow-wave sleep stabilizes descending pain inhibition and reduces hypervigilant arousal states. In chronic sciatica, this effect reduces central amplification and facilitates tissue healing by improving nocturnal recovery.

Gut–Hormone Crosstalk — Estrobolome, Bile Acids, and Inflammatory Setpoints

The gut microbiome dynamically modulates estrogen metabolism and receptor responsiveness. The estrobolome—microbial genes with β-glucuronidase activity—controls enterohepatic recycling of estrogens, thereby influencing symptom patterns and systemic exposure.

Estrobolome Dynamics

  • Elevated β-glucuronidase increases reabsorbed free estrogen, potentially driving mastalgia, PMS-like symptoms, and irregular bleeding.
  • Low β-glucuronidase activity may reduce circulating estrogen metabolites, worsening vasomotor instability.

Bile Acid Signaling

  • FXR and TGR5 mediate bile acid impacts on glucose homeostasis, lipid metabolism, and inflammatory tone.
  • Oral estrogens skew bile acid pools via hepatic stimulation; transdermal estradiol reduces hepatic burden and may be wiser in NAFLD or cholestatic tendencies.

LPS and Systemic Inflammation

LPS elevates inflammatory signaling that blunts hormone receptor function. Diets rich in whole foods, fiber, and polyphenols, coupled with targeted probiotics, sleep optimization, and stress modulation, reduce LPS load and restore hormonal responsiveness.

Practical Tools

  • Nutrition: Dietary fiber, cruciferous vegetables (I3C/DIM), polyphenols (green tea catechins, resveratrol, quercetin).
  • Probiotics: Lactobacillus and Bifidobacterium strains to reshape estrogen metabolism and strengthen gut barrier function.
  • Hepatobiliary support: taurine, glycine, phosphatidylcholine to assist bile flow; omega-3 PUFAs and berberine to improve lipid and inflammatory profiles.

Nutrient Modulators of Hormone Receptor Activity — Magnesium, Vitamin D, Iodine Balance, Omega-3, Polyphenols

Hormone therapies achieve their best outcomes in a well-tuned receptor microenvironment. Key nutrients and cofactors modulate the robustness of intracellular signaling and the inflammatory balance.

  • Magnesium: Supports ATP-dependent receptor signaling and buffers NMDA excitability; evening magnesium glycinate or taurate aids relaxation and cardiac stability.
  • Vitamin D: Influences steroidogenic enzymes, immune resilience, and bone; target 25(OH)D ~40–60 ng/mL, individualized by comorbidity and sun exposure.
  • Iodine balance: Excess can destabilize thyroid autoimmunity; aim for diet-first adequacy and cautious supplementation with regular thyroid surveillance.
  • Omega-3 PUFA: Rebalance eicosanoids, lower CRP, improve endothelial function, and reduce edema linked to aromatase-driven inflammation.
  • Polyphenols: Engage SIRT and AMPK pathways, supporting metabolic flexibility and balanced estrogen metabolism.

Selecting and Individualizing Hormone Modalities — Transdermal, Oral, Injection, Pellet

Delivery route shapes hepatic load, thrombotic risk, pharmacokinetic stability, and the ease of titration.

  • Transdermal Estradiol: Preferred in VTE, migraine-prone, hypertriglyceridemia, and NAFLD; patches for stability, gels/sprays for flexibility.
  • Oral Micronized Progesterone: Neurosteroid benefits and reliable endometrial protection; favorable breast tissue signals compared to many progestins.
  • Testosterone Injections: Weekly micro-dosing reduces kinetic volatility; monitor erythrocytosis and estradiol.
  • Transdermal Testosterone: Lower erythrocytosis risk, steady-state exposure; adherence and dermal absorption education required.
  • Pellets: Convenience with limited titration; counsel patients about removal challenges if side effects emerge.

Managing Side Effects and Complications — Algorithms and Clinical Reasoning

Adverse effects are feedback signals. Rational algorithms help refine dosing, route, and adjuncts.

  • Breast Tenderness: Reassess estradiol dose and progesterone balance; optimize estrobolome via fiber and polyphenols; evaluate thyroid status.
  • Abnormal Bleeding: Rule out structural causes; adjust hormones; consider cyclic progesterone; evaluate iron and endometrial thickness.
  • Mood Lability: Stabilize dosing intervals; add magnesium; align sleep hygiene; correct gut dysbiosis/inflammation.
  • Edema/Weight Fluctuations: Lower dose; increase omega-3 intake; check sodium and cortisol circadian rhythm; encourage lymphatic mobilization through movement.
  • Testosterone-Related Acne/Hair: Titrate down; improve insulin sensitivity; provide topical dermatologic support; consider targeted anti-androgen topicals for women while maintaining physiologic levels.
  • Erythrocytosis: Dose reduction or interval extension; screen for sleep apnea; ensure hydration; therapeutic phlebotomy as needed with appropriate indications.

Finding Hormonal Harmony- Video

"Finding Hormonal Harmony: Restoring Balance to the HPA Axis" | El Paso, Tx (2023)

Hormones and Musculoskeletal Pain — Integrating with Sciatica Rehabilitation

At Sciatica. clinic, we intersect hormonal optimization with structured rehabilitation for sciatica and chronic spine pain.

  • Estradiol supports collagen turnover, tendon healing, and anti-nociceptive
  • Testosterone boosts motor unit recruitment and an anti-catabolic state to improve load-bearing capacity.
  • Progesterone stabilizes sleep-dependent pain inhibition and calms central arousal.

Integrated Plan

  • Hormonal optimization with safety-first titration.
  • Anti-inflammatory nutrition (Mediterranean patterns, glycemic stability).
  • Progressive loading tailored to nerve root irritability.
  • Neuromuscular re-education: breathing mechanics, pelvic control, gluteal activation, hip hinge retraining.
  • Sleep restoration: progesterone timing, magnesium support, light hygiene, consistent sleep-wake cycles.

Revisiting Legacy Trials and Modern Guidance — Contextualizing Risk and Benefit

The Women’s Health Initiative (WHI) produced headlines that conflated oral conjugated equine estrogens (CEE) and medroxyprogesterone acetate (MPA) with all hormone therapy. Subsequent analyses clarified:

  • The CEE-only arm showed neutral or favorable outcomes for breast cancer incidence in some analyses and lowered all-cause mortality in certain age-stratified cohorts.
  • Timing is pivotal; initiation near menopause leverages intact endothelial and neurocognitive responsiveness.
  • North American Menopause Society (NAMS) and professional guidelines now emphasize individualized therapy and reject routine discontinuation at arbitrary ages.

Neuroprotection and Cognitive Health — Estrogen’s Role in the Aging Brain

Estradiol supports neuroprotection via:

  • Reduction in beta-amyloid accumulation; modulation of tau
  • Upregulation of synaptic proteins and mitochondrial biogenesis; reduced reactive oxygen species.
  • Microglial phenotypic shift from pro-inflammatory to reparative; improved neurovascular coupling.

Clinically, women 2–5 years post-menopause often present with brain fog, sleep disruption, and stress intolerance. Thoughtful estradiol plus progesterone, alongside exercise and Mediterranean nutrition, frequently improves memory, sleep architecture, and executive function.

Stroke Resilience and Vascular Health — Beyond Risk, Toward Repair

Estradiol improves endothelial function, reduces oxidative stress, and stabilizes vascular smooth muscle tone. Mechanistic and translational studies suggest estradiol reduces infarct size and recruits pro-survival pathways. While not standard acute therapy, maintaining physiologic estradiol signaling in appropriate patients may lower first-event risk and improve recovery trajectories.

Immune Modulation and Infection Outcomes — Estradiol’s Coordinating Role

Estradiol shapes T cell function, macrophage polarization, cytokine balance, and antiviral responses. Observational data during recent pandemics indicated lower mortality among postmenopausal women on estrogen therapy, consistent with estradiol’s tempering of hyperinflammation and support for adaptive responses. Clinical practice integrates hormone therapy with micronutrients (vitamin D, omega-3, magnesium) and sleep to stabilize immune oscillations.

Bone Remodeling and Osteoimmunology — Synergy with Androgens and Progesterone

Bone is mechanosensitive and immune-active. Estradiol decreases RANKL, increases OPG, and supports osteoblast differentiation, while androgens and progesterone contribute to osteoanabolic balance. Resistance training and adequate protein intake amplify these signals. Therapy less than five years may not confer durable protection after cessation; individualized, long-range plans often outperform arbitrary stop dates.

Metabolic Health — Insulin Signaling, Lipids, and Visceral Adiposity

Estradiol enhances GLUT4 signaling, improves lipid profiles, reduces visceral adiposity, and supports hepatic lipid handling. Transdermal routes minimize hepatic stimulation of triglyceride and clotting factor synthesis, making them preferable in metabolic syndrome or NAFLD phenotypes. When combined with nutrition-first strategies, hormones enhance lifestyle benefits, often reducing the need for polypharmacy.

Chronic Pain and Central Sensitization — Hormone Insufficiency as an Amplifier

Hormonal insufficiency overlaps with hyperalgesic neural states. Estradiol modulates nociceptor sensitivity, glial activation, and collagen turnover. Integrating hormone therapy with movement retraining and sleep restoration reduces central amplification and strengthens resilience against flare-ups.

Sexual Health and Urogenital Integrity — Estradiol’s Mucosal and Vascular Support

Estradiol maintains vaginal epithelium, urinary tract integrity, and pelvic floor synergy. Localized vaginal estrogen addresses genitourinary syndrome of menopause (GSM); systemic estradiol supports libido and erectile function via dopaminergic and NO signaling. Balance is essential—both low and high extremes disrupt sexual health.

The Estrobolome and Detoxification Pathways — Clinical Levers in Everyday Practice

The liver conjugates estrogens; gut microbes deconjugate via β-glucuronidase, altering reabsorption. Nutritional strategies that increase fiber intake, enhance phase II conjugation, and rebalance gut flora are practical levers for optimizing estrogen homeostasis. Attention to methylation capacity (folate, B12, B6) and hepatic health ensures safe and effective estrogen dynamics.

Myths, Misconceptions, and Data Clarity — Cleaning the Lens

  • Myth: “Estrogen causes breast cancer.”
  • Clarification: Estrogen-alone therapy post-hysterectomy reveals neutral or reduced risk in several analyses. Risk signals have been observed with certain synthetic progestins. Individualize and screen.
  • Myth: “Stop hormones at age 65.”
  • Clarification: Contemporary guidelines recommend individualized continuation; many patients preserve bone, cognition, and quality of life past 65.
  • Myth: “Progesterone equals progestins.”
  • Clarification: Bioidentical progesterone differs fundamentally from synthetic progestins in neurovascular and immune effects.
  • Myth: “Estradiol is only for hot flashes.”
  • Clarification: Estradiol affects the brain, vasculature, bone, immune, metabolic, and urogenital systems.

Practical Framework — Assessment, Molecule Selection, Dosing, Monitoring, Integration

  1. Assessment
  • History: vasomotor symptoms, sleep, mood, cognitive changes, pain, sexual health; family history of breast/ovarian cancer, VTE, dementia; migraines with aura; metabolic syndrome; liver disease; autoimmune signals.
  • Labs: estradiol, progesterone, testosterone (total/free), SHBG, lipid panel, A1c, fasting insulin, hs-CRP, Lp(a) (select cases), vitamin D, thyroid panel, ferritin, homocysteine, and APOE genotype in select precision contexts.
  • Imaging: DEXA baseline; consider coronary calcium scoring and carotid IMT in specific cardiometabolic risk profiles.
  • Molecule and Route
  • Estradiol: favor transdermal 17β-estradiol for thrombotic/metabolic advantages.
  • Progesterone: oral micronized at night for endometrial protection and sleep.
  • Testosterone: physiologic dosing in women; mid-normal free testosterone in men; avoid routine aromatase inhibitors.
  • Dosing Philosophy
  • Start low; titrate to symptom relief and functional targets; avoid supraphysiologic peaks.
  • Monitoring
  • Clinical outcomes: sleep quality, cognition, mood, sexual health, pain, exercise tolerance.
  • Safety: blood pressure, lipids, A1c, liver enzymes, hemoglobin/hematocrit (if androgens), breast/gynecologic screening cadence.
  • Integration with Lifestyle
  • Nutrition: whole-food patterns, adequate protein, fiber, polyphenols; reduce alcohol and refined sugars.
  • Exercise: aerobic conditioning, resistance training, and impact loading for bone.
  • Sleep: circadian regularity, light hygiene, caffeine moderation; progesterone support as needed.
  • Stress: autonomic balance, mindfulness, and graded exposure for pain.

Why These Techniques Work — Physiological Rationale and Clinical Logic

  • Transdermal estradiol minimizes hepatic induction of clotting factors and triglycerides, lowering VTE risk and improving metabolic neutrality.
  • Micronized progesterone engages GABA-A receptors, enhancing sleep architecture and indirectly supporting glymphatic clearance and daytime cognition.
  • Early initiation in menopause capitalizes on endothelial plasticity and hippocampal responsiveness—maximizing neurovascular benefit.
  • Resistance training synergizes with estradiol and androgens via mechanotransduction, stimulating osteoblasts and collagen synthesis while hormones restrain catabolic signaling.
  • Gut strategies reduce excess β-glucuronidase and LPS load, optimizing estrogen homeostasis and receptor function.

Case Patterns from Sciatica Clinic — Translating Physiology to Outcomes

  • Pattern: Postmenopausal cognitive drift, night sweats, elevated LDL
  • Plan: Transdermal estradiol 50–75 mcg/day + oral micronized progesterone 100–200 mg qHS; Mediterranean diet; magnesium glycinate at night; progressive resistance training.
  • Outcome: Better sleep within 2 weeks; improved recall, executive function, LDL reduction, and CRP downtrend by 3 months.
  • Pattern: Osteopenia, vertebral height loss, joint pain
  • Plan: Estradiol + progesterone; supervised resistance training; vitamin D repletion; protein adequacy; consider low-dose androgens if indicated.
  • Outcome: DEXA improvement at 12–18 months; reduced pain and improved mobility.
  • Pattern: Chronic low back pain with central sensitization
  • Plan: Hormone optimization; sleep stabilization; anti-inflammatory nutrition; graded exposure; nerve mobility and movement retraining.
  • Outcome: Lower pain intensity, greater resilience, fewer flare-ups, reduced reliance on analgesics.

Safety and Shared Decision-Making — Patient-Centered Hormone Plans

  • VTE history: prefer transdermal; evaluate thrombophilia; weigh absolute/relative risk.
  • Migraines with aura: stabilize hormone levels via transdermal routes; monitor closely.
  • Breast cancer risk: individualize with oncology collaboration; consider local therapies for GSM; maintain screening cadence.
  • Liver disease: Use transdermal routes to reduce hepatic burden.
  • Monitoring cadence: reassess at 6–12 weeks; follow-ups every 6–12 months with labs and symptom review.

Transparent conversations about benefits, uncertainties, and alternatives empower patients to make informed choices that align with goals and values.

Testosterone in Women — Physiology, Evidence, and Ethical Practice

Although there are no FDA-approved testosterone products for women in the United States, physiology supports the role of androgens in sexual desire, arousal, musculoskeletal strength, bone health, mood, and motivation. In carefully selected women with documented deficiency and corresponding symptoms, low-dose transdermal testosterone may be considered off-label with rigorous monitoring for androgenic side effects, lipids, liver enzymes, and hematologic parameters. When estradiol is optimized, physiologic androgen support can further improve bone density, mood, and pain tolerance.

Nutrition Foundations — Teaching Metabolic Stability

We emphasize nutrition-first strategies alongside hormone therapy:

  • Reduce ultraprocessed foods, added sugars, and pro-inflammatory fats that sensitize nociceptors and disrupt insulin signaling.
  • Build glucose-stable meals with adequate protein, fiber, and polyphenols.
  • Consider time-restricted eating or circadian-aligned meal timing where appropriate.
  • Prioritize sleep, as it synchronizes hormonal rhythms, glymphatic clearance, and pain modulation.

Hormones then act as a biological “permission slip,” enabling tissues to respond to these salutary inputs with maximal effect.

Implementation Pathway — From Evaluation to Maintenance

  • Pre-therapy counseling: Clarify goals (cognition, bone, vasomotor, sexual health, pain), screen risks, and co-create a monitoring plan.
  • Initiation: Favor transdermal estradiol with oral micronized progesterone (if uterus present); add localized vaginal estrogen for GSM as needed.
  • Reassessment: 6–12 weeks—evaluate sleep, cognition, vasomotor status, mood, sexual function, pain; labs as indicated.
  • Adjustment: Titrate doses; refine nutrition and training plans; support gut-liver axis.
  • Long-term: Annual or semiannual follow-ups; DEXA per guidelines; maintain breast/gynecologic screening; revisit goals.

Research Landscape — Frontiers of Precision Endocrinology

  • Development of ERβ-selective modulators for neuroprotection.
  • Combination strategies targeting mitochondria, microglia, and synaptic plasticity.
  • Precision medicine incorporating APOE, Lp(a), and microbiome profiling to tailor therapy.
  • Long-term trials with bioidentical estradiol and micronized progesterone assessing dementia, fracture, and mortality endpoints.

Clinicians must remain adaptable, integrating emergent evidence with patient-centered care.

Summary

This educational post integrates hormone physiology with practical clinical workflows. We established that:

  • Estradiol—particularly transdermal 17β-estradiol—delivers vascular, neurocognitive, and bone benefits when initiated near menopause and individualized for risk. Micronized progesterone complements endometrial protection and sleep architecture.
  • Testosterone supports anabolic integrity and mood across sexes; dosing and route selection should minimize erythrocytosis and androgenic side effects, and avoid routine use of aromatase inhibitors in men to preserve estradiol’s neurovascular contributions.
  • Gut–hormone crosstalk via the estrobolome, bile acids, and LPS shapes receptor responsiveness and inflammatory set points; nutrition and probiotics translate into real improvements in hormonal outcomes.
  • Nutrient co-factors—magnesium, vitamin D, omega-3s, polyphenols—modulate receptor signaling and reduce inflammatory tone.
  • Modality matters: transdermal estradiol lowers hepatic and thrombotic load; pellets trade convenience for titration limits.
  • Side effects are feedback loops to be algorithmically addressed.
  • In sciatica, harmonizing hormones materially improves pain inhibition, sleep, and rehab tolerability; integrated plans yield durable outcomes.

Clinicians should employ shared decision-making, precise monitoring, and multimodal rehab to realize comprehensive improvements in function and quality of life.

Conclusion

Modern hormone optimization is the physiological scaffolding that supports recovery across cardiovascular, neurocognitive, skeletal, and musculoskeletal domains. When integrated with nutrition, sleep, and gut health strategies, along with targeted rehabilitation, it becomes a catalyst for reversing chronic disease trajectories and restoring function. The key is personalization: selecting molecules and routes aligned with phenotypes, judiciously dosing, rigorously monitoring, and adjusting within a systems-biology framework. Patients benefit most when care is transparent, evidence-based, and centered on their goals.

Key Insights

  • Timing and route of administration are decisive for estradiol’s risk-benefit profile; transdermal routes minimize hepatic and thrombotic concerns.
  • Micronized progesterone offers neurosteroid advantages and endometrial protection with favorable safety signals compared to many synthetic progestins.
  • Testosterone requires careful dosing and monitoring to balance anabolic gains against hematologic and dermatologic risks; avoid routine estradiol blockade in men.
  • The gut microbiome modulates estrogen metabolism; addressing dysbiosis amplifies therapeutic success.
  • Nutrients and lifestyle align receptor responsiveness and reduce inflammation, potentiating hormone therapy outcomes.
  • Multimodal integration—hormones plus rehabilitation—improves sciatica outcomes by enhancing pain modulation, tissue repair, and muscular control.

References

  • North American Menopause Society (NAMS) Position Statements on Menopausal Hormone Therapy and Individualized Care.
  • Women’s Health Initiative (WHI) main and follow-up analyses: CEE-only vs CEE+MPA arms; age-stratified and timing analyses.
  • Canonico M, et al. Venous thromboembolism risk with transdermal versus oral estrogen.
  • Brinton RD, Yao J, et al. Estrogen regulation of mitochondrial bioenergetics and neuroprotection.
  • Hammes SR, Levin ER. Extranuclear estrogen receptors and rapid signaling.
  • Maki PM, Henderson VW. Hormone therapy, dementia, and cognition—contextualizing WHI after 20 years.
  • Lobo RA, et al. Cardiometabolic effects of menopausal hormone therapy by route and regimen.
  • Arévalo MA, et al. ERβ-mediated mechanisms in neuroprotection.
  • Clarke BL, et al. Estrogen in bone remodeling and osteoimmunology: synergy with androgens.
  • Resnick SM, et al. Imaging studies of amyloid in menopausal transition.
  • Clinical observations and integrated protocols from Sciatica. clinic (https://sciatica.clinic/), aligned with contemporary best evidence.

Keywords

Estradiol optimization, Transdermal estrogen, ERα, ERβ, Micronized progesterone, Synthetic progestins, Testosterone therapy, Erythrocytosis, Aromatase inhibition, Estrobolome, Bile acids, LPS inflammation, Magnesium, Vitamin D, Omega-3, Polyphenols, Menopause timing hypothesis, Sciatica rehabilitation, Endothelial nitric oxide, BDNF, RANKL, NF-κB, Shared decision-making, Evidence-based hormone therapy.

Disclaimer: This is educational content and is not medical advice. Do not start, stop, or change any medication or therapy based on this material.

Disclaimer: Every individual’s medical situation is unique. All readers must seek personalized recommendations, diagnosis, and treatment from their own licensed healthcare providers.

1234...155Page 3 of 155
Sciatica Specialist
STOP SUFFERING! We specialize in advanced non-surgical approaches in treating sciatica. Our focus is to stop the pain, remove the cause and prevent chronic recurrence of complex sciatica pain syndromes. We treat with advanced protocols and supportive care plans. Blessings - Dr. Alex Jimenez DC, MSACP, IFMCP, CIFM, ATN
Contact us: [email protected]
Facebook Instagram Linkedin Pinterest Twitter Youtube

POPULAR POSTS

POPULAR CATEGORY

© Website Design: El Paso Sciatica Specialist®
Tel: 915-412-6677
Email: [email protected]